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Abstract 
 
This thesis details investigations and the optimisation of N-arylation reactions using precious-
metal-free conditions. It is an important motif in several pharmaceutical and agrochemical 
molecules.  In 1965 Bock  et al described the use of concentrated sulfuric acid and acetic acid 
as the solvent in a modified version of the Hofmann-Lӧffler-Freytag to carry out direct 
amination of aromatics via N-haloamines.1  
The first section looks at the UV irradiation chemistry where we utilised N-halo species which 
under photolytic conditions form the aminium radicals. Several examples of 
tetrahydroquinolines being synthesised in flow have been carried out.  
Investigations into amination of electron-deficient heterocycles such as pyridines were also 
investigated. Unfortunately, no N-arylation was observed under the various conditions trialled. 
Similar investigations have been carried out into the photolysis of N-chloroamides with varying 
degrees of chain length and position of the amide. Under neutral conditions in the presence of 
a Lewis acid some success in N-arylation reactions has been observed.  
In the second section the use of iron(II) salts has been investigated towards the N-arylation 
reaction via the aminium radial generated from the N-halo species. A variety of substrates 
containing electron-poor and electron-rich aromatic rings have been synthesised under these 
conditions. 
This methodology has been expanded to include an iron salt variant of the work with examples 
of intramolecular and intermolecular direct N-arylation described. Using our methodology 
some simple aromatics and the drug naproxen have now been aminated successfully. The use 
of hydroxylamines as alternative precursors to the aminium radical has also been investigated 
with some success in the synthesis of various substrates. 
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Chapter 1 Introduction 
 
1.1 Importance of Aryl C-N Bond Formation in the Pharmaceutical Industry 
 
Within the pharmaceutical industry there are many examples of drug molecules which contain 
an aryl C-N bond. A few examples of important drug molecules that contain this motif are 
shown in Figure 1.1. This makes research into the different ways this bond can be formed vital.2 
 
 
Figure 1.1  
 
A study carried out in 2011 by Roughly and Jordan et al showed that N-arylation reactions 
made up 6.3% of the total reactions carried out by medicinal chemists in AstraZeneca, Pfizer 
and GlaxoSmithKline over the course of a year. The most common ways of carrying out this 
transformation were SNAr and Pd catalysed Buchwald-Hartwig cross coupling reactions.3 A 
similar review was also carried out by Carey, Williams and Laffan et al in 2006 who showed 
that in process chemistry 19% of the total  reactions carried out were heteroaromatic alkylations 
and arylations, of which N-substitution made up 57%. N-arylation reactions made up 17% of 
these reactions with more examples of this being carried out due to the development of 
Buchwald and Hartwig’s N-arylation methodology.4 
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1.2 Methods of C-N bond formation 
 
There are different methods that can be undertaken to form an aryl C-N bond one of the 
traditional methods is nitration to install the nitro group then reduction of the nitro to afford the 
amine. This can then be alkylated as desired. Another method of C-N aryl bond formation is 
SNAr although this has limitations as it requires electron-withdrawing groups in the ortho or 
para positions and a fluorine as a leaving group for the substitution, More modern methods 
involve the use of precious metals such as palladium complexes, require prefunctionalised 
aromatic rings such as a halogen and boronic acids. A more desirable method would be direct 
amination of the aromatic ring and developments in this area will be the focus of this 
discussion. 
 
 
Figure 1.2 
 
This chapter will contain a brief review that will look into the different reactions that have been 
used traditionally for such bond formations, focusing firstly on the formation of the aryl C-N 
bond by several different methods including a closer look into the applications of N-centred 
radicals in this area. 
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1.3 Transition Metal Catalysed Aryl C-N Bond Formation 
 
There are many examples of metals being used as catalysts and initiators in the formation of 
aryl C-N bonds; this section will look at the different metals involved. 
 
1.3.1 Ullmann Coupling  
 
In 1901, Ullmann et al. first reported the coupling between 2 equivalents of aryl halide 4 using 
finely powdered copper which afforded a symmetrical biaryl 5 (Scheme 1.1).5 This reaction is 
formally known as the Ullmann coupling. 
 
 
Scheme 1.1  
 
Modifications to this methodology in subsequent years by Ullmann, expanded the scope of the 
reaction to allow copper to couple aryl halides to different oxygen, carbon and nitrogen 
nucleophiles (Scheme 1.2).6,7 
  
 
Scheme 1.2  
 
The Ullmann coupling reaction requires harsh conditions with high temperatures and 
stoichiometric amounts of copper being used. In 1906 Goldberg demonstrated amide 
nucleophiles could be used, and later in the same year went on to show the first catalytic version 
of the reaction (Scheme 1.3).8 
 
 
Scheme 1.3  
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The mechanism of the reaction has been widely disputed as it has been proposed to proceed 
through non-radical and radical pathways.9 A proposed catalytic mechanism for amination of 
aryl halides is shown in Scheme 1.4. It involves the copper halide species 12 which reacts with 
the nucleophile and base to yield the copper-nucleophile species 14. Oxidative addition of the 
aryl halide generates the copper species 16. Reductive elimination affords the desired aryl 
compound 17 and regeneration of the catalyst.10 
 
 
Scheme 1.4  
 
Modifications to the Ullmann reaction introduced by Buchwald et al. have shown that aryl 
halides (iodide is required in most cases) can be coupled to amines using catalytic copper(I) 
salts at lower temperatures than previously used (Scheme 1.5).11 
 
 
Scheme 1.5  
 
Recent developments by Ma et al have shown the use of aryl chlorides and lower temperature 
reactions to carry out transformation (Scheme 1.6).12 The synthesis of a new ligand allowed 
these changes in conditions to be achieved. They observed that more electron-rich anilides and 
bulkier ligands gave the best yields. This has been shown to work on electron-rich as well as 
electron-poor aromatic rings and on heterocycles such as pyridine. 
9 
 
 
Scheme 1.6 
 
1.3.2 Buchwald-Hartwig Cross Coupling Reaction 
 
In 1983 Migita et al. showed the first Pd-catalysed formation of aryl C-N bonds using 
aminostannanes and palladium catalysts.13 This methodology was investigated further by 
Buchwald and Hartwig in the 1990s (Scheme 1.7).14,15 These reactions however did have some 
issues due to the instability of some of the aminostannanes, thereby reducing the scope of the 
reaction. Some of the instability issues observed could be overcome by forming the 
aminostannane in situ.16 
 
 
Scheme 1.7  
 
Later both Buchwald and Hartwig went on to show that with the addition of an appropriate 
base and ligands, amines could be used directly and aminostannanes were not required, 
therefore relieving any issues of instability. The use of a strong base in these reactions allows 
for the formation of the aromatic amines from the corresponding halides and amines with it 
now being one of the most commonly used N-arylation reactions. There are many examples of 
these throughout the literature (Scheme 1.8).17 
 
 
Scheme 1.8  
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The proposed mechanism of the reaction is shown in Scheme 1.9. The first step is the oxidative 
addition of the aryl halide 15 to the palladium(0) to form an arylpalladium(II) species 32. 
Subsequently the amine group 33 then coordinates to the palladium centre 34. The base then 
deprotonates the coordinated amine after which reductive elimination yields the desired 
product 36.  
 
 
Scheme 1.9  
 
There are some issues observed with the reductive elimination step when electron-rich aryl 
halides are employed (electron-deficient palladium species undergo reductive elimination more 
readily). The amide can instead undergo hydrodehalogenation which yields the reduced arene 
41 as a side product of the reaction (Scheme 1.10). 17 
 
 
Scheme 1.10  
 
In 2016  Macmillian and Buchwald et al  demonstrated together that a nickel catalyst could be 
used in conjuction with a photocatalyst to carry out the amination on an aromatic ring (Scheme 
1.11).18 A variety of aromatic rings could be aminated using aryl bromides under these 
conditions without the need for other ligands or high temperatures. The photocatalyst 
regenerates the nickel catalyst 45 through a single electron transfer. 
11 
 
 
Scheme 1.11 
 
1.3.3 Chan-Evans-Lam cross coupling reaction 
 
In 1998 Chan-Evans-Lam cross coupling was described which involves the cross-coupling 
between a boronic acid and a heteroatom (Scheme 1.12).19,20,21 The initial reaction conditions 
required the use of stoichiometric copper salts and a tertiary amine base. It was shown to work 
on amines, amides, phenols and nitrogen containing heterocycles with a variety of arylboronic 
acids. 
 
 
Scheme 1.12 
 
Several groups have investigated the reaction further and developed conditions that allow the 
use of catalytic copper and have reduced reaction times compared to the original conditions. 
Combs et al described the first polymer supported version of the reaction which dramatically 
decreased the reaction times through microwave irradiation.22 A variety of N-heterocyles where 
synthesised using this method (Scheme 1.13). 
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Scheme 1.13 
 
Collman et al. established a catalytic version of Chan-Evans-Lam reaction which used 10 
mol% of a TMEDA complexed copper catalyst.23 This was shown to work between several 
boronic acids and imidazoles, with air being the oxidant to return the copper to the original 
oxidation state (Scheme 1.14). 
 
 
Scheme 1.14 
 
Several probes into the mechanism of the reaction have been made latterly by Watson et al 
who used 4-phenyl-phenylboronic acid and piperidine (Scheme 1.15).24 They propose that the 
[Cu(OAc)2]2.2H2O complex 55 is denucleated to a mononuclear Cu(II) complex 56 which then 
undergoes transmetallation with the organoboron reagent 57 to afford the Cu(II) species 58. 
Oxidation of the Cu(II) species 60 to the Cu(III) species via disproportionation gives complex 
62. Reductive elimination then yields the desired product 63 and a Cu(I)OAc species 64 which 
is oxidised by O2 and HX to regenerate the Cu(II) species 56. Through this study, improved 
reaction reliability has been shown due to the use of additives. 
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Scheme 1.15 
 
1.4 C-H activation amination reactions 
 
In recent years C-H activation methodology has been expanded to include the formation of C-
N aryl bonds under a variety of conditions, a few examples of which will be discussed in this 
section. There are other examples within the literature that heated azides to form nitrenes, 
however this is an undesirable method due to safety concerns.25 Driver et al. established milder 
conditions which utilises rhodium catalysis to transform azides into various heterocycles 
focusing mainly on the synthesis of indoles (Scheme 1.16).26 
 
 
Scheme 1.16 
 
In 2005 Buchwald et al. first described the C-H activation reaction that resulted in C-N bond 
formation, involving amide precursors 67, using palladium as the catalyst towards the synthesis 
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of carbazoles 68.27 These reactions utilised Cu(OAc)2 as a stoichiometric co-oxidant in the 
reactions (Scheme 1.17).  
 
 
Scheme 1.17 
 
This reaction did have some disadvantages due to the incompatibility of some functional groups 
with Cu(OAc)2. In subsequent years it was found by Buchwald et al. that when DMSO was 
used as the solvent Cu(OAc)2 was not required as a co-oxidant. The scope of the reaction was 
increased due to the increase in the variety of functional groups that could be tolerated (Scheme 
1.18).28 
 
 
Scheme 1.18 
 
In 2008, Buchwald et al. described a copper-mediated amination reaction involving amidines 
that proceeded via C-H activation to afford benzimidazoles (Scheme 1.19).29 It was found that 
electron-donating and electron-withdrawing groups on the N-aryl ring were tolerated well 
within the reaction. Further investigations established that 2-alkylated instead of arylated 
benzimidazoles could also be afforded under these conditions, however, this was limited to 
amidines bearing the tert-butyl group only. When smaller alkyl groups were used only 
decomposition of the starting material was observed and no desired product was obtained. 
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Scheme 1.19 
 
1.5 Amination reactions involving Aminyl and Iminyl Radicals  
 
There are different types of N-centred radicals that can be formed, examples of which are 
shown in Figure 1.3.  
 
 
Figure 1.3  
 
1.5.1 The Hofmann-Löffler-Freytag Reaction (HLF) 
 
The HLF reaction was discovered in 1878 by Hofmann who observed that when secondary 
chloroamines containing alkyl chains with at least four carbons are treated with H2SO4 and 
photolysed the resulting product was a cyclic tertiary amine.30,31 Following this, further work 
was carried out by Löffler and Freytag who demonstrated this could be applied to secondary 
amines as well. This method could be employed in the general synthesis of pyrrolidines 80 as 
shown in Scheme 1.20.32 
 
 
Scheme 1.20  
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The mechanism of the HLF reaction was initially investigated by Wawzonek et al. who 
proposed that it proceeded via a radical reaction, which was later investigated thoroughly by 
Corey et al (Scheme 1.21).33,34 The reaction is initiated via heating, external radical initiator or 
irradiation of the reaction mixture with UV light, which generates an aminium radical via 
homolytic cleavage of the N-halo bond of the protonated chloroamine 81. Following this the 
nitrogen-centred radical readily undergoes an intermolecular 1,5-hydrogen atom transfer 
resulting in 83. The alkyl radical then undergoes radical recombination to form the alkyl-
halogen bond 84. Finally treatment with a base which deprotonates the salt, allowing the 
internal nucleophilic substitution reaction to occur yielding the pyrrolidine 80, with excellent 
regioselectivity observed.  
 
 
Scheme 1.21  
 
In 1974, Oishi et al. demonstrated that the chloroamine could be generated in situ and irradiated 
directly under UV light to obtain 87 under neutral conditions (Scheme 1.22).35 This 
photocyclisation differs from the HLF reaction in three main aspects. One is that a six-
membered ring is formed instead of the five-membered ring which shows that other pathways 
are possible even though 1,5- is usually favoured. The formation of the six-membered ring 
17 
 
might be preferred as it would proceed via a carbon centred radical which is stabilised by the 
adjacent nitrogen lone pair. No strong acid was present in the reaction mixture and the 
cyclisation therefore occurred without any treatment with base. 
 
 
Scheme 1.22  
 
In 1983 Suarez et al. published another modified version of the HLF reaction that eliminates 
the need to use strongly acidic conditions, which are not suitable for all functional or protecting 
groups (Scheme 1.23).36 The alternative method involved reacting N-nitroamines, N-
cyanamines or N-phosphoramides with hypervalent iodine species under neutral conditions, 
generating the nitrogen centred radicals. 
 
 
Scheme 1.23  
 
An adapted HLF reaction that utilises an iridium photocatalyst to access the aminyl radicals, 
from N-chlorosulfonamides precursor 90 was published in 2015 by Yu et al.37 They found that 
lower catalyst loadings increased the yield of the desired product (Scheme 1.24). 
 
 
Scheme 1.24 
 
They then went on to apply this methodology to late stage modifications of biologically 
important molecules. In one example the matrix-2 protein inhibitor (–)-cis-myrtanylamine 
derived N-chlorosulfonamide 92 was subjected to the newly established methodology and 
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piperidine 93 was isolated as one isomer (Scheme 1.25). Due to the restricted conformation of 
the N-chlorosulfonamide 92 the six-membered ring was formed over the generally preferred 
five membered ring. 
 
 
Scheme 1.25 
 
1.5.2 Arylation of aminyl and iminyl radicals  
 
When attempting the synthesis of indenopyrrolidine 95, Dey et al. and Robinson et al. both 
reported that instead of the expected hydrogen abstraction occurring for an HLF reaction, 
amination occurred on the aryl ring instead to yield the tricyclic compound 96 (Scheme 1.26). 
This result showed that amination on aryl rings could be achieved without the use of transition 
metals.38, 39 
 
 
Scheme 1.26  
 
Interestingly, alternative groups to chlorine have been investigated. One example is N-
alkyloximes 97 that are used to form iminyl radicals 99, in the synthesis of heterocycles shown 
by Rodriguez et al (Scheme 1.27).40 They have shown that this reaction can be carried out 
under neutral conditions and after a solvent screen, t-butanol was found to be optimal. It has 
been shown by Walton et al. through studies carried out using EPR spectroscopy, that the 
reaction proceeds via the iminyl radical.41 
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Scheme 1.27  
 
Rodriguez et al. have expanded on this work to show amination can occur on heterocyclic rings 
including pyridine and thiophene rings, again under neutral conditions (Scheme 1.28).42 
 
 
Scheme 1.28  
 
In 2012 Sarpong et al. demonstrated the use of  aromatic amination via a modified HLF reaction 
under basic conditions in the total synthesis of arboflorine.43 The acidic conditions using H2SO4 
that had been successfully demonstrated by Day and Robinson (i.v. Scheme 1.26) gave no 
desired N-arylation product 103, yielding starting material only. The reaction was also 
attempted under conditions described by Oishi et al. (c.f. Scheme 1.22), with irradiation of the 
chloroamine under neutral conditions, however these gave the desired product in a low 8% 
yield.35 The reaction was then tried with a base and the desired product was afforded, with the 
best results seen through the presumed formation of the N-iodoamine in situ (Scheme 1.29). 
 
 
Scheme 1.29  
 
1.5.3 Amination of Aryl rings by N-centred Radicals Generated by Transition Metals 
 
Minisci et al. described intermolecular examples of homolytic aromatic amination using Fe2+ 
salts as radical initiators in either concentrated H2SO4 or a mixture of H2SO4 and AcOH 
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(Scheme 1.30).44 The reaction was shown to work with benzene and various amino substrates 
with alkyl chains, phenyl groups or primary amines. The yields of these reactions are dependent 
on various factors, one of which is the bulk of the substituents on the chloroamine (the bulkier 
the group the lower the yield).  
 
 
Scheme 1.30  
 
Minisci et al. have also developed an intramolecular variation of this reaction. 45 The reaction 
of N-methyl-N-(phenylethyl)-N-chloroamine 107 and FeSO4 in concentrated H2SO4 is an 
exothermic reaction that is very sensitive to temperature. When the reaction was carried out 
without cooling, once above 35 oC low yields of N-methylindoline 108 were observed, whereas 
when the reaction is cooled and kept at -5 oC 27% of N-methylindoline 108 is formed, with the 
formation of benzyl chloride 109 as a side product also (Scheme 1.31). 
 
 
Scheme 1.31  
 
N-Methylindoline 108 is formed by the intramolecular addition of the aminyl radical to the 
aromatic ring and then subsequent oxidation by the Fe2+ salt. An alternative mechanism that 
was proposed was a radical chain addition followed by the elimination of HCl to yield the 
product 114. β-Scission to form the benzyl chloride product 114 is promoted due to the 
formation of a benzyl radical (Scheme 1.32) 
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Scheme 1.32  
 
When this reaction was attempted with methyl-3-phenylpropyl-N-chloroamine 115 the 
tetrahydroquinoline 116 was afforded in much higher yields (81%) as no β-scission was 
observed (Scheme 1.33).  
 
 
Scheme 1.33  
 
Minisci et al. also investigated the use of different leaving groups to generate the protonated 
aminyl radical by using either hydroxylamine 118a or hydroxylamine O-sulfonic acid 118b for 
intermolecular N-arylation reactions.44, 46 Either can be used to install an amine group on the 
aromatic ring. More electron-rich rings are favoured and higher yields are obtained. A higher 
yield is also obtained when using the hydroxylamine O-sulfonic acid although these are 
reportedly unstable (Scheme 1.34). When comparing the two hydroxylamines reacting with 
anisole it can been seen that a different ratio of ortho and para substitution is obtained this 
could be due to the different counter ions generated in the reaction.  
 
22 
 
 
Scheme 1.34 
 
In 2016 Morandi et al described the use of a different hydroxylamine derivative with mesylate 
on the oxygen 121 to install an amine group on the aromatic ring (Scheme 1.35).47 A range of 
substrates with a variety of substituents have been shown to work again with the electron rich 
rings being preferred. The distribution of the isomers synthesised is again more in preference 
of the ortho and para positions. 
 
 
Scheme 1.35 
 
Jiao et al has also investigated an alternative hydroxylamine derivative for the amination of 
aromatics (Scheme 1.36).48 They carried out investigations into various substituents on the 
oxygen where they found the nitrobenzoate to be the best leaving group. Again slight selectivity 
for the para position over the ortho position was observed. A range of electron-rich aromatics 
were shown to work under these conditions along with a few unactivated arenes. 
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Scheme 1.36 
 
There have been some examples within the literature that show the use of photoredox for the 
amination of aromatic rings (Scheme 1.37). Nicewicz et al described the amination of a variety 
of electron rich aromatics using nitrogen heterocycles such as pyrazole and triazoles.49 It was 
found that increasing the mol% of TEMPO from 10 mol% to 20 mol% showed improved 
yields. 
 
 
Scheme 1.37 
 
Leonori et al described the use of O-aryl hydroxylamines 128 to form aminium radicals in the 
presence of Ru(bpy)3 and visible light through a single electron transfer (SET) mechanism. 
Using the conditions established they have successfully aminated a variety of aromatic rings 
including pyrrole and indole (Scheme 1.38).50 
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Scheme 1.38 
 
 Apart from the examples discussed there have been few N-arylation reactions via aminyl 
radicals described within the literature. In regard to aminating aromatic rings with 
hydroxylamines this work has been limited to just installing amine groups with no substituents 
on the amine present. 
 
1.6 Arylation reactions of imidyl radicals  
 
In 1976 Cadogan et al. demonstrated how N-tosyloxyphthalimides 133 readily underwent UV 
photolysis at room temperature in aromatic solvents to give N-arylphthalimides 134 via a 
proposed radical mechanism (Scheme 1.39).51 The isomer ratios that were observed when 
carrying out the reaction under photolytic or thermolytic conditions suggests that it proceeds 
via an electrophilic phthalimido radical rather than a nitrenium ion (when compared to known 
radical reactions), which is supported by previous work carried out by Lidgett et al.52 
 
 
Scheme 1.39  
 
This work was later expanded upon by Skell et al. in 1986, who showed N-centred radicals 
could be generated from photolysis of N-bromophthalimide 135 (Scheme 1.40).53 This N-
centred radical could then be used for amination reactions on alkyl chains and aryl groups as 
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well. The problem that was encountered was the side reaction involving the bromo radical and 
the alkyl chain or aryl group, with bromination occurring on these groups. This was overcome 
through the addition of a sacrificial alkene into the reaction mixture.   
 
 
Scheme 1.40  
 
Work carried out by Sanford et al. focused on iridium photoredox catalysts being used 
alongside visible light to activate N-oxyphthalimides 137.54 This work was based on the 
previous research carried out by Skell on arylation using phthalimides (Scheme 1.41). A wide 
range of mono-, di- and trisubstituted arene species were successfully aminated under the 
conditions developed by Sanford et al. Some substrates shown to work under these conditions 
were unstable under the high temperatures or strong oxidising conditions that were previously 
used. The conditions have also been shown to work on heterocycles. 
 
 
Scheme 1.41  
 
The mechanism that was proposed for this reaction is shown in Scheme 1.42. Excitation of the 
Ir(ppy)3 photocatalyst 140 with visible light forms the Ir(ppy)3* species 141*. A single electron 
is transferred from the excited catalyst species 141* to N-acyloxyphthalimide 137 which 
generates the N-phthalimidyl radical 138, which then reacts with the arene 104. The radical 
species 142 is then oxidised by the iridium species 139+ to form 143 and regenerate the 
photocatalyst. The trifluoroacetate anion formed during the breaking of the N-O bond, 
deprotonates 143, releasing the product 136 and TFA as a by-product.54   
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Scheme 1.42  
 
In 2014 Baran et al. reported a metal mediated intermolecular N-arylation reaction between 
heteraromatics and N-succinimidyl derivatives.55 The first substrate imide 144 underwent 
decarboxylation/deformylation to generate the imidyl radical which was shown to react with 
methoxypyridines (Scheme 1.43). 
 
 
Scheme 1.43 
 
Unfortunately, the scope of the reaction could not be increased with this set of imidyl radical 
precursors and so instead the N-succinimide perester radical precursors were investigated. This 
new system was shown to work on electron-rich and electron-poor heteraromatic/ aromatic 
systems an example of which is shown in Scheme 1.44. 
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Scheme 1.44 
 
1.7 C-N bond formation by amidyl radicals 
 
In section 1.5 the formation of aminyl radicals for use in the formation of C-N bonds has been 
looked at in detail. In this section we will focus on the use on amidyl radicals in the formation 
of C-N bonds. A variety of different methods have been utilised for the formation of the amidyl 
radical ranging from alternative subunits to different initiators which will be described in this 
section. 
 
1.7.1 Nitrosoamides 
 
Following on from work by Barton et al. and the success of establishing conditions for the 
photolysis of nitrite esters as a useful synthetic method in the synthesis of the natural product 
aldosterone, investigations were carried out into the photolysis of nitrosamines.56 However this 
did not lead to any improvement . It was hypothesised that this was due to the increased strength 
in the bond that was being broken, N-O (37 kcal/mol) to an N-N (43 kcal/mol). Kuhn et al. 
went on to show that the N-N bond of a nitrosamide is considerably weaker than a nitrosamine 
and that these compounds underwent facile photochemical reactions (Scheme 1.45).57  
 
 
Scheme 1.45 
 
They studied how the different structures of the nitrosoamides affected whether the amidyl 
radicals abstracted hydrogens intermolecularly or intramolecularly. The N-methylvaleramido 
radical 150 can only abstract hydrogens intramolecularly when it is in the trans- conformer, 
whereas the conformation of the N-pentylacetamido radical 151 can be either cis- or trans- and 
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the intramolecular hydrogen abstraction can still occur (Figure 1.4). To minimise 
intermolecular hydrogen abstraction non-polar solvents such as benzene can be used. 
 
 
Figure 1.4  
 
This work was investigated further and expanded upon by Perry et al. in 1972, who established 
an effective intramolecular cyclisation through the formation of an amidyl radical.58 In their 
work they reported the successful formation of amidyl radicals via the homolytic cleavage of 
N-N. The photolysis of each compound was carried out in neutral conditions and the leaving 
group was incorporated into the cyclisation products. When the nitroso compound underwent 
photolysis a mixture of products containing the oxide or the hydroxylamine of which both the 
syn- and anti-geometric isomers were observed due to the incorporation of the N-OH group 
(Scheme 1.46).  
 
 
Scheme 1.46  
 
1.7.2 Halo-amides 
 
Perry et al. not only showed the successful cyclisations of nitrosoamides but also chloroamides. 
They observed that when chloroamides underwent photolysis, chlorine was incorporated into 
the final product in either the syn- or anti- position (Scheme 1.47).58 
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Scheme 1.47 
 
In 1975 Kuehne et al. further investigations into whether the formation of the kinetically less 
favoured 6-membered ring, over the favoured 5-membered, could be forced were also carried 
out.59 Irradiation of the N-chloroamide 156 lead to the 5-exo-trig cyclisation in 35% yield, 
however when N-chloroamide 158 was irradiated the major product was the amide 160 with 
no 6-exo cyclisation occurring (Scheme 1.48). 
 
 
Scheme 1.48  
 
This methodology for the formation of the 5-membered rings was expanded to include bicyclic 
compounds. When the N-chloroamide 161 was subjected to irradiation it could form either a 
spirocycle by 5-exo-trig or fused ring by 6-endo-trig, however the only cyclised product 
obtained from the reaction was the spiro-lactam 162, showing preference for 5-exo cyclisations 
(Scheme 1.49).  
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Scheme 1.49 
 
 With the knowledge obtained of the preference for 5-exo cyclisations the synthesis of the 
perhydroindole skeleton which is prevalent in several alkaloid classes was successfully 
demonstrated (Scheme 1.50). 
 
 
Scheme 1.50 
 
Glover et al. extended the scope of the amidyl radical cyclisation to include examples of 
amination onto aromatic rings, shown to work with bi-aryl systems first.60,61 They achieved 
this through photolysis of the iodoamide 166 which was formed in situ. The de-aromatised 
compound 168 was isolated in 19% yield alongside the desired product 167 (Scheme 1.51).  
 
 
Scheme 1.51 
 
Only slight success was observed for the thermal and photolysis conditions on the single aryl 
system 169 (Scheme 1.52) with isolated yields of the desired cyclised product much lower than 
for the bi-aryl system. This could be due to the system being less constrained and therefore not 
being held in the correct conformation to promote cyclisation. 
 
31 
 
 
 Scheme 1.52  
 
The activation of  N-chloroamides can be achieved through methods other than photolysis one 
of which was described by Waegall et al. in 1978 who used dibenzoyl peroxide as a chemical 
initiator.62 This has been shown to increase the yields of the cyclised product in reactions where 
the less favoured 6-membered ring is formed compared to results obtained under photolytic 
conditions (Scheme 1.53) 
 
 
Scheme 1.53  
 
The yields of the desired cyclised product from N-alkyl chloroacetamides were a lot lower than 
those of similar N-methyl chlorocarboxamides. N-Chloro carboxamide 171 when initiated with 
dibenzoyl peroxide affords 79% yield of the desired cyclised product (Scheme 1.53). However, 
when the same reaction is carried out using the corresponding N-chloroacetamide 174 none of 
the desired product is obtained, and instead 90% of the amide 176 is recovered. (Scheme 1.54). 
This can be explained in terms of steric interactions which is expected to be larger for N-alkyl 
chloroacetamido radical than for the N-methylcarboxamido radicals according to the models 
that they made. 
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Scheme 1.54  
 
Success was observed with the N-chloroacetamide 177 in the formation of the more favoured 
5-membered ring 178 (Scheme 1.55). However, the desired product was afforded in lower 
yields than had been observed for the N-methyl chlorocarboxamide 179 with which 92% of the 
desired compound 180 was obtained. This could be due to the greater rotational freedom that 
N-chloroamide 177 experiences as a result of the CH2 group, increasing the chance of hydrogen 
abstraction before the cyclisation occurs. 
 
 
Scheme 1.55  
 
In a subsequent paper by Lessard et al. another way was described to access the amidyl radicals 
from the chloroamides which used chromium(II) chloride.63  It showed increased yields in the 
formation of the disfavoured 6-membered ring compared to when the reaction was carried out 
under photolytic or chemical initiation with dibenzoyl peroxide (Scheme 1.56). The 
disadvantage to this method is the long reaction times required for some of the substrates and 
the use of chromium (II) chloride. 
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Scheme 1.56  
 
When the chromium(II) chloride conditions were utilised in the reactions of the N-chloro 
acetamides 181 an improvement in the yields was observed. Interestingly, reactions that had 
failed previously under the dibenzoyl peroxide conditions, afforded good yields of the desired 
product when using chromium(II) chloride (Scheme 1.57). 
 
 
Scheme 1.57  
 
1.7.3 PTOC (N-hydrozypyridine-2-thione) imidate esters 
 
There has been some work to find alternative methods to generate the amidyl radical which 
would alleviate the limitations of functional groups. A class of radical precursors that has been 
developed by Newcomb et al.64 is the PTOC imidate ester 184 which are structurally similar 
to the PTOC ester 183 used by Barton et al (Figure 1.5).65 
 
 
Figure 1.5 
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The use of t-BuSH with the amidyl radical was effective for the radical cyclisation chain 
process rather than a simple amidyl reduction taking place (Scheme 1.58).  
 
 
Scheme 1.58  
 
Newcomb et al. also showed radical cascade reactions could be initiated to afford bi-cyclic 
systems (Scheme 1.59).64 The reaction can either proceed through the cascade pathway or the 
radical will be trapped after the first cyclisation. It can be forced to proceed via the cascade 
reaction when the reaction is carried out at a higher dilution. 
 
 
Scheme 1.59  
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1.7.4 Sulfur amides 
 
Newcomb et al. established an alternative class of radical precursors, N-(phenylthio)amides, as 
suitable sources of amidyl radicals.66 The N-thioamides can be prepared easily through the 
reaction of amides with phenylsulfenyl chloride and triethylamine to yield the desired N-
thioamide 196 (Scheme 1.60).  
 
 
Scheme 1.60  
 
These compounds have been shown to undergo intramolecular cyclisation reactions to form 
five-membered rings. When amide 197 was treated with Bu3SnH whilst heating in benzene it 
afforded 77% of the desired compound (Scheme 1.61). 
 
 
Scheme 1.61 
 
Using these conditions tandem radical cyclisations have been shown to occur which form the 
bicyclic systems instead of trapping the radical after the first cyclisation (Scheme 1.62). The 
cyclisation of amide 198 gave the bi-cyclic amide 199 in a 95% yield and a 3:1 mixture of the 
diastereoisomers. 
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Scheme 1.62  
 
In 2004 Zard et al. published a new method for the formation of amidyl radicals which involves 
the exclusion of sulfur dioxide from the N-amidosulfonimide.67 The first step in the radical 
initation involves an addition-fragmentation to the allyl group which produces the N-sulfonyl 
radical 201a (Scheme 1.63). The initiators used in the reaction were substiochiometric amounts 
of Lauroyl peroxide to generate the radical from xanthate 202a or 202b. Xanthate was chosen 
as the reversible transfer of the xanthate group to the product in the last step regenerates the 
initial radical (which reacts with the allyl group of the starting material) and also introduces 
useful functionality into the product. The desired amidyl radical 201b is then formed via loss 
of sulfur dioxide. This last step is slow and could lead to the N-amidosulfonyl radicals 
abstracting a hydrogen from the solvent or cyclising onto the olefin. Careful selection of 
solvents with poor hydrogen-donating capabilities can prevent hydrogen abstraction from the 
solvent. 
 
Scheme 1.63  
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It was observed that when an alkyl group was present on the nitrogen, cyclisation of the N-
amidosulfonyl radical onto the alkene occurred, whereas when the ethyl group was changed 
for a phenyl group none of the N-amidosulfonyl radical cyclisation products were observed: 
only an epimeric mixture of the desired lactam was observed (Scheme 1.64).  
 
 
Scheme 1.64 
 
1.7.5 Hydroxamic acids 
 
In 1978 Hosangadi et al. found that when they irradiated hydroxamic acid 212 instead of 
affording the expected lactam 211a or 2-arylsulfinylbenzamide 211b,68 they instead obtained 
2-arylthiobenzamide 214 as the product of the reaction which they believed to be formed 
through the amidyl radical intermediate (Scheme 1.65). 
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Scheme 1.65 
 
The formation of the amidyl radical upon irradiation of the hydroxamic acid derivatives was 
further explored for the use in cyclisation reactions by Zard et al. in 1995.69 Instead of forming 
the radical by photolysis of the O-benzoyl hydroxamic acid 215 its formation was initiated 
using tributyltinhydride and AIBN. This lead to successful cyclisations of the amidyl radicals 
onto olefins (Scheme 1.66). 
 
 
Scheme 1.66 
 
The amidyl radical precursors were incorporated into various cyclisation cascade reactions an 
example of which is shown in Scheme 1.67, in which tricyclic compound 219 was afforded. 
 
 
Scheme 1.67 
 
Application of Zard’s conditions was demonstrated by Clark et al. in 1998 for the synthesis of 
lactams involving a 4-exo-trig cyclisation of the amidyl radical (Scheme 1.68). 70Although the 
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lactam 221 was formed in the reaction there were issues with competition reactions, one of 
which formed the amide 222 (found to be the major product). The issues with the formation of 
the amide could be addressed through two methods, one of which was to carry out the reaction 
at a higher dilution. The other method was the addition of a group which would stabilise the 
carbon centred radical formed to form compound 223. 
 
Scheme 1.68 
 
Following on from the success in the cyclisations of hydroxamic acid, milder conditions for 
the amidyl radical formation were shown by Weinreb et al., who used tert-butylsulfonyl 
chloride or diethyl chlorophosphite, Hunig’s base and low temperatures.71 Various radical 
trapping agents such as diphenyl diselenide, diphenyl disulfide and TEMPO were used to 
successfully yield the desired products (Scheme 1.69), with a preference shown for the 
formation of the 5-endo products. These conditions were applied to the synthesis of the key 
intermediate for the alkaloid (+/-)-peduncularine to synthesis the key intermediate 225. 
 
 
Scheme 1.69  
 
1.8 Summary 
There have been many advances in the different techniques that are used in the formation of C-
N bonds which has expanded the scope of the reactions. Many of the reactions unfortunately 
use expensive metals such as palladium and iridium. Reactions such as the Buchwald-Hartwig 
reaction use expensive ligands in the synthesis. 
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There have also been advances in utilising UV and visible light in the formation of C-N bonds, 
many of which avoid the use of expensive metals and don’t require the addition of other 
reagents. Although there have been advances in the area of light mediated reactions, there are 
only a few examples within the literature, detailing the formation of ring systems such as 
tetrahydroquinolines. The same can also be said for the metal-mediated versions of the reaction. 
With regards to amidyl radicals there are a very limited number of examples of N-arylation 
reactions.   
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Chapter 2 Intramolecular N-arylation reactions 
 
2.1 Flow chemistry and benefits over batch reactions 
 
Flow chemistry has been commonplace within the petrochemical and bulk chemical industry 
for many years, but only recently has it become the focus for the chemical development 
industry. A recent review by Hughes et al discussed the benefits gained from the use of flow 
in recent syntheses of API’s, and included:72 
1) Enables chemistry that is difficult to scale in batch such as electrochemistry, microwave 
heating and photochemistry. 
2) Can access extreme conditions such as high and low temperatures and high pressures 
readily. 
3) Scale up is more straightforward as mixing and heat transfer are maintained as scale is 
increased. 
4) Safer execution of hazardous chemistry as only a small number of unstable 
intermediates are generated at any one time. The high surface area to volume allows for 
excellent control of exothermic chemistry (helping to avoid reaction ‘runaway’). 
 
This demonstrates the appeal for using these systems in API synthesis, however there are still 
challenges facing the progression of flow chemistry in chemical development. Some of the 
issues faced are the lack of knowledge and skill set required to implement such methodology 
along with chemists being traditionally trained in batch chemistry and therefore unaware of 
when flow chemistry could benefit their process.  
 
2.1.1 Flow chemistry in the synthesis of API’s 
 
Within Patents submitted in 2016 and 2017 there are examples of drug molecules which have 
a continuous step described within the possible synthesis. Each of these have described a 
benefit of using flow over traditional batch methods. In the synthesis of ingenol mebutate there 
was improved regioselectivity reported in the acylation of the C3 alcohol which also benefitted 
from avoiding the need for protection/deprotection steps used in the previous synthesis. In the 
optimised flow conditions, a flow of ingenol/LiHMDS was mixed with angelic anhydride at 0 
oC this was followed by a continuous quench with a third flow of 1M HCl at 25 oC. This allowed 
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isolation of the desired compound 227 in a 40% yield and the starting material could be 
recovered. The previous batch reaction gave a 37% yield over three steps and had a very 
difficult final deprotection step which had to be carefully controlled to prevent isomerisation, 
which took 7 days to achieve (Scheme 2.1).  
 
 
Scheme 2.1 
 
This demonstrates one of the many advantages that flow chemistry can achieve over the 
corresponding batch reactions. 
 
2.1.2 Continuous photochemistry 
 
On a small-scale, UV-light-mediated reactions are commonly carried out in immersion well 
reactors. Larger scale versions of these batch reactors encounter a major drawback due to the  
uneven distribution of photons through the reaction obtained. This leads to poor translation of 
reactions in scale-up. In 2005, Booker-Milburn et al described how a standard immersion well 
reactor could be converted into a continuous photochemical reactor by wrapping UV-
transparent fluorinated ethylene propylene (FEP) tubing around the outside of the immersion 
well.73 This was either done with a mono-layer of tubing or a triple-layer of the tubing on the 
reactor to compare the yields of each reactor and the associated benefits of each. Several 
examples were then shown within the paper to demonstrate the benefits of the continuous flow 
system in comparison to the traditional batch methods, especially upon scale-up of the 
reactions. Using the reactor, the authors managed to obtain high yields with high projected 
productivities for the reactions of over a 24 h period. The intermolecular [2+2] cycloaddition 
between hexyne and maleimide afforded high levels of productivity with the mono-layer FEP 
reactor at 0.2 M with a 24 h projection of 363 g being achieved (Table 2.1, Entry 1). By 
226 
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switching to the triple-layer FEP reactor and increasing the concentration to 0.3 M a projected 
productivity of 408 g was achieved (Table 2.1, Entry 2). The authors also demonstrated the 
benefits of using a more powerful lamp: by switching to a 600 W lamp from a 400 W lamp, 
the productivity increased to 685 g over the 24 h period (Table 2.1, Entry 3). The indicates that 
an increase in the flux of protons is a more effective way to increase the yield of the reaction 
over a change in the flow rate. 
 
 
Entry 
Conc 
(M) Lamp (W) 
Layers of 
FEP 
Flow rate 
(mL/min) 
Conversion 
(%) 
Projected 24 h 
yield of x (g) 
1 0.2 400 1 8 88 363 
2 0.3 400 3 6 88 408 
3 0.4 600 3 8 83 685 
Table 2.1 
 
An example that highlights the benefits of flow over batch is the [2+2] cycloaddition shown in 
the scheme below. When comparing the batch conditions (Table 2.2, Entry 1) with flow we 
can see the productivity increases from 6.56 g to 8.55 g for the triple layer FEP flow reactor 
(Table 2.2, Entry 2). For the mono-layer flow reactor (Table 2.2, Entry 3) we can see the 
productivity is slightly lower than that of the batch reactions.74 The lower yields for the mono-
layer reactor over the triple-layer reactor could be attributed due to the fact light can escape 
between the gap in the tubes whereas in the triple-layer reactor the light would then interact 
with another tube, this increase absorption by the reaction mixture and in turn productivity. 
  
 
44 
 
 
Entry Mode Conditions Yield (%) Productivity at 
batch end (g) 
1 Batch 0.096 M, 180 min 68 6.56 
2 Flow[a] 0.096 M, 3 mL min-1 68 8.55 
3 Flow[b] 0.096 M, 2 mL min-1 68 5.70 
[a] triple layer FEP reactor, [b] mono layer FEP reactor 
Table 2.2 
 
Three trends can be observed from the comparison of these reactions: 
1) Yields for batch and flow reactors in synthetic photochemistry are essentially the same 
at full conversion. 
2) Triple-layer FEP reactors have on average 20% higher productivity compared to the 
same batch end point. 
3) Mono-layer FEP reactors have on average 20% lower productivity compared to the 
same batch end point. 
 
2.1.3 Space-Time Yield (STY) calculation 
 
The space-time yield (STY) calculation is a useful way to determine the efficiency of a 
continuous reactor as well as allowing for comparisons between reactors of differing sizes. It 
gives the yield for the process as a unit of space-time. The STY is calculated using equation 
[1] and the units are g L-1 h-1.75 
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The STY for each of the substrates synthesised in over investigatons was calculated to allow 
for comparison between them.  
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2.1.4 Previous work in the Marsden group  
 
Previous work carried out within the Marsden group has established a modified HLF 
methodology that utilises UV light under acidic conditions in the formation of C-N bonds. This 
method avoids the need to use expensive metals (such as palladium) and ligands previously 
employed. The optimised conditions have been shown to work on a range of substrates with a 
variety of substitution on the aromatic ring, the alkyl chain and on the nitrogen (Scheme 2.2).76  
 
 
Scheme 2.2 
 
This methodology was shown to work in both batch and flow. A continuous photochemical 
reactor was built following the design described by Booker-Milburn et al, with a dual syringe 
pump attached to a T-junction to allow both flow rates of the chloroamine and the MeSO3H to 
be equal.73 A reactor volume of 5 mL was chosen. The length of the UV-transparent FEP tubing 
(with an internal diameter of 2.7 mm) had been calculated using the equation [2] for the volume 
of a cylinder. 
 
V = π r2 h [2] 
  
Inputting the values gave 87.4 cm of tubing for a 5mL reactor volume. An additional 50 cm of 
the tubing was added to either end of the reactor volume to allow the transportation of the 
reactants to and from the photochemical reactor. A 125W high pressure mecury lamp was used 
for these investigations. The FEP tubing was attached to the immersion well of the reactor 
using double-sided tape and Sellotape. One end of the reactor was attached to a T-junction to 
which two syringes in a dual syringe pump were connected using PTFE tubing with an I.D of 
1/32nd of an inch. The photochemical reactor was contained in foil and directly attached to a 
water supply to cool the lamp. In the event of the flow of water failing the lamp automatically 
turns off. The reactor was additionally contained within a red box which blocked any stray UV 
radiation. 
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Figure 2.1 
 
The first flow reactor built as described above, was used to carry out the N-arylation step 
depicted in Figure 2.1. The system was tested at two different flow rates to find the optimal 
conditions. Based on the overall productivity the flow rate was set at 1 mL min-1 for all future 
flow reactions, as there was no substantial increase in yield observed from slowing the flow 
rate down. The STY for the faster flow rate was calculated to be 248 g h-1 (Table 2.3). 
 
 
 
Entry 
Flow rate (mL min-1) Yield (%) Productivity (g h-1) 
1 0.33 66 0.45 
2 1 62 1.25 
Table 2.3 
 
After the success of this methodology in flow it was then decided to telescope the chlorination 
reaction mixture to the N-arylation step. The chloroamine once formed was then mixed with 
115 
116 
 RV = 5 mL 
FR = 1 mL min
-1
 
           
MeSO
3
H 
Sol. In DCM 
6M 
Sol. In DCM 
0.5 M 
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MeSO3H then flowed into the UV reactor for the N-arylation reaction to occur. An issue with 
the dual reactor setup was that the concentration of the reaction had to be lowered due to the 
limited solubility of NCS in DCM (maximum concentration 0.41 M). This meant that when the 
chloroamine was mixed with the solution of MeSO3H the concentration halved again to 0.1 M 
which lowers the overall concentration of the reactor by 2.5 times compared to the single step 
reactor.  
Two substrates were synthesised using this dual reactor to show its overall benefits. The yield 
of the THQ 116 was lower when carried out in the dual reactor as opposed to the single step 
processes, nevertheless the dual flow reaction is more productive than the batch reactions 
(Table 2.4, entry 1). Cyclisations to yield the natural product angustureine did not afford the 
desired product cleanly instead a side product was observed, with a mass that was consistent 
with that of the chloroamine (Table 2.4, entry 2). 
 
 
 
Entry 
Substrate Yield (%) Productivity (g h-1) STY (g L-1 h-1) 
1 
 
34 0.29 9.6 
2 
 
25 0.165 5.5 
Table 2.4 
 
The postulated side-product was the δ-chloroamine, arising from an intramolecular 1,5-hydride 
abstraction. It was hypothesised that the formation of this side product might be avoided or 
lowered by carrying out the chlorination step and the N-arylation step in flow separately. 
 
236 
           
MeSO
3
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Sol. In DCM 
NCS 
Sol. In DCM 
0.4 M 
RV = 5 mL 
FR = 0.5 mL min
-1
 
 RV = 5 mL 
FR = 1 mL min
-1
 
Sol. In DCM 
0.4 M 
116 
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Figure 2.2 
 
The work detailed in this section is a continuation of this work to investigate other substrates 
to find the scope of this process. The investigations looked at carrying out the chlorination and 
the photolysis in separate steps due to the reduction in yield that was previously observed with 
the two-step flow reactor. 
 
2.1.5 Chlorination in flow 
 
Due to the issues with solubility of NCS in DCM which lead to lower concentrations for the 
dual flow reactor which in turn lead to lower yields of the desired cyclised product it was 
decided to carry out investigations into a single step chlorination flow reactor. When carried 
out in batch the large scale chlorination reactions gave relatively poor yields and therefore flow 
could be a way around this issue. 
A flow reactor was built by connecting a dual syringe pump (to allow addition rates to be equal 
for both the amine and the NCS) to a T-junction using PTFE tubing with an I.D of 1/32nd of an 
inch. The other end of the T-junction was connected to 10 m of the same PTFE tubing which 
gave a reactor volume of 5 mL. The end of the PTFE tubing fed into a conical flask where the 
reactants were collected and the tubing itself was covered in tin foil to exclude light that may 
have resulted in product degradation.  
The reaction was run at a rate of 0.5 mL min-1, and after discarding the first reactor volume, 
which is just DCM, the rest was collected in a conical flask. The collected reactor volumes 
were concentrated and purified by column chromatography to afford the desired chloroamines. 
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Figure 2.3 
 
A variety of chloroamines were synthesised using the flow reactor as shown in Table 2.5. The 
synthesis of the amines used in the process will be discussed in chapter 3. The productivities 
and yields are higher than would be expected during batch reactions as when over ~750mg (5 
mmol scale) of the starting material is used the yield of the chlorination decreases. This could 
be due to an exotherm in the reaction mixture which on a small scale the heat can be dissipated 
effectively but affects the chloroamine when the reaction is scaled up as there is a larger build-
up of heat and the surface area:volume ratio is lower. The STY was calculated using the 
equation shown in section 2.1.3. The residence time for the reactor was 0.17 h and the reactor 
volume was 0.005 L, so for the allyl substrate (Table 2.5, entry 1) which yields 0.153g per 
reactor volume a STY of 180 g L-1 h-1. Assuming for the batch reaction a 0.5 g scale and a 3 
hour reaction time, the STY would be 142 mg L-1 h-1, showing the benefits of the flow in 
regards to productivity. 
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Entry Product 
Yield 
(%) Productivity (g h
-1) STY (g L-1 h-1) 
1 
 
73 0.92 180 
2 
 
72 1.13 221 
3 
 
61 0.97 129 
4 
 
61 0.95 100 
5 
 
51 0.78 91 
Table 2.5 
With the successful synthesis of the chloroamines attention then turned to carrying out the N-
arylation step in flow. 
 
2.1.6 N-Arylation in flow 
 
The chloroamines synthesised using the flow reactor were then subjected to the flow conditions 
for the N-arylation step. A reactor matching the one previously used within the group and 
described in Section 2.1.4, was built for this purpose. The mono-layer reactors have previously 
236 
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been shown not to be as efficient as triple-layer reactors and could contribute to lower yields 
(20-30%) than observed in the batch reactions.77 The flow reactions however do have a much 
higher productivity than the batch reactions which are limited to production of 0.5 g in 3-5 
hours. During the reactions up to 7 column volumes (CV) were collected though the first two 
were discarded. The remaining CV were worked up individually and analysed by 1H NMR, 
then these were combined and purified by column chromatography. The yields of the N-
arylation reactions are all moderate with the exception of the bromo compound 246 (Table 2.6, 
Entry 4) for which a good yield of 60% was obtained. The natural product angusteriene (Table 
2.6, Entry 5) had shown problems previously with the competing formation of the HLF side-
products, this issue was not alleviated by carrying out the chlorination and the photolysis 
separately with a similar yield overall being obtained (20% over the two steps). For the STY 
calculation, the reactor volume is 0.005 L and the residence time is 0.083 h. In the case of the 
allyl substrate (Table 2.6, Entry 1) 0.084 g per reactor volume were isolated giving a STY of 
198 g L-1h-1. 
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Entry Starting material Product 
Yield 
(%) 
Productivity 
(g h-1) 
STY (g 
L-1 h-1) 
Batch 
Yields77 
1 
 
 
38 1.00 198 40 
2 
 
 
43 1.29 260 82 
3 
 
 
60 1.62 325 72 
4 
 
 
35 0.76 152 72 
5 
 
 
40 0.65 130 50 
Table 2.6 
 
The N-arylations yields in flow were slightly lower than the batch yields however the 
productivity is higher and the yields could also be potentially increased with multilayer reactors 
as previously described (Section xx) Due to the success of the reactions in flow in both the 
chlorination and the N-arylation step it was therefore decided to carry out the reaction on a 
larger scale. 
115 
116 
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FR = 1 mL min
-1
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3
H 
Sol. In DCM 
6M 
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53 
 
2.1.7 Large scale chlorination and flow chemistry  
 
With the success of the chlorination in flow and the N-arylation it was decided to see if it was 
possible to carry this out on a larger scale as previously the N-arylation was carried out on 
under a gram of material. 
The chlorination step was carried out using a flow rate of 0.5 ml min-1 as before; overall 3 g of 
the amine 236 were used in the reaction which afforded a 45% yield of the desired chloroamine 
115 which is lower than expected however still better than would have been achieved in batch 
on such a scale (40% yield obtained in a 1g batch reaction). The N-arylation was then carried 
out using the previously described reactor at a flow rate of 1 mL min-1. The first two reactor 
volumes were discarded and the rest of the reactor volumes were collected in a conical flask. 
The productivity was slightly lower for the N-arylation than had previously been observed 
within the group on a smaller scale. The lower productivity of the chlorination step could be 
attributed to the issues with the solubility of the NCS in DCM and some solid was observed to 
have formed in the syringe. This issue could be avoided potentially through a faster flow rate 
or using alternative chlorination conditions. The slightly lower productivity for the N-arylation 
step could be caused by decomposition of the chloroamine before it entered the photochemical 
reactor. 
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Entry Reaction Yield (%) Productivity (g h-1) STY (g L-1 h-1) 
1 Chlorination 45 0.498 97 
2 N-arylation 58 1.12 224 
Table 2.7 
 
A process has been successfully established for the scale up of both the chloroamines and the 
N-arylation to synthesis THQs, with the successful synthesis of a variety of substrates with 
various substitution problems. 
 
2.2 Investigation of potential heteroaromatic N-arylations 
 
As stated previously the Marsden group has established a modified HLF methodology that 
utilises UV light under acidic conditions for the formation of C-N bonds. These results are 
consistent with the proposed reaction mechanism which states the intermediate involves a 
protonated aminyl radical. In contrast to these results as shown in Scheme 2.3, Sarpong et al. 
have shown that an N-arylation of a pyridine can be carried out under basic conditions under 
UV irradiation.43 
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Scheme 2.3 
 
However when these basic conditions were applied to the substrates that worked under acidic 
conditions, in our group, no reactions were observed (Scheme 2.4).77  
 
 
Scheme 2.4 
 
It was decided to investigate whether the basic conditions detailed by Sarpong et al. could be 
utilised to N-arylate other heteroaromatic rings. With this in mind, similar compounds to those 
previously shown to work within the group were proposed, however this time with a pyridine 
ring instead of the phenyl ring, with substitution in the 3- and 4- positions of the pyridine being 
investigated (Figure 2.4). Once synthesised, the N-halo amines were irradiated with UV light 
under both basic and acidic conditions, to see what the effect the heterocyclic rings would have. 
 
 
Figure 2.4 
 
2.2.1 Substrate synthesis 
 
The synthetic route used to afford the desired substrates is shown in Scheme 2.5. The first step 
was a Wittig reaction between pyridine carboxaldehyde 250 and the ester 251. Both the 3- and 
the 4- substituted pyridinecarboxaldehydes were used. Hydrogenation of the alkenes 252 
afforded the esters 253 in 83-95% yield. Following literature procedures for similar compounds 
the N-methyl amides 254 could be obtained by heating the esters with excess MeNH2 solution, 
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achieving 78-86% yields.78 LiAlH4 reduction was used to obtain the N-methylamines, however 
due to the polarity of the products, isolation was difficult, resulting in low yields (crude yield 
50%) and therefore the crude material was telescoped through to the next step. The final step 
in the synthesis was the formation of the chloroamine 255. Following the conditions used by 
De Luca et al., the crude amine was stirred with N-chlorosuccinimide in DCM for 3 hours 
followed by purification by column chromatography to remove the succinimide by-product.79 
This unfortunately provided low yields over the two steps (20-25 %) but enough material was 
obtained to try the N-arylation reaction under various conditions. 
 
 
Scheme 2.5 
 
2.2.2 Intramolecular N-arylation reactions on pyridine substrates 
 
With the successful synthesis of the chloroamine derivatives achieved, investigations into the 
light-mediated N-arylation under conditions previously detailed by Sarpong et al. were 
attempted.43 This involved photolysis of the chloroamines 256a and 256b with Et3N in DCM 
(Table 2.8, Entries 1-2) Using a 125W high pressure mercury lamp. Unfortunately, when basic 
conditions were employed the product was not observed by LC-MS analysis or 1H NMR and 
only amines 259 and 261 was isolated. The reaction was also attempted under the acidic 
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conditions that have previously been shown to work the best within the Marsden group (Table 
2.8, Entries 3-4). The use of both MeSO3H and conc. H2SO4 was attempted however, no 
product was observed in either reaction and only the dechlorinated amine was recovered (Table 
2.8, Entries 3-5).  
 
 
 
Entry Substrate Conditions Products 
1 3-pyridine 256a Et3N, DCM, hυ, RT, 5 h Amine 259 
2 4-pyridine 256b Et3N, DCM, hυ, RT, 5 h Amine 261 
3 3-pyridine 256a MeSO3H, DCM, hυ, RT, 5 h Amine 259 
4 4-pyridine 256b MeSO3H, DCM, hυ, RT, 5 h Amine 261 
5 4-pyridine 256b H2SO4, hυ, RT, 5 h Amine 261 
Table 2.8 
 
Under the acidic conditions the pyridine nitrogen would be protonated, making the system 
more electron-deficient. Therefore, it is likely to show decreasing reactivity towards the 
electrophilic aminyl radical as it requires a more nucleophilic species to react with. 
 
 
Figure 2.5 
 
After a lack of success with the chloroamines it was proposed that the iodoamine could be 
formed in situ then photolysed as detailed by Sarpong et al (Scheme 2.6).43 The reaction was 
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carried out exactly as described in Sarpong’s paper, however no desired product was observed 
by 1H NMR or LC-MS analysis and only the amine 259 was recovered. 
 
 
Scheme 2.6 
 
2.2.3 Methoxypyridine substrates 
 
Due to the lack of success with the pyridyl series under a range of conditions, a new substrate 
was proposed. The structure was based on the core of arboflorine 103 which was constructed 
through metal-free N-arylation methodology by Sarpong et al.43 The pyridine ring in this case 
is more electron rich due to the methoxy group, two alkyl substituents and the heteroaryl group. 
 
 
Figure 2.6 
 
A methoxy group was added in the 2-position of the pyridine to make a more electron-rich 
system than the previous substrates with the hope of promoting the cyclisation. With the alkyl 
chain para to the methoxy this would then allow cyclisation to either the 4 or 6-position of the 
pyridine ring (compound 263). 
 
 
Figure 2.7 
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The synthesis of the methoxypyridine substrate 263 was carried out via the same synthetic 
route used for the previous substrates (Scheme 2.7). The Wittig reaction used to form ester 266 
provided higher yields than previously seen in the pyridyl series. Hydrogenation afforded ester 
267 in 88% yield, which was converted to the amide 268 in 94% yield. The amide 268 was 
reduced to the amine using LiAlH4, which was directly converted to the chloroamine 263 in a 
48% yield over 2 steps. The yield over these 2 steps was an improvement on the yields observed 
for the previous pyridyl substrates and it allowed us to access enough of the desired 
chloroamine 263 to test various N-arylation conditions. 
 
 
Scheme 2.7 
 
The substrate 263 was subjected to conditions already applied to previous substrates (Table 
2.9). Under basic conditions none of the desired product was observed by LC-MS analysis or 
1H NMR with the amine being the major product of the reaction (Table 2.9, Entry 1). The acidic 
conditions that have been successful for other substrates within the Marsden group were 
applied, however no desired product was observed when using either H2SO4 or MeSO3H (Table 
2.9, Entries 2-3).  
 
 
Entry Conditions Product 
1 Et3N (6 eq), DCM, hυ, RT, 5 h Amine 271 
2 MeSO3H (10 eq), DCM, hυ, RT 5 h Amine 271 
3 H2SO4 (80% soln. in H2O), hυ, RT, 5 h Amine 271 
Table 2.9 
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The last set of conditions that were trialled were Sarpong’s (Scheme 2.8) which forms the 
iodoamine in situ, again however this did not yield any of the desired product and only amine 
271 was obtained. 
 
 
Scheme 2.8 
 
In summary the intramolecular aromatic amination of the pyridine has been unsuccessful using 
the substrates that we have proposed both with and without the methoxy group present. 
Sarpong’s conditions used in the synthesis of arboflorine were also applied however no desired 
products were obtained. These conditions could have been successful in Sarpong’s case due to 
the enforced proximity of the reactive aminyl radical to the pyridine ring. In the pyridine 
substrates that we have investigated there is a higher degree of rotational freedom of the radical 
which is not held in close proximity to the pyridine ring. This decreases the likelihood of 
cyclisations and increasing the possibility of hydrogen abstraction before the radical can 
cyclise. 
 
2.3 Amidyl radicals 
 
To continue our investigations into N-arylation reactions of nitrogen-centred radicals and to 
expand the substrate scope, amidyl radicals were tested under various conditions. 
 
2.3.1 Synthesis of substrates for tetrahydroquinolinones 
 
Due to previous success within the Marsden group with similar amine substrates, the amide 
276 was proposed. The proposed synthesis for the amide 276 is shown in Scheme 2.9. The first 
step was a hydrogenation reaction to reduce the double bond which afforded the ester 274 in a 
94% yield. Initial trials to convert ester 274 to amide 275 in one step by refluxing in 
methylamine as had been previously used in the pyridine substrate synthesis was not successful 
and gave a mixture of the starting ester 274, ethyl ester and the amide 276. Therefore, it was 
decided to proceed via saponification of ester 274 to yield the carboxylic acid 275 in a 74% 
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yield. The acid 275 was converted via an amide coupling reaction with methylamine to afford 
the desired amide 276 in a 72% yield. 
 
 
Scheme 2.9 
 
Due to issues previously encountered within the group when attempting the chlorination of an 
amide using NCS, in which no chlorination was observed, it was decided to proceed with 
bromination instead. However, the conditions found within the literature did not yield the 
desired product and instead only the starting amide 276 was recovered (Scheme 2.10). 
 
 
Scheme 2.10 
 
With the unsuccessful attempts to brominate the amide, alternative conditions were found for 
chlorination.80 This reaction involves the in situ formation of tert-butyl hypochlorite. This 
reaction proceeded well using one equivalent of each reagent and afforded the desired 
compound 278 in reasonable yields (Scheme 2.11). 
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Scheme 2.11 
 
Different equivalents of the reagents were investigated to see if the yield could be increased 
(Table 2.10).  Gratifyingly the yield was shown to improve with the best results being seen 
when using 1.5 equivalents of each reagent; no chlorination on the aryl ring was observed 
(Table 2.10, entry 3).  
 
Entry Equivalents of reagents 
Yield of chloroamide 
278 
1 NaOCl (1.00 eq), AcOH (1.00 eq), tBuOH (1.00 eq) 54 % 
2 NaOCl (1.05 eq), AcOH (1.05 eq), tBuOH (1.05 eq) 66 % 
3 NaOCl (1.50 eq), AcOH (1.50 eq), tBuOH (1.50 eq) 83 % 
Table 2.10 
 
With the chloroamide 278 in hand, the compound was irradiated under UV light using a 125W 
high pressure mercury lamp under a range of conditions for the N-aryl cyclisation reaction. The 
acidic, basic and Lewis acid conditions were chosen due to previous work carried out within 
the Marsden group.77 Neutral conditions which utilise a range of solvents of increasing polarity 
were chosen in line with what had been used previously in literature.81 When the reaction was 
tried under basic conditions or neutral conditions this did not yield any of the desired product 
(Table 2.11). A similar result was seen when the reaction was carried out in the presence of a 
Lewis acid (Table 2.11, Entry 9). Only the dechlorinated amide 276 was isolated at the end of 
the reactions. An interesting result was observed when the reaction was carried out in 10 
equivalents of methanesulfonic acid; the benzylic chloride 280 was isolated in a 52% yield 
(Table 2.11, Entry 2). One way in which the benzylic chloride product 280 could be formed is 
if after homolytic cleavage of the N-Cl bond the amidyl formed abstracts a hydrogen from 
another chloroamide. This would generate a benzylic radical which could then abstract a 
chlorine from another molecule of chloroamide. This reaction was repeated in the dark to 
establish if this reaction was photochemically mediated. Only the chloroamide was obtained 
after 5 hours showing that it is a light mediated process. The same result however was not 
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found in the stronger acidic conditions when concentrated H2SO4 was used (Table 2.11, Entry 
3). 
 
 
Entry Conditions Products 
1 Et3N (6 eq), DCM, hυ, RT, 5 h Amide 276 (90%) 
2 MeSO3H (10 eq), DCM, hυ, RT, 5 h 280 52% yield 
3 H2SO4 (80% soln. in H2O), hυ, RT, 5 h Amide 276 (85%) 
4 DCM, hυ, RT, 5 h Amide 276 (93%) 
5 Toluene, hυ, RT, 5 h Amide 276 (84%) 
6 CH3CN, hυ, RT, 5 h Amide 276 (89%) 
7 t-Butanol, hυ, RT, 5 h Amide 276 (88%) 
8 2-Methyl but-2-ene (1 eq), DCM, RT, hυ, 5 h Amide 276 (86%) 
9 BF3.OEt2(5 eq), DCM, hυ, RT, 5 h Amide 276 (85%) 
Table 2.11 
 
The structure of 280 was assigned through the NOESY NMR spectrum to confirm which 
carbon the chlorine was on. It showed there was a long range correlation between H2 and the 
amide proton but no correlation between H1 and the amide proton. The signal for H1 showed a 
correlation to H2 but no long range correlation was observed between H1 and H3 (Figure 2.7). 
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Figure 2.8 
 
2.3.2 Synthesis of substrates for N-acetyltetrahydroquinolinones 
 
Investigations within the literature into amidyl radicals looked at both the amide both in and 
outside of the ring. Therefore, the second substrate that we investigated for the formation of 
the six-membered rings via amidyl radicals, had the inverted amide bond so the carbonyl would 
be exo- to the forming ring. The first step in the synthesis of the chloroamide 283 was the 
acetylation of phenylpropylamine 281, which proceeded in quantitative yield (Scheme 2.12). 
The chlorination of the amide 282 was carried out under the previously established conditions 
to afford chloroamide 283 in 65% yield. 
 
Scheme 2.12 
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The same conditions for the N-arylation reaction were screened against the chloroamide 283 
(Table 2.12). Unfortunately, none of the conditions afforded any of the desired product with 
the major product being the amide 282.  
 
 
Entry Conditions Products (isolated yields) 
1 Et3N (6 eq), DCM, hυ, RT, 5 h Amide 282 (90%) 
2 MeSO3H (10 eq), DCM, hυ, RT, 5 h Amide 282 (89%) 
3 H2SO4 (80% soln. in H2O), hυ, RT, 5 h Amide 282 (87%) 
4 DCM, hυ, RT, 5 h Amide 282 (92%) 
5 Toluene, hυ, RT, 5 h Amide 282 (88%) 
6 MeCN, hυ, RT, 5 h Amide 282 (93%) 
7 t-Butanol, hυ, RT, 5 h Amide 282 (88%) 
8 2-Methyl but-2-ene, DCM, hυ, RT, 5 h Amide 282 (86%) 
9 BF3.OEt2, DCM, hυ, RT, 5 h Amide 282 (85%) 
Table 2.12 
 
Within the literature a control experiment was carried out by Kuehne et al to show whether the 
amidyl radical would carry out a 6-exo cyclisation, however this reaction only yielded the 
amide 160.59  
 
 
Scheme 2.13 
 
This could explain why the trials to form the tetrahydroquinolones under our conditions; even 
when a 6-membered ring could be formed, have been unsuccessful and no cyclisation product 
was observed. If the same stereoelectronic traits were at play then preference for the 5-
membered ring formation would lead to the formation of the spiro compound 285. This might 
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not be a facile process due to the inability of this compound to re-aromatise making this process 
unfavourable.  
 
 
Figure 2.9 
 
2.3.3 Synthesis of substrates for dihydroindolones 
 
Due to the unsuccessful investigations into cyclisations to form 6-membered rings studies into 
the 5-membered ring formation were initiated. The amide 287 was constructed from 
phenylacetic acid 286 and methylamine via an amide coupling reaction in 74% yield. The next 
step was the chlorination of amide 287 which was carried out under the previously established 
conditions and afforded the desired chloroamide 288 in 84 % yield (Scheme 2.14). 
 
 
Scheme 2.14 
 
Applying the neutral and basic conditions previously used did not yield any of the desired 
product (Table 2.13). Also, no product was observed in concentrated sulphuric acid, however 
when 10 equivalents of methanesulfonic acid was used, product 289 was observed by 1H NMR 
and LC-MS analysis. Unfortunately, none of the desired product was isolated with only the 
amide 287 isolated. The conditions using the BF3.OEt2 in DCM yielded 10 % of the desired 
product 289 with the amide 287 being the major product.  
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Entry Conditions Product (isolated yield%) 
1 Et3N (6 eq), DCM, hυ, RT 5 h Amide 287 (88%) 
2 MeSO3H (10 eq), DCM, hυ, RT, 5 h Amide 287 (80%) + dihydroindolones 
289 (trace) 
3 H2SO4 (80% soln. in H2O), hυ, RT, 5 h Amide 287 (85%) 
4 Toluene, hυ, RT, 5 h Amide 287 (92%) 
5 DCM, hυ, RT, 5 h Amide 287 (95%) 
6 t-Butanol, hυ, RT, 5 h Amide 287 (96%) 
7 BF3.OEt2 (5 eq), DCM, hυ, RT, 5 h Dihydroindolones 289 (10% yield) 
Table 2.13 
 
With the initial success seen with the Lewis acid conditions in DCM a different Lewis acid was 
examined. It was also hoped that less polar solvents would force the Lewis acid to interact with 
the chloroamide 288 and promote the cyclisation to form the desired product 289 (Table 2.14). 
Toluene was chosen as the solvent and desired product was isolated in 9% yield, however a 
large amount could not be separated from an unidentified side product. Other solvents tried 
included anisole and chlorobenzene however the desired product was not isolated from either 
of these reactions. The other investigation that was carried out looked into changing the Lewis 
acid and for this aluminium trichloride was picked. This did not afford any of the desired 
product. The reaction was also carried out in the dark (as a control) to observe whether the 
dichlorination to form the free amide light mediated or not. After five hours only the 
chloroamide 288 was observed by 1H NMR and LC-MS analysis showing that the light is a 
key factor in the reaction. 
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Entry Conditions Products (isolated yield%) 
1 BF3.OEt2, DCM, hυ, RT, 5h Amide 287 +  product 289 (10% yield) 
2 BF3.OEt2, toluene, hυ, RT, 5h Amide 287 + product. 289 (9% yield) 
3 BF3.OEt2, anisole, hυ, RT, 5h Amide 287 (95%) 
4 BF3.OEt2, chlorobenzene, hυ, RT, 5h Amide 287 (92%) 
5 AlCl3, DCM, hυ, RT, 5h Amide 287 (93%) 
6 BF3.OEt2, DCM, dark, RT, 5h Chloroamide 288 (98%) 
Table 2.14 
 
2.3.4 Synthesis of substrates for N-acetyldihydroindolones 
 
Following on from our previous investigations into amidyl radicals it was also decided to 
investigate the acetylated version where the amide would be in the exo- position to the ring 
after cyclisation. This could also show whether having the sp2
 
internal or external has an effect 
on the cyclisation of the amidyl radical. The first step in the synthesis was the acetylation of 
phenylethylamine 290 which gave the desired product 291 in 84% yield (Scheme 2.15). The 
next step was the chlorination of the amide using the previously established conditions to afford 
chloroamide 292 in a 78% yield.  
 
 
Scheme 2.15 
 
The same conditions that were tested previously were applied to the chloroamide 292 (Table 
2.15). No desired product was observed under the basic conditions or acidic conditions with 
only the dechlorinated amide being isolated. The Lewis acid conditions yielded a more positive 
result with traces of the product being observed by 1H NMR and LC-MS analysis. However, 
after purification only 3% yield of the desired compound were obtained with impurities.  
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Entry Conditions Result 
1 Et3N (6 eq), DCM, hυ, RT, 5h Amide 291 (92%) 
2 MeSO3H (10 eq), DCM, hυ, RT, 5h Amide 291 (93%) 
3 Toluene, hυ, RT, 5h Amide 291 (94%) 
4 DCM, hυ, RT, 5h Amide 291 (88%) 
5 MeCN, hυ, RT, 5h Amide 291 (90%) 
6 t-Butanol, hυ, RT, 5h Amide 291 (94%) 
7 BF3.OEt2 (5 eq), DCM, hυ, RT, 5h Amide 291 + product 293 (3% 
yield impure) 
Table 2.15 
 
As a result of the success of the Lewis acid reaction, the compound was tested with an 
alternative Lewis acid and other non-polar solvents (Table 2.16). When toluene was used as 
solvent none of the desired product was observed by 1H NMR or LC-MS analysis. However, 
when it was tested in hexane the product was observed by 1H NMR and 6% yield of the product 
was isolated after purification with impurities present. When the reaction was carried out using 
the AlCl3 none of the desired product was isolated. As before, the reaction using BF3.OEt2 in 
DCM was also carried out in the dark. After 5 hours only the chloroamide 292 was present in 
the reaction mixture. 
 
 
Entry Conditions Products (isolated yields%) 
1 BF3.OEt2 (5 eq), DCM, hυ, RT, 5h Amide 291 + D.P. 293 (3% yield impure) 
2 BF3.OEt2, toluene, hυ, RT, 5h Amide 291 (95%) 
3 BF3.OEt2, hexane, hυ, RT, 5h Amide 291 + D.P. 293 (6% yield impure) 
4 AlCl3, DCM, hυ, RT, 5h Amide 291 (94%) 
Table 2.16 
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2.3.5 Constrained systems 
 
Due to success that had been seen previously in the group with less conformationally free 
substrates it was decided to try and see if this would have an effect for amidyl radicals. An 
example of a biaryl system was found within the literature in which they formed the iodoamide 
166 in situ which then cyclised.61 The amide 165, was prepared by an amide coupling with 
biphenylcarboxylic acid 294 and methylamine in 72% yield (Scheme 2.16).  
 
 
Scheme 2.16 
 
The conditions to form the iodoamide in situ were then attempted with the only change made 
to the conditions was DCM used instead of carbon tetrachloride (Scheme 2.17). In the paper 
the reaction was irradiated under UV light for 1.5 hours, however in our hands this only yielded 
trace product. It was therefore decided to extend this time to 5 hours but again only trace 
product was observed by 1H NMR.  
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Scheme 2.17 
 
The signals corresponding to the amide 165 were still observed as the major component of the 
reaction mixture in the crude 1H NMR spectrum (Figure 2.9). The signals that are outlined in 
green in Figure 2.10  correspond to the desired product.61 The same result is observed whether 
the reaction mixture is irradiated under UV light for 1.5 or 5 hours.  
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Figure 2.10 
 
It was then decided to try and see if the chloroamide 295 might give better results. There were 
issues with the formation of the chloroamide for this compound due to solubility issues with 
the starting material. Better results were seen with toluene, as opposed to MTBE or EtOAc, 
and a small amount of the chloroamide 295 was obtained (Scheme 2.18). 
 
 
Scheme 2.18 
 
The substrate 295 was subjected to the neutral conditions and photolysis with a Lewis acid. 
Unfortunately, no product was observed when the reaction was carried out under neutral 
conditions using DCM as solvent (Scheme 2.19). Only the amide 165 was isolated at the end 
of the reaction. 
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Scheme 2.19 
 
Photolysis of the bi-aryl system was also attempted under the Lewis acid conditions that had 
previously shown success with a different substrate, trace product was observed by 1H NMR 
(Scheme 2.20). A control experiment was also carried out in the dark after 5 hours only the 
chloroamide was present in the reaction mixture showing the irradiation under UV light is key 
to the formation of the product. There was no improvement under these conditions compared 
with the formation of the iodoamide in situ. 
 
 
Scheme 2.20 
 
The intramolecular aromatic amination reactions using the amidyl reactions to form the six-
membered quinolone substrates has been unsuccessful under a range of conditions. This could 
be due to the preference for five membered rings. 
 With regards to the cyclisation to form five-membered rings some success with the addition 
of Lewis acids to the reaction mixture with the desired product isolated in 10% yield. These 
conditions have been applied to several substrates with limited success seen.  
The conformationally restrained systems also showed limited success under the conditions 
found within the literature and under the conditions that had proved to be the most successful 
for our proposed substrates. There was also difficulty in chlorinating the bi-aryl systems due to 
solubility issues with the compound which also added to its limited success. 
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Chapter 3 N-arylation reactions using chloroamines and iron salts 
 
3.1 Introduction 
 
Current N-arylation techniques, such as the Buchwald-Hartwig cross-coupling reaction and the 
Ullmann coupling, often require expensive or bespoke ligands (eq xphos, tBuBrettphos), 
require pre-functionalised aryl species and precious-metal catalysts leading to high-cost 
synthetic routes.7,11 An alternative method that can be used is direct aromatic amination of 
unfunctionalised aromatics with aminium radicals which can be generated through a variety of 
methods such as photolysis, single electron transfer and thermolysis.  
A modified version of the HLF reaction was demonstrated by Minisci who showed that 
chloroamines could be used to aminate aromatic rings in either intermolecular or 
intramolecular reactions. The limited examples in the literature use Fe(II) and Ti(III) salts in 
concentrated acid (Scheme 3.1).45  
 
 
 
Scheme 3.1 
 
This process suffers from problems associated with using concentrated sulfuric acid as the 
reaction solvent, such as its highly corrosive nature, the viscosity of the reaction and the 
aqueous nature of it which leads to heterogenous reaction mixtures. It was therefore decided to 
investigate whether the iron salts could be used in conjunction with the homogenous organic 
media conditions that have been previously established within the Marsden group for use in 
photolysis, which utilise MeSO3H in DCM (Scheme 3.2). Intial investigations focused on the 
formation of THQs so a direct comparison with the photochemical approaches developed 
within the group can be carried out. There had also been one THQ example within the literature 
demonstrated by Minisci where R’ = H and R = Me, which utilised the aqueous conditions. 
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Scheme 3.2 
 
3.2 Intramolecular amination 
 
Initial investigations were carried out on the chloroamine substrate 115, which Minisci et al. 
had shown was able to cyclise using concentrated sulfuric acid as the reaction medium; this 
was readily synthesised through reductive amination of hydrocinnamaldehyde 298 followed by 
chlorination of amine 237 using NCS (Scheme 3.3). 79 The chloroamines can be purified by 
column chromatography and most can be fully characterised, some decompose during LC-MS 
analysis to the parent amine. 
 
Scheme 3.3 
 
The conditions used by Minisci et al. utilised H2SO4/AcOH (3:1) as the solvent.45 These 
conditions were initially tested upon chloroamine 115; pleasingly, when the reaction was 
cooled to 0 oC, a 39% yield of the desired product 116 was obtained (Table 3.1, entry 1). Upon 
further cooling to -5 oC, the yield increased dramatically to 80%, as it eliminated the production 
of a resinous compound observed when the reaction is not cooled. Both of the reactions were 
carried out in the dark, which was ensured by wrapping the flask in tin foil, to ensure that light 
was not responsible for the breaking of the N-Cl bond to form the nitrogen centred radical. The 
reactions were also carried out open to light and the same yield for the products was obtained 
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Entry Conditions Yield of 116 (%) 
1 FeSO4.7H2O (10 mol%), H2SO4, AcOH (3:1), 0 oC, 1 h 39 
2 FeSO4.7H2O (10 mol%), H2SO4, AcOH (3:1), -5 oC, 1 h 80 
Table 3.1 
 
Due to the success of this substrate under the aqueous conditions, it was chosen as a model 
substrate for optimisation of organic media-based conditions. Investigations into screening a 
variety of acids, iron salts and stoichiometries of both, were undertaken in DCM initially. The 
reason DCM was used before any solvent screen was carried out was due to previous studies 
carried out into the photochemical version of the reaction. 
 
3.2.1 Acid screen 
 
A variety of acids were investigated using 10 eq. of each in the attempted N-arylation reaction 
of the chloroamine 115 (Table 3.2). Investigations into the photochemical version of the 
reaction within the Marsden group demonstrated that 10 eq. of acid gave the best results 
therefore investigations began with 10 eq. of acid. The poor solubility of p-TsOH and 
camphorsulfonic acid in DCM could be the reason why no reaction occurred and only SM was 
observed after 1 hour (Table 3.2, entry 1-2). Test reactions with these acids were also carried 
out in methanol to improve the solubility of the acids, however again only SM was observed 
after 1 hour. When 3N HCl in MeOH was used the amine 236 was the only product of the 
reaction (Table 3.2, entry 4). The result with acetic acid (Table 3.2, entry 5) suggests that the 
pKa of the acid may also play a key role in whether the acid will aid the formation of the desired 
product. The pKa for methanesulfonic acid in water is -2.42 which is comparable to that of p-
TsOH (-2.8), this suggests that it is the solubility of p-TsOH acid in DCM that could be 
hindering the reaction in this case rather than the strength of the acid. This is based on the pKa’s 
of the acids being similar in DCM or following similar trends observed in water. The only acid 
screened that generated the desired THQ 116 was MeSO3H, with all other acids affording the 
amine 236 or SM 115 after 1 hour (Table 3.2, entry 6).  
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Entry Acid (10 eq.) Product (isolated yield%) 
1 p-TsOH Starting material 115 
2 Camphorsulfonic acid Starting material 115 
3 TFA Starting material 115 
4 3N HCl in MeOH Amine 236 (90% recovery)  
5 AcOH Starting material 115 
6 MeSO3H THQ 116 (73%) 
Table 3.2 
 
The reaction was carried out using MeSO3H at RT, 0 oC and -5 oC with similar yields obtained 
at the lower temperatures, but at RT more of the dechlorinated starting material 236 was formed 
(Table 3.3). It was noted that the reaction is exothermic upon the addition of the acid which 
suggests higher temperatures are detrimental to the cyclisation of the aminium radical. The 
order of addition of the reagents doesn’t affect the overall yield. Therefore, reactions were 
carried out at 0 oC from this point onwards. Control experiments were also carried out in the 
absence of acid or iron salt. In both cases only the SM 115 was observed after 1 hour, and no 
decomposition of the SM was observed. 
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Entry Conditions Product (isolated yield%)
 
1 FeSO4.7H2O (10 mol%), MeSO3H (10 eq.), RT, 1 
h 
THQ 116 (50%) 
2 FeSO4.7H2O (10 mol%), MeSO3H (10 eq.), 0 oC, 1 
h 
THQ 116 (73%) 
3 FeSO4.7H2O (10 mol%), MeSO3H (10 eq.), -5 oC, 
1 h 
THQ 116 (73%) 
4 FeSO4.7H2O (10 mol%), 0 oC, 1 h SM 115 
5 MeSO3H (10 eq.), 0 oC, 1 h SM 115 
Table 3.3 
 
With the best acid for the reaction and the optimum temperature in hand, a range of iron salts 
were screened. 
 
3.2.2 Iron salt screen 
 
It was then decided to screen a variety of Fe(II) salts. The formation of the desired product 116 
was observed when using either FeSO4.7H2O, FeCl2 or ferrocene (Table 3.4, Entries 1,2 and 
4). When Fe(CO2CH3)2 and Fe(OTf)2 were used, only the amine 236 was obtained (Table 3.4, 
Entries 6-7). The best yields were observed with FeSO4.7H2O, and therefore this was used for 
the further optimisation of the reaction conditions. Investigations were also carried out using 
an Fe(III) salt to demonstrate that the reaction is initiated by a single electron transfer from the 
iron salt to the N-Cl bond rather than by Lewis acid catalysis. When using FeCl3, it was found 
that after an hour only the SM 115 was present, therefore supporting the theory of electron 
transfer from the iron salt (Table 3.4, Entry 3). Colourisation of the solutions was observed in 
the reactions using ferrocene, Fe(acac)2 and Fe(OTf)2 suggesting that the iron(II) source was 
soluble in DCM giving a homogenous reaction mixture. 
 
78 
 
 
Entry Change in Iron Salt (10 
mol%) 
Products (isolated yield%) 
1 FeSO4.7H2O THQ 116 (73%) 
2 FeCl2 THQ 116 (63%) 
3 FeCl3 SM 115 (90%) 
4 Ferrocene THQ 116 (20%) and chlorinated THQ 
299 (trace) 
5 Fe(acac)2 SM 115 (88%) 
6 Fe(CO2CH3)2 Amine 236 (88%) 
7 Fe(OTf)2 Amine 236 (85%) 
Table 3.4 
 
Through each of these investigations it was shown that the best conditions were FeSO4.7H2O 
(10 mol%) and MeSO3H (10 eq.) in DCM. With these successful conditions in hand it was then 
decided to investigate the optimal number of equivalents of both the acid and the iron salt. 
 
3.2.3 Iron salt and acid equivalents optimisation 
 
A range of equivalents of acid and iron salt (2.5 – 10 eq.) were investigated, as shown in Table 
3.5. The reactions are carried out at 0.2 M. As can be seen in Table 3.5, the number of 
equivalents cannot be lowered to below 2.5 mol% of iron or 2.5 eq. of acid, as this leads to 
none of the desired product 116 being formed, only the SM 115 is observed after 1 hour. The 
best yield is observed when 10 eq. of MeSO3H and 10 mol% of iron salt is used. There appears 
to be a correlation between the number of equivalents of acid and the loading of iron: a change 
in the balance is detrimental, leading to either the formation of amine 236 or only SM 115 
being observed by LC-MS analysis after 1 hour. 
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Iron Salt (mol%) 2.5 5 7.5 10 
10 0% 0% 70% 73% 
7.5 0% 54% 68% 53% 
5 0% 55% 53% 56% 
2.5 0% 0% 0% 0% 
*Red = SM or free amine, Amber = d.p. yield less than 60%, Green = d.p. yield over 60% 
** Average isolated yields shown in table for replicate runs of each reaction. 
Table 3.5 
 
With the optimised set of conditions in hand with regards to the iron salt and the acid, it was 
decided to screen a variety of solvents with differing degrees of polarity.  
 
3.2.4 Solvent screen 
 
Using the optimised reaction conditions established previously, a solvent screen was carried 
out to establish if DCM was the best solvent. The use of EtOAc stopped the reaction occurring 
and only the SM 115 was observed after 1 hour (Table 3.6). When the reaction was carried out 
using 2-methylTHF, the only compound observed after 1 hour was the amine 236. A trace of 
the desired product 116 was observed by 1H NMR analysis when using dioxane, however none 
was isolated. Both 2-methylTHF and dioxane can act as a source of hydrogen atom which can 
be readily abstracted by the electrophilic aminium radical, this could explain why the amine 
236 is observed rather than the cyclised product.82 When the reaction was carried out in toluene 
it was observed that the MeSO3H was immiscible and although the desired product 116 was 
isolated in a 45% yield, this could be a contributing factor to the decrease in yield observed 
compared to when DCM is used. 
 
 
 
 
 
Equivalents of Acid 
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Entry Solvent Products (isolated yield%) 
1 MeOH Amine 236 (85%) 
2 EtOAc SM 115 (90%) 
3 2-methyl THF Amine 236 (88%) 
4 Dioxane Trace THQ 116 and Amine 236 (50%) 
5 DCM THQ 116 (73%) 
6 Toluene THQ 116 (45%) and trace amine 236  
Table 3.6 
 
Through carrying out this solvent screen using a variety of polar to non-polar solvents it was 
shown that DCM is the optimal solvent in which to carry out this reaction. Therefore, with an 
optimised set of conditions in hand, the scope of the reaction could be investigated. 
 
3.3 Substrate scope 
 
Substrates possessing a variety of different substitution patterns were synthesised by altering 
the groups on the aromatic ring, the nitrogen and the alkyl chain, to investigate the scope of the 
reaction. 
 
3.3.1 Nitrogen substitution  
 
Different substitution patterns on the nitrogen can be achieved through changing the amine 
used during the reductive amination of hydrocinnamaldehyde 298, which has been previously 
done within the group.77 The synthesis of the allyl-, butyl- and hexyl-substituted chloroamines 
is shown in Table 3.7. The reductive amination with each of the corresponding amines 
proceeded well, however, purification issues with the hexyl substrate led to a lower yield. 
Chlorination of each of the amines using NCS afforded the desired chloroamines in good 
yields. 
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Entry Substrate (R=) Step (i) Yield (%) Step (ii) Yield (%) 
1 Allyl a 91 71 
2 Butyl b 85 70 
3 Hexyl c 31 70 
Table 3.7 
 
These substrates were subjected to the standard conditions for N-arylation. Pleasingly the 
desired products from the cyclisations were achieved in good yields (Table 3.8). 
 
 
Entry Substrate Yield (%) 
1 Allyl a 69 
2 Butyl b 43 
3 Hexyl c 48 
Table 3.8 
 
With regards to the hexyl substrate, previous work carried out within the group on the 
photolysis of chloroamine 302c showed that there was a competition reaction between the HLF 
and the N-arylation reaction (Scheme 3.4). Due to the length of the chain, a 1,5-hydride 
abstraction followed by a radical recombination reaction to give the chloroalkylamine 306 is 
possible. However, none of chloroalkylamine 306 was observed by LC-MS or 1H NMR 
analysis, when subjected to the standard N-arylation conditions developed within this work. 
The 1,5-hydride abstraction can occur, however, as no chlorine radical is generated in the 
breakdown of the chloroamines, the radical recombination step that forms the chloroalkylamine 
306 cannot occur via that mechanism. 
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Scheme 3.4 
 
Successful synthesis of these substrates has demonstrated that substitution on the nitrogen is 
tolerated for different groups. 
 
3.3.2 Substituted aromatics 
 
It was then envisaged that a variety of substrates with different substituents and substitution 
patterns on the aromatic ring could be synthesised via the synthetic route shown in Scheme 3.5. 
The first step would involve substitution of a benzyl bromide or a benzyl mesylate with a 
Grignard reagent (allylmagnesium bromide) to afford the terminal alkene 308. Compound 308 
could then undergo an ozonolysis reaction to afford the corresponding aldehyde 309. Reductive 
amination of compound 309 followed by chlorination would afford the desire chloroamine 311. 
 
 
Scheme 3.5 
 
Depending on the availability of starting materials, either a benzyl bromide or a benzyl alcohol 
was chosen for the Grignard displacement reaction. The substrates synthesised using the 
corresponding benzyl bromide 312, along with the yields, are shown in Table 3.9. All the 
corresponding terminal alkenes were obtained in excellent yields.  
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Entry Substrate Yield (%) 
1 4-Me 308a 93 
2 3,5-Me 308b  95 
3 3-Cl 308c 99 
Table 3.9 
 
The benzyl alcohols were converted to benzyl mesylates and the crude material was telescoped 
through to the next step (Table 3.10). Displacement of the mesylate by allylmagnesium 
bromide afforded the desired terminal alkenes 308. The range of substrates synthesised using 
this method are shown in Table 3.10. The yields were slightly lower than those of the benzyl 
bromides, but desired products were obtained in adequate yields. 
 
 
Entry Substrate Yield (%) 
1 4-Cl 308d 42 
2 2-Cl 308e 62 
3 4-Br 308f 68 
4 4-OMe 308g 63 
Table 3.10 
 
With the terminal alkenes 308 in hand, the rest of the synthetic route was carried out to afford 
the desired chloroamines. Ozonolysis of the terminal alkenes 308 afforded the aldehydes 309 
in 60-87% yields. Reductive amination of aldehydes 309 generated the amines 310 in excellent 
yields. Chlorination of amines 310 yielded enough of the desired chloroamines 311 to proceed 
to the N-arylation reactions. The conditions and the yields of each step for the corresponding 
substrates is shown in Table 3.11. 
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Entry Substrate Step (i) Step (ii) Step (iii) 
1 4-Me a 72 97 73 
2 3,5-Me b 73* 95 66 
3 3-Cl c 76 88 85 
4 4-Cl d 87 88 67 
5 2-Cl e 68 72 59 
6 4-Br f 80 86 75 
*crude yield – material was telescoped through 
Table 3.11 
 
Unfortunately, when the aromatic ring is substituted with a methoxy group the aldehyde cannot 
be formed through ozonolysis due to potential oxidation of the aromatic ring. When ozonolysis 
was trialled only trace of the desired product was isolated nothing else could successfully be 
isolated (myriad of spots by TLC). Therefore, an alternative step to obtain the aldehyde was 
proposed, as shown in Scheme 3.6. The diol 315 was formed from dihydroxylation of the 
alkene 308g followed by oxidative cleavage using sodium periodate, which afforded the 
desired aldehyde 316 in quantitative yield. The aldehyde 316 was then converted to amine 317 
via reductive amination. Another problem was encountered during the chlorination step. The 
conditions used previously, which utilise NCS in the chlorination step, cannot be used as they 
were found to chlorinate the electron-rich aromatic ring. Alternative conditions found involve 
the in situ formation of tert-butyl hypochlorite which allows the nitrogen to be selectively 
chlorinated.80  
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Scheme 3.6 
 
With the desired chloroamines in hand, the key N-arylation reaction was then carried out for 
each of the substrates (Scheme 3.7). Pleasingly, the p-Me product 324 was obtained in a good 
yield (78%). The yield of the di-methyl product 321 was lower due to competing chlorination 
on the aromatic ring, which was observed by LC-MS analysis, and which may have occurred 
as a result of the aromatic being more electron-rich. The substrates which are more electron-
poor, such as substrates with p-Br 322, m-Cl 325 and p-Cl 320 substituents, did undergo N-
arylation, however, the reaction time needed to be increased from 1 hour to 8 hours for 
complete conversion. The yields for the m-Cl 325 and p-Cl compounds 320 were lower which 
could be due to the increased electronegativity of chlorine rendering the aromatic ring more 
electron-poor and was accompanied by an increase in the formation of the dechlorinated 
starting material. Although the chlorine was tolerated in the m-position and p-position of the 
aromatic ring, it was not tolerated in the o-position, which led only to the formation of the 
amine 310e. This could be due to blocking one of the positions for attack of the aminium radical 
on a substrate which has poor reactivity for N-arylation. The methoxy group was also not 
tolerated, with mainly the reduced amine observed. A product whose mass matched the 
chlorinated tetrahydroquinoline was observed by LC-MS analysis, however, it could not be 
isolated. 
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Scheme 3.7 
 
There has been success with the synthesis of substrates with a variety of substitution patterns 
on the aromatic ring. Some problems have been observed with electron-withdrawing 
substituents, especially chlorine in the o-position which resulted in only SM being isolated 
from the RM. Similar yields are obtained when using the photochemical conditions. Chlorine 
in the 2-position is tolerated under the photochemical conditions. 
 
3.3.3 Alkyl substitution 
 
Substrates with different alkyl substituents were achieved through a variety of methods. The 
first method attempted involved the reductive amination of 4-phenyl-2-butanone 327 with 
methylamine to afford the amine 328 in excellent yields (Scheme 3.8). The amine 328 was then 
subjected to the standard chlorination conditions to afford the desired chloromine 329 in good 
yields. With the chloroamine 329, in hand the N-arylation reaction was attempted, and 
pleasingly, the desired THQ 330 was afforded in a 79% yield. 
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Scheme 3.8 
 
Previous work carried out within the group synthesised the amine 237 in one-pot via a Grignard 
reaction using 3-phenylpropionitrile and pentylmagnesnium bromide, the product of which was 
trapped with ethyl chloroformate to form the imino-carbamate (Scheme 3.9).83 The imino-
carbamate could be reduced using LiAlH4 to form the desired amine 237, which is a precursor 
to the natural product angustureine 333, and could be chlorinated in a good yield to afford 
chloroamine 243. A sample of the chloroamine 243 that was previously synthesised in the 
group using the described method was subjected to the established N-arylation conditions 
which afforded the desired racemic natural product angustureine 333 in reasonable yield.84  
 
 
Scheme 3.9 
 
 
It has been demonstrated that variations in substitution on the alkyl chain are supported and 
that functional groups that could be used for functionalisation later are tolerated as well. 
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3.3.1 Benzomorpholines  
 
To expand the substrate scope it was decided to investigate substrates which include another 
heteroatom in the saturated ring (Figure 3.1). It was hypothesised that substrates including 
oxygen and nitrogen could be synthesised. 
 
 
Figure 3.1 
3.3.2 Substrate Synthesis 
 
The required N-chloroamine could be synthesised in three steps. A substitution reaction 
involving phenol and chloroacetone afforded the ketone 337 in a moderate yield (60%). 
Reductive amination of ketone 337 yielded the desired amine 338 (Scheme 3.10). 
 
 
Scheme 3.10 
 
With the desired amine 338 in hand focus was turned to the formation of the corresponding 
chloroamine 339. Previously we had observed issues with chlorination of amines in the 
presence of electron rich aromatic rings; this could be overcome using alternative conditions 
which utilised the formation of tert-butyl hypochlorite in situ. It was therefore decided to 
investigate chlorination of the amine using both sets of conditions. Pleasingly in this case 
chlorination of the amine proceeded well under both sets of conditions and chlorination on the 
aromatic ring was not an issue, with good yields of the desired chloroamine 339 obtained 
(Scheme 3.11). 
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Scheme 3.11 
 
With the desired chloroamine in hand the N-arylation reaction could be attempted. 
 
3.3.3 N-Arylation of the benzomorpholine precursors 
 
When the N-chloroamine was subjected to the N-arylation conditions the desired compound 
alongside some of the chlorinated product was afforded in 4:1 ratio which were inseparable by 
column chromatography (Scheme 3.12).  
 
 
Scheme 3.12 
 
Conditions previously established within in the group utilise UV light to initiate the formation 
of the aminium radical. It was decided to trial these conditions and see if the yield obtained 
was comparable or an increase in yield was observed. However, when the N-chloroamine 339 
was subjected to these conditions none of the desired product was observed and only the amine 
338 was observed (Scheme 3.13). 
 
O
N
Cl
MeSO3H (10 eq),
h , DCM
0 oC, 1 h N
O
339 340  
Scheme 3.13 
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It was therefore decided to investigate the substrate scope using the FeSO4.7H2O N-arylation 
conditions as these afforded the desired product. Substitution on the nitrogen and the aromatic 
ring were investigated which have been shown to work on the carbon containing rings. 
 
3.3.4 Substitution on the Nitrogen 
 
Initial investigations used allylamine and butylamine as these were shown to give the best 
results previously. The synthesis of these could be achieved through the already established 
route with the substitution reaction between phenol and chloroacetone to generate ketone 337 
(Scheme 3.14). This was followed by reductive amination with the corresponding amine 341. 
Both amines were synthesised in good yields and were chlorinated using NCS to afford the 
desired N-chloroamines 342 in good yields. 
 
 
Scheme 3.14 
 
With the chloroamines in hand they were then subjected to the N-arylation conditions. The 
butylamine substrate cyclised to afford the desired benzomorpholine 344 in a 11% yield 
(Scheme 3.15). However, the allyl amine substrate did not cyclise and the amine 341b was 
instead recovered from the reaction mixture (60% yield of recovered amine). 
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Scheme 3.15 
 
3.3.5 Substitution on the aromatic ring  
 
Substrates with bromine on the aromatic ring had shown good yields before so this was selected 
as one to try for the benzomorpholine substrates (Figure 3.2). The 4-chloro substrate was also 
chosen to establish whether the oxygen being attached to the aromatic ring makes it more 
electron rich and therefore allow N-arylation on electron poor rings. A decrease in yield and a 
more sluggish reaction has been observed previously due to chloro- substitution on the ring. 
 
 
Figure 3.2 
 
The synthesis of the substrates was achieved through a substitution reaction of the 
corresponding phenol with chloroacetone. The corresponding ketones then underwent 
reductive amination followed by chlorination to afford the desired chloroamines (Scheme 
3.16). 
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Scheme 3.16 
 
The corresponding chloroamines were then subjected to the N-arylation conditions (Scheme 
3.17). The 3-bromo substrate 345b cyclised to afford the desired compound 350 in a 15% yield. 
Unfortunately, the 4-chloro substrate 345a did not afford the desired product and instead the 
amine 348a was isolated at the end of the reaction (65% recovery of the amine). 
 
 
Scheme 3.17 
 
With some examples of the benzomorpholine substrates successfully synthesised but in 
moderate yields, it was decided to investigate the synthesis of the nitrogen compounds to form 
benzopiperazines. 
 
3.3.6 Synthesis of benzopiperazine substrates 
 
It was hypothesised benzopiperidine 351 version could be synthesised in the same way as the 
benzomorpholine precursors. 
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Figure 3.3 
 
The substitution reaction between the tosylprotected aniline proceeded well. Unfortunately, the 
reductive amination of ketone 353 was unsuccessful and therefore an alternative route had to 
be found (Scheme 3.18). 
 
 
Scheme 3.18 
 
It was found that a substitution reaction between dibromoethane 355 and the tosyl-protected 
aniline 352 afforded the bromoalkane 356 (Scheme 3.19). Heating the bromo compound 356 
in methylamine afforded the desired amine 357 in excellent yields. To avoid any potential 
chlorination on the aromatic ring the conditions which utilise the formation of tert-butyl 
hypochlorite was used. The desired chloroamine 358 was synthesised in a moderate yield but 
enough of the N-chloroamine was obtained to attempt the N-arylation reaction. 
 
 
Scheme 3.19 
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Two N-arylation reactions were attempted, one under the standard conditions and another with 
double the equivalents of acid were used due to the presence of the second nitrogen in the 
substrate to ensure that the N-chloroamine was fully protonated (Scheme 3.20). Unfortunately, 
only the amine 357 was recovered at the end of the reaction (over 55% amine). 
 
 
Scheme 3.20 
 
It was therefore decided to stop further investigations due to unsuccessful attempts to synthesis 
the benzopiperizine under both the iron salt and UV irradiation N-arylation conditions. 
 
3.3.7 Mechanistic investigation 
 
Radical reactions frequently proceed through the kinetically more favourable cyclisation 
pathway which more often than not generates the 5-membered ring over the 6-membered 
ring.85 5-membered-spiro cyclisations are more favoured due to a better orbital overlap in the 
transition state which is not the case for 6-membered-ortho cyclisations.86,87 In an attempt to 
probe the mechanism as to whether within our systems the 5-membered ring was formed 
initially before a migration occurred to form the observed THQ, a substrate with both o-
positions blocked was proposed. It was hypothesised that this would allow us to observe 
alternative dearomatised products arising from either the 5-exo or 6-exo intermediates giving 
an insight into the mechanism of the reaction (Figure 3.4). This has previously been carried out 
within the group in the UV-initiated reactions. 
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Figure 3.4 
 
The desired chloroamine 365 was synthesised in three steps from the crotonamide 361 (Scheme 
3.21). The crotonamide 361 underwent a rhodium-catalysed 1,4-conjugate addition which 
afforded the corresponding amide 363.88 The amide 363 was reduced using LiAlH4 which 
worked in excellent yield to afford the desired amine 364. Chlorination of amine 364 was 
carried out in good yield using NCS to afford chloroamine 365. Compound 366, which has 
undergone migration of a methyl group, was isolated in a reasonable yield,  in accordance with 
the previous work carried out in the group using photolysis. 
 
 
Scheme 3.21 
 
A possible mechanism for the formation of a tetrahydroquinoline is shown in Scheme 3.22. 
The required six-membered ring intermediate 381 could either be formed directly or from 
migration of the spiro cyclisation product either at the radical 380 or cation 379 stage. DFT 
calculations that have previously been carried out within the group have shown that for the 
cyclisation of an unsubstituted aromatic the 6-membered ring is favoured. 
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Scheme 3.22 
  
The cyclisation of the aminium radical onto the aromatic ring would form the intermediate 382 
this could then proceed via two different pathways to generate the migratory product 387 
(Scheme 3.23). In one pathway the radical species 382 could then be oxidised by the iron(III) 
or chloroamine to give the cation 383. This means that the methyl group could migrate to form 
the more stable cation 384. Rearomatisation can then occur to afford the observed compound 
387. In the second pathway the methyl can migrate via a radical mechanism before 
rearomatisation occurs.89 
 
 
Scheme 3.23 
 
Previous work in the group has shown that this migration does not occur for other substrates 
such as 2,6-dichlorophenyl where substitution of one of the ipso-chloro atoms occurs instead, 
therefore this was not investigated further. 
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3.3.8 Reactivity studies 
 
The proposed aminium radical intermediate is a highly electrophilic species and therefore 
should react with more electron-rich aromatic rings preferentially.44 The mechanism of the 
reaction can therefore be probed as far as showing that it proceeds through a highly 
electrophilic intermediate. With this in mind, two substrates were designed in which a phenyl 
ring competes with either an electron-rich (green) or electron-poor aromatic ring (red)  (Figure 
3.5). 
 
 
Figure 3.5 
 
A rhodium-catalysed 1,4-conjugate addition of tolylboronic acid or (trifluoromethyl)boronic 
acid to methyl cinnamate afforded the esters 391 in excellent yields. Saponification of the 
resulting esters 391 afforded the acids 392 in good yields. Amide coupling of acids 392 with 
methylamine yielded amides 393 (Table 3.12). The yield of the amide coupling for the CF3 
compound 393b was lower due to purification issues. 
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Entry R group Step i Step ii Step iii 
1 4-Me a 91 79 78 
2 3-CF3 b 96 73 34 
Table 3.12 
 
The amide 393a was then reduced using LiAlH4 to afford the desired amine 394 in high yields. 
Chlorination of amine 394 using NCS afforded the desired chloroamine 388 in a good yield 
(Scheme 3.24). Due to issues previously found within the group in regards to the reduction of 
the amide 393b with LiAlH4, which resulted in partial reduction of CF3 group to CF2H, it was 
decided to carry out the reduction using borane.90 The yields for the reduction were lower 
however enough material was obtained to carry on to the next step.
  
The chlorination of amine 
395 to afford chloroamine 389 proceeded in excellent yields, and enough material was obtained 
to test the N-arylation reaction. 
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Scheme 3.24 
 
With the chloroamines in hand, the N-arylation reactions were carried out (Scheme 3.25). In 
both cases there was high selectivity for the more electron-rich ring. In the case of the tolyl 
compound there was a 10:1 selectivity, which was determined by 1H NMR analysis, in favour 
of the tolyl aromatic ring over the phenyl. In the case of the CF3 compound 389, there was 
complete selectivity for reaction at the unsubstituted phenyl ring. The same results were 
observed when the study was carried out under the photochemical conditions established within 
the group. 
 
 
Scheme 3.25 
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The selectivity observed for the more electron-rich ring in each of the cyclisations supports the 
hypothesis that this reaction proceeds through a highly electrophilic intermediate. 
 
3.3.9 One-pot procedure 
 
To alleviate the need to isolate potentially unstable chloramines, and to reduce the number of 
individual steps required, it was envisaged that the chlorination and N-arylation could be 
carried out in a one-pot process. The number of equivalents of NCS was decreased from a slight 
excess (1.25 eq.) to one equivalent to avoid any chlorination of the aromatic ring in the product. 
A control experiment was carried out using succinimide, which is the by-product from the 
chlorination reaction, to ensure its presence during the N-arylation reaction was not 
detrimental. Pleasingly, the presence of succinimide did not affect the reaction (Scheme 3.26). 
 
 
Scheme 3.26 
 
Unfortunately, when 1 eq. of NCS was used to form the chloramine in situ there was only a 
trace amount of product observed by LC-MS analysis at the end of the reaction (Table 3.13). 
The issue may have been due to a slight excess of the NCS reacting with the Fe(II) which 
prevented the N-arylation step – for example by reacting with FeCl2 to generate FeCl3 which is 
inactive in the reaction conditions. By decreasing the number of equivalents of NCS to 0.9 eq. 
(to ensure there was no excess chlorinating reagent), the yield over the two steps increased to 
65% (yield calculated relative to NCS). The reaction was repeated for both table entries and 
the same result was observed each time 
 
 
Entry Equivalents of NCS Average yield of x (%) 
1 1.00  <5 
2 0.90  65 
Table 3.13 
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Pleasingly, we have established a one-pot process which alleviates the need to isolate 
potentially unstable chloroamines. It was therefore decided to investigate this process with 
regards to some of the substrates previously synthesised in order to compare the results (Table 
3.14). The first substrate tried was the N-substituted butyl compound; although there was a 
slight decrease in the yield when the one-pot process was carried out it alleviates the need for 
a purification step and isolation of the chloroamine itself. When the 3-Cl amine (Table 3.14, 
Entry 3) was subjected to the one-pot process a similar yield was obtained to that which was 
observed for the overall two-pot process. Again, an increased reaction time was required due 
to the more electron-poor ring. 
 
 
Entry R R’ One-pot yield 
(%) 
Two-pot yield 
(%) 
1 allyl H 45 49 
2 butyl H 57 30 
3 Me 3-chloro 42 41 
Table 3.14 
 
An alternative one-pot process has been established which alleviates the need to isolate the 
chloroamine and therefore eliminates a purification step. This could be beneficial when 
working with less stable chloroamines and would hopefully avoid decomposition issues. 
 
3.3.10 Scale up  
 
It was decided to see whether a large batch reaction was possible under the optimised 
conditions using both the one-pot and two-pot processes (Table 3.15). The one-pot process was 
carried out on 1g of the amine 236; the yield obtained of the desired product however was very 
low. It has been previously noted that the chlorination process using NCS can produce lower 
yields at higher scales. This could lead to NCS being present still in the reaction mixture which 
has been shown to decrease the yields of the desired product. For the two-pot process the 
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chlorination step achieved a 67% yield and to avoid the lower yields observed on scale-up of 
the chlorination this was carried out on a 3 x 500 mg scale. Pleasingly for the N-arylation step 
carried out on a 1g scale a 65% yield was achieved showing that this process can be scaled up 
successfully. 
 
 
One-pot process yield (%) Two-pot process (%) 
9 44 (639 mg of THQ isolated) 
Table 3.15 
 
3.4 Intermolecular reactions 
 
With the success of the intramolecular reactions it was envisaged that the developed reaction 
conditions could be applied to intermolecular reactions with the ultimate goal of using the 
protocol in late stage amination reactions. It was previously discussed in Chapter 1 section 
1.5.3 how Minisci had shown examples of intermolecular amination using chloroamines with 
the aromatic being used in excess. Using the aromatics in large excess is not favourable when 
it comes to late stage functionalisation of drug molecules. 
 
3.4.1 Initial substrate investigations 
 
Initial investigations were carried out into the substitution with tetralin and chloroamine 401. 
The chloroamine 401 could be synthesised by free-basing the 4-benzoylpiperidine HCl salt and 
then chlorination with NCS to afford the desired chloroamine in good yields (Scheme 3.27). 
 
 
Scheme 3.27 
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 The concentration of the reaction and the equivalents of the aromatic were varied to find the 
optimum conditions. The initial experiments investigated how increasing the concentration of 
the reaction affects the yield. Pleasingly when increasing the concentration to 1M the yield 
improved dramatically (Table 3.16).  
 
 
Entry Concentration with respect to 
chloroamine 
Isolated Yield of product 403 
(%) 
1 0.45 M 14 
2 1 M 33 
Table 3.16 
 
It was then decided to see how varying the equivalents of tetralin 402 would affect the yield. It 
was found that with 5 eq. of tetralin, there was a significant decrease in the yield of the desired 
product (Table 3.17). By increasing to 15 eq. no further increase in the yield was observed. 
However, inversion of the reagents such that the chloroamine was in excess resulted in a vast 
increase in yield. The use of 1.5eq. proved to be optimum, further increasing the equivalents 
of chloroamine to 2 eq. and 3 eq. resulted in a decrease in yield. This result is favourable for 
our goal of late stage functionalisation of drug molecules. 
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Entry Eq. of chloroamine Eq. of tetralin Average isolated yield of 
product 403 (%)* 
1 1 5  19 
2 1 10 33 
3 1 15 30 
4 1.5 1 78 
5 2 1 51 
6 3 1 30 
*average yield of two reactions 
Table 3.17 
 
However, the results of an increase in yield observed through having the chloroamine in excess 
with respect to the aromatic seem to be substrate specific, as when this was tried with toluene 
no increase in yield was observed (Table 3.18).  
 
 
Entry Equivalents  Combined yield, ratio (o : m : p) 
1 1 eq. chloroamine, 10 eq. toluene 29%, (3.6 : 7.2 : 5.5) 
2 1.5 eq. chloroamine, 1 eq. toluene 28%, (3.6 : 7.2 : 5.5) 
Table 3.18 
 
The regioisomers can be identified through characteristic peaks for the para-isomer (the 
doublet at 7.07), ortho- the double doublet at 6.71 and meta- through the triplet at 7.15 (Scheme 
3.28). 
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Scheme 3.28 
 
Therefore, from this point onwards all new substrates were tried using the optimal conditions 
with either the chloroamine in excess or the aromatic in excess. In the case of toluene the 
aminated products were obtained as an inseparable mixture of the ortho, meta and para 
regioisomers which were identified by 1H NMR through which the ratio of each could be 
calculated. 
With the reaction conditions in hand, another N-chloroamine 410 was trialled. This could be 
synthesised through the chlorination of the commercially available 4-phenylpiperidine 409 
(Scheme 3.29). 
 
 
Scheme 3.29 
 
 In the case of tetralin, only a trace of the ortho substitution product was observed by LC-MS 
analysis, and it could not be isolated (Scheme 3.30). The meta product was isolated in a 26% 
yield. Again, in the case of toluene the aminated product was obtained, in a 39% yield, as an 
inseparable mixture of the ortho, meta and para regioisomers. 
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Scheme 3.30 
 
In the reaction between both chloroamines and tetralin we observe selectivity for the meta 
position, where as in the case of toluene a mixture of ortho meta and para products is observed. 
Minisci et al observed similar results in their investigations of chloroamines reacting with 
aromatics they suggested this was caused due to two factors: the bulk of the chloroamine being 
used and the reaction medium. With regards to steric bulk it was noted that the regioselectivity 
was lower in the case of dimethylchloroamine 413 when compared to piperidine chloroamine 
416. In the case shown in Scheme 3.31 the methoxy group also has an electronic influence that 
installs the amine either in the ortho or para position.44 
 
 
Scheme 3.31 
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Minisci et al also showed when tetralin was reacted with dimethylchloroamine 413 the 6- 
regioisomer was favoured in a 60:40 ratio with the 5-regioisomer (Scheme 3.32). Therefore, in 
our case since the steric bulk is increased the favoured amination in the 6-position can be 
rationalised.44  
 
 
Scheme 3.32 
 
Minisci et al also noted that changing the reaction medium had an effect on the regioisomers 
obtained when reacting toluene and chloroamines. When the ratio of acetic acid increased in 
the reaction medium the regiochemistry switched from favouring the para substitution to meta 
substitution (Table 3.19).44 Although the distribution of the regioisomers changed between 
meta and para the ortho substitution products remaining low. This could be due to the differing 
solvation of the aminium radical with the different counter ions. 
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Entry 
N-
chloroamines 
Solvent 
(H2SO4 : 
CH3COOH) 
% Toluidines 
o- m- p- 
1 
 
100 : 0 
90 : 10 
85 : 15 
80 : 20 
70 : 30 
9.6 
10.2 
9.6 
10.8 
10.2 
43.6 
47.6 
54.2 
59.7 
59.4 
46.8 
42.2 
36.2 
29.5 
30.4 
2 
 
100 : 0 
80 : 20 
60 : 40 
40 : 60 
4.6 
4.6 
3.6 
3.6 
39.2 
58.0 
61.7 
61.7 
56.2 
37.4 
34.7 
34.8 
Table 3.19 
  
Our results observed with the reaction of toluene and the chloroamine show a similar trend 
with the ortho product being the minor one observed. The distribution between the meta and 
para products differs but this could be due to the different steric bulk of the chloroamines. With 
an optimised set of conditions in hand for the intermolecular reactions it was decided to carry 
out a catalyst poisoning screening test to establish which functional groups are tolerated within 
the reaction. This was due to the unsuccessful attempts to aminate N-methylindole and 
benzoxazole.  
 
3.4.2 Catalyst poisoning reaction 
 
It has been shown by Glorius et al. that the scope of a reaction, with regards to functional group 
tolerance, can be carried out through using the highest yielding reaction and the addition of 
additives to it.91 The additives would contain a variety of functional groups to test the reactions 
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robustness to the presence of them within the reaction mixture. Using the optimal reaction 
conditions, 1 equivalent of the additive would be spiked into the reaction to see its effects on 
the yields an example of which is shown in Table 3.20. It can be seen that the presence of 
terminal alkynes and nitrogen containing heterocycles are not tolerated by the reaction. 
 
HN O
Br
MeO
N
MeO
O
PdCl2[P(o-tolyl)3]2 (2 mol%),
NaOtBu, toluene
100 oC, 3 h
421 422 423
 
Entry Additive Product yield 
(%) 
Additive remaining 
(%) 
SM remaining 
(%) 
1 
None 89   - - 
2 
 
0     100   100 
3 
 
82    85    0 
4 
 
0     81    99 
5 
 
10    0      36 
Table 3.20 
 
 Initial investigations focused on a catalyst poisoning screens using the best reaction from the 
intramolecular substrates (as the yields were better than with the intermolecular version) with 
a variety of additives. Each trial was carried out with 10 mol% and 1 eq. of the additives relative 
to the substrate (Table 3.21). The table has been colour coded: green refers to a yield of 58-
73%, amber refers to a yield of 43-58% and red refers to a yield of 0-43%. There was a slight 
decrease in the yield when benzaldehyde, benzyl alcohol, benzoic acid, methyl benzoate, 
chlorobenzene and pyridine were added to the reaction. There was a large decrease in the yield 
of the desired product when 1 eq. of piperidine was added. Only a few compounds poisoned 
the reaction to the extent that no desired product was afforded. In the cases of the 
heteroaromatic rings it could be due to side reactions hindering the reaction which could be the 
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additive abstracting the chlorine from the chloroamine therefore preventing the formation of 
the aminium radical. 
 
N
Cl N
FeSO4.7H2O (10 mol%),
MeSO3H (10 eq.), DCM,
[Additive]
0 oC, 1 h
115 116
 
Entry Additive 10 mol%-Yield of 116 (%) 1 eq. – Yield of 116 (%) 
1 No additive 73  73  
2 Benzaldehyde 53  50  
3 Benzyl alcohol 57  57  
4 Benzoic acid 62  59  
5 Methyl benzoate 50  53  
6 Chlorobenzene 68  70  
7 N-Methylindole 44  0  
8 Benzothiophene 34  0  
9 Benzofuran 38  0  
10 Piperidine 58  9  
11 Pyridine 58  56  
Table 3.21 
 
With an insight into what functional groups are tolerated by the reaction, it was decided to 
investigate the N-arylation of tolerated heteroaromatic rings and late stage functionalisation of 
drug compounds. Late stage functionalisation has become more important in recent years as 
the number of drug molecules being approved has declined and a renewed interest in exploiting 
the structural diversity of natural products has occurred. This has largely been underexplored 
due to the synthetic challenges that accompany the structural complexity and diverse 
functionality of natural products. This shows the importance of developing new methodologies 
to allow the exploration and optimisation of natural product scaffolds.92 
111 
 
3.4.3 Heteroaromatic ring N-arylation 
 
In 2012 Sarpong et al. demonstrated the use of aromatic amination of a pyridine ring via a 
modified HLF reaction under basic conditions in the total synthesis of arboflorine (Scheme 
3.33).43  
 
 
Scheme 3.33 
 
The previously described catalyst poisoning experiments have shown that the presence of 
pyridine does not inhibit the reaction. Previous work carried out within this project which was 
discussed in chapter 2 section 2.2, had screened a variety of conditions with no success in the 
cyclisation of the aminium radical onto the pyridine ring. A hypothesis of why this was 
unsuccessful was that the nitrogen of the pyridine is protonated under the acidic conditions, 
therefore the system is more electron-poor and the cyclisation of the electrophilic aminium 
radical is disfavoured. Therefore, it was decided to attempt the N-arylation reaction using the 
optimised conditions on pyridine N-oxide. The electrons from the oxygen are delocalised 
around the aromatic ring and therefore the 2- and the 4- position are more susceptible to 
electrophilic attack (Figure 3.6). 
 
 
Figure 3.6 
 
Unfortunately, none of the desired product was observed by LC-MS analysis when using 
pyridine N-oxide at various equivalents with respect to the chloroamine (Table 3.22), with only 
the chloroamine 401 and the declorinated amine 429 being observed. 
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Entry Conditions Result 
1 1.5 eq. chloroamine, 1 eq. pyridine N-oxide Amine 429 
2 1.5 eq. chloroamine, 1 eq. pyridine N-oxide, 13 eq. MeSO3H Amine 429 
3 1 eq. chloroamine, 10 eq. pyridine N-oxide, 20 eq. MeSO3H Amine 429 
4 1 eq. chloroamine, 10 eq. pyridine N-oxide, no acid SM 401 
Table 3.22 
 
It was then decided to try 2- or 4- quinoline along with their respective N-oxides to see whether 
this slight change in electronics was enough to allow the amination to occur. The benzene ring 
of the quinoline is favoured for electrophilic substitution in the C-5 and C-8 position (Table 
3.23). The N-oxide of quinoline can be used so that electrophilic substitution occurs on the 
pyridine ring of the quinoline. The energy required for dearomatisation of quinoline is lower 
than that required for pyridine due to stabilisation from the second aromatic ring. As shown in 
table 3.23 under various reaction conditions none of the desired compound was observed by 
LC-MS analysis. 
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Entry Equivalents Result 
1 1 eq. quinoline, 1.5 eq. chloroamine Amine 429 
2 10 eq. quinolone, 1 eq. chloroamine Amine 429 
3 1 eq. quinoline N-oxide, 1.5 eq. chloroamine Amine 429 
4 10 eq. quinoline N-oxide, 1 eq. chloroamine Amine 429 
5 1 eq. Isoquinoline, 1.5 eq. chloroamine Amine 429 
6 10 eq. Isoquinoline, 1 eq. chloroamine Amine 429 
7 1 eq. Isoquinoline N-oxide, 1.5 eq. chloroamine Amine 429 
8 10 eq. Isoquinoline N-oxide, 1 eq. chloroamine Amine 429 
Table 3.23 
 
Under the developed reaction conditions amination of heteroaromatic rings proved not to be 
possible, we therefore decided to move on and investigate the late stage functionalisation of 
drug compounds. 
 
3.5 Late-stage functionalisation 
 
It was then decided to see whether late-stage functionalisation of a drug could be achieved. The 
first drug chosen was the methyl ester of naproxen 432 which is a non-steroidal anti-
inflammatory. It was found that at the reaction concentration of 1M, with naproxen in excess 
(10 eq.) the drug compound could not be fully solubilised. This led to only trace amounts of 
the aminated product being observed by LC-MS analysis but unfortunately it could not be 
isolated. By using the chloroamine in slight excess (1.5 eq.) with regards to the naproxen the 
aminated product could be isolated. In both cases it was the over-chlorinated product that was 
isolated which was identified by LC-MS and 1H NMR (Scheme 3.34). Only one regioisomer 
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was isolated. This product could be formed by the aminated product abstracting a chlorine from 
a molecule of chloroamine and could explain the lower yield. 
 
Scheme 3.34 
 
It has been shown that late stage functionalisation of simple drug molecules is feasible however 
care needs to be taken regarding acid labile groups within the molecule. Preferentially they 
would be installed in the compound after the N-arylation step. 
 
3.6 Hydroxylamine amination reactions 
 
One of the problems encountered when using chloroamines for intermolecular N-arylation 
reactions was chlorination of the desired product. It was therefore decided to investigate the 
use of a different nitrogen radical source precursor to avoid this undesirable side reaction. 
 
3.6.1 Amination using hydroxylamines 
 
It has been shown by Minisci that hydroxylamine HCl can be used to aminate a variety of 
aromatic rings (Scheme 3.35).44 
 
 
Scheme 3.35 
 
115 
 
Recent work by Jiao et al and Morandi et al has also demonstrated amination of aromatic rings 
with alternative hydroxylamine derivatives which stabilise the negative charge generated on 
the O when the N-O bond is cleaved (Scheme 3.36).47,48 Both examples showed improved 
yields compared to Minisci’s results.  
 
 
Scheme 3.36 
 
To date within the literature, no example of substitution on the nitrogen has been shown. This 
section will detail investigations carried out into intermolecular N-arylation reactions using N-
substituted hydroxylamines. 
 
3.6.2 Initial trial  
 
It was decided to use hydroxylamines with no activating substitution on the oxygen as this is a 
more atom economical route, with the by-product of the reaction being water. Initial 
investigations, with the conditions based on previous work and the reactions carried out by 
Minisci et al, were carried out using methylhydroxylamine HCl 436 and pleasingly the desired 
product 437 was obtained in a 25% yield (Scheme 3.37). One regioisomer was obtained which 
could be determined through 1H NMR analysis. 
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Scheme 3.37 
 
Although the desired product was synthesised successfully it was decided if this methodology 
was to be utilised in the late stage functionalisation of drug molecules then the aromatic should 
be the limiting reagent. Therefore, a design of experiment was carried out to optimise the 
reaction with anisole as the limiting reagent. 
 
3.6.3 Design of Experiment (DOE) 
 
Design of experiment is a methodology developed by the statistician Ronald Fisher in 1958 
which has the objective of getting as much information as possible from the minimum number 
of experiments.93 Traditional methods of optimising a reaction look at individual factors against 
the reaction yield and therefore the optimal conditions might be missed or take a long time to 
establish. Design of experiment can be used to screen several factors at the same time to 
identify which of the factors are critical within the reaction. For our investigations, a three-
factorial system was used; for this 2 values for each of the 3 reaction conditions are investigated 
which leads to 8 reactions and 2 control experiments (Figure 3.7).  
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Figure 3.794 
 
3.6.4 DOE with FeCl2 and FeSO4.7H2O 
 
The Iron salts FeCl2 and FeSO4.7H2O were selected for the DOE as they had previously shown 
the best results in our investigations into N-arylation using chloroamines. For the investigations 
into the N-arylation with hydroxylamine a three-factorial system was used which investigated 
the loading of iron salt (3-25 mol%), equivalents of methylhydroxylamine HCl (1.1-2.9 eq) 
and the concentration of the reaction (0.1-2.1 M). The amounts were decided upon based on 
the current reaction conditions and a random order was generated of the reaction conditions to 
carry out the DoE (whether the high or low value was used). The reactions were monitored by 
HPLC analysis which was uncorrected at this stage (75% area product peak correlates to a 10% 
isolated yield of the desired product). When comparing Entry 1 and Entry 5 where the 
concentration of the reaction is increased from 0.1 M to 2.1 M the percentage area of the 
product observed increases from 2.8% to 72.0%. This shows how important the concentration 
of the reaction is (Table 3.24, Entries 1 and 5). In the case of catalyst loading the lower catalyst 
loading in reaction 7 gives an area% of 75.0 whereas the higher catalyst loading in reaction 8 
only achieves an area% of 10.2 for the product this demonstrates the benefits of lower catalyst 
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loading (Table 3.24, Entries 7 and 8).  In both cases lower catalyst loading and higher 
concentration of the reaction gave the better yields. The reaction profile was cleaner with FeCl2 
and gave the same conversion as FeSO4.7H2O.  
 
O
MeNHOH.HCl
O
HN
FeCl2, MeOH
60 oC, 24 h
117 436 437
 
Entry 
Catalyst charge 
(mol% vs 
RNHOH) 
MeNHOH.HCl charge 
(mol eq vs Anisole) 
Conc (Anisole, 
mol/L) 
HPLC, 
Product 
Area % 
HPLC, 
SM 
Area % 
1 3 1.1 0.1 2.8 78.6 
2 25 1.1 0.1 12.1 68.3 
3 3 2.9 0.1 15.5 73.3 
4 14 2 1.1 62.8 21.4 
5 3 1.1 2.1 72.0 24.9 
6 25 2.9 0.1 58.9 35.4 
7 3 2.9 2.1 75.2 20.8 
8 25 2.9 2.1 10.6 22.5 
9 14 2 1.1 62.9 22.0 
10 25 1.1 2.1 32.8 23.8 
Table 3.24 
 
Due to the improved reaction profile and the similar yields obtained it was decided to continue 
with FeCl2. 
 
3.6.5 Solvent screen 
 
Using the optimised conditions established in the DOE a solvent screen was carried out to 
ensure methanol was the best solvent. A range of polar solvents were tried with the best results 
being observed with ethanol and isopropanol.  Analysis was carried out using HPLC analysis 
with uncorrected Area% (75% equates to a 10% isolated yield). Good solubility of the 
hydroxylamine was observed when using isopropanol, ethanol and methyl isobutyl ketone 
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(MIBK) (Table 3.25 entries 5, 7 and 9). This could explain the increased conversions of the 
alcohols compared to the other solvents trialled.  
 
O
MeNHOH.HCl
O
HN
FeCl2, [solvent]
60 oC, 24 h
117 436 437
 
Entry Solvent Area% 
1 EtOAc 5.29 
2 THF 17.44 
3 2-methyl THF 12.5 
4 Dioxane 13.93 
5 Isopropanol 67.50 
6 MeCN 15.55 
7 Ethanol 71.43 
8 IPAC - 
9 MIBK - 
Table 3.25 
 
It was therefore decided to continue using methanol as the solvent of choice for the reaction 
and if problems with solubility arose then ethanol or isopropanol could be used instead. 
 
3.6.6 Mixed catalyst system  
 
Despite our best efforts to optimise the system only a maximum of a 10% isolated yield of the 
desired product was obtained when the aromatic was used as the limiting reagent. Within the 
literature Tordo et al. describe the use of a mixed catalyst system which utilises Fe(II) and 
Fe(III) sources (Scheme 3.38).95 An increase in yield was observed when the mixed catalyst 
system in the reaction between N-chloroamines and alkenes. In the reaction double the amount 
of Fe(III) catalyst was used in comparison to Fe(II) catalyst. The benefit of this could be the 
Fe(III) can accept an electron from the pyrrolidine and therefore regenerate the Fe(II) catalyst. 
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Scheme 3.38 
 
It was therefore decided to see whether this could be applied to our system to increase the yield. 
Initial results showed only a slight increase in yield from 10% to 13% which is within 
experimental error (Scheme 3.39). 
 
 
Scheme 3.39 
 
To ensure this was the best combination of iron salts for the reaction, a variety of Fe(II) salts 
were tested. Analysis was carried out using HPLC with the percentage areas corresponding to 
the actual yield of the product formed. It can be seen from this table that the addition of FeCl3 
to the reaction does increase the yield of the desired product being formed. The best example 
of this can be seen when using ferrocene: the yield goes from 0.3% (Table 3.26, entry 1) after 
24 hours to 7% (Table 3.26, Entry 2) just through the addition of FeCl3 into the system. This 
could be due to the FeCl3 accepting the electron from the aromatic allowing it to rearomatize 
and in turn regenerating Fe(II) catalyst which can then go on to generate more of the protonated 
amiunium radical or scavenge halides. 
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O
MeNHOH.HCl
Fe(II) salt (5 mol%),
FeCl3 (10 mol%),
MeOH
60 oC, 24h
O
HN
1.1 eq.1 eq.
13%
117 436 437
 
Entry Reaction 30 
mins 
1 
hour 
2 
hours 
4 
hours 
22 
hours 
1 Ferrocene - - - - 0.30 
2 Ferrocene, Iron(III) chloride 0.22 0.44 0.81 1.27 7.00 
3 Iron acetate 0.84 1.16 1.99 2.76 9.63 
4 Iron acetate, Iron(III) chloride 2.29 2.84 4.71 5.80 10.41 
5 Iron phthalocyanine,  - - - - - 
6 Iron phthalocyanine, Iron(III) 
chloride 
0.56 0.91 0.93 0.96 3.99 
*values represent conversion to product on HPLC trace 
Table 3.26 
 
The catalyst screen showed that FeCl2 in conjunction with FeCl3 gave the best results and this 
would be the catalyst system that would be used from now on. It was hypothesised that by 
carrying out a DOE this time investigating the loading of the FeCl2 (5-20 mol%), FeCl3 (5-60 
mol%) and the equivalents of methylhydroxylamine HCl (1.1-2.9 eq) an increase in yield could 
be obtained. The mol% of FeCl3 was calculated by multiplying the FeCl2 mol% by either 1-3 
depending on the factor being high, low or the middle control (2x).  With the higher loadings 
of FeCl2 (20 mol%) more impurities were observed after 24 hours, whereas with lower loading 
of FeCl2 a much cleaner reaction profile was observed (Table 3.27). The best results were 
observed in reactions 5 and 7, this showed that the higher loading of the methylhydroxylamine 
HCl was important as well as the lower loading of FeCl2. There is a slight increase in yield 
from reaction 5 to 7 in which the loading of FeCl3 is higher. 
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Experiment Fe(II) mol% Fe(III) mol% MeNHOH.HCl 
(eq) 
Conversion by 
HPLC 
1 5 5 1.1 9 
2 20 20 1.1 7 
3 5 15 1.1 11 
4 12.5 25 2.0 18 
5 5 5 2.9 20 
6 20 60 1.1 7 (many impurities) 
7 5 15 2.9 24 
8 20 60 2.9 24 (impurity at 23%) 
9 12.5 25 2.0 18 
10 20 20 2.9 20 
Table 3.27 
  
To see whether this slight increase in yield between reaction 5 and 7 is due to the increase in 
FeCl3, it was decided to carry out a reaction using FeCl2 (5 mol%), FeCl3 (100 mol%) and 
methylhydroxylamine HCl (2.9 eq) (Figure 3.8). The graph below shows that there is in fact 
an increase in the yield when the loading of FeCl3 is increased from 5 mol% to 100 mol%.  
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Figure 3.8 
 
It was observed from the reaction profiling that the conversion of the SM to the desired product 
appears to stop after four hours (Figure 3.9). This could be due to the methylhydroxylamine 
HCl being reduced to methylamine. 
 
 
Figure 3.9 
 
To establish whether this was the case a second loading of 2.9 eq of methylhydroxylamine HCl 
was added at four hours (Figure 3.10). As can be seen from the reaction profile below the yield 
of the desired product continued to increase due to the second addition therefore supporting the 
hypothesis that the hydroxylamine is limiting the formation of the product. The second addition 
is highlighted by the green arrow. The reaction was left to stir for 16 h in total and a 40% yield 
was obtained at the end. 
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Figure 3.10 
 
An additional experiment was carried out in which 4 additions of 2.9 eq methylhydroxylamine 
HCl was carried out to see whether a higher yield would be obtained (Scheme 3.40). It was 
found however that only a 40% yield was obtained despite double the amount of 
hydroxylamine being added to previous reactions. This suggests there are other limiting factors 
of the reaction, potentially the formation of methylamine or water could be an issue after a 
certain level is reached.  
 
 
Scheme 3.40 
  
Control reactions carried out on the single component catalyst system previously showed that 
increasing amounts of water in the reaction did decrease the overall yield of the reaction. 
Analysis of the reaction mixture was carried out using HPLC the values at this time are 
uncorrected and 75% equates to a 10% yield. Small amounts of water such as 5-20% of the 
solvent is not detrimental to the reaction (Table 3.28, Entry 2-3). When the solvent was made 
up of 35% water a decrease in the conversion was observed (Table 3.28, Entry 4). This supports 
the hypothesis that the build up of water in the reaction over time is hindering the overall yield. 
 
0
5
10
15
20
25
30
35
40
0 1 2 3 4 5 6 7
Y
ie
ld
 (
%
)
Time (hour)
125 
 
 
Entry %water in solvent %Area uncorrected 
1 0% 75 
2 5% 75 
3 20% 73 
4 35% 57 
Table 3.28 
It has therefore been established that 5 mol% of FeCl2 and 1 eq FeCl3 is the best catalyst 
combination for the reaction. The addition of 5.8 eq of the methylhydroxlamine HCl in two 
portions 4 hours apart gives the best isolated yields of 40%. 
 
3.6.7 Slow addition experiments 
 
Due to the success of the second addition of MeNHOH.HCl after 4 hours, it was decided to 
investigate slow addition of the hydroxylamine into the reaction mixture. The addition was 
carried out over 3 hours, 6 hours and 9 hours to compare the yields. Additional samples were 
taken after addition had stopped was submitted for HPLC analysis to confirm the reaction had 
finished one hour after the addition finished. The graphs in Figure 3.11 show that the yields 
obtained over 6 hours and 9 hours give very similar. Further slow addition experiments would 
be carried out over the 6 hours period as there was no substantial benefit of addition over 9 
hours. 
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Figure 3.11 
 
With the optimised conditions in hand and the option for slow addition reactions to decrease 
the reaction time from 16 hours to 6 hours it was decided to investigate the substrate scope of 
the reaction. 
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3.6.8 Substrate screening experiments 
 
A variety of aromatics were chosen ranging from heteraromatics to polar and non-polar 
substituted aromatics (Table 3.29). It can be seen from the results that nitrogen containing 
heteroaromatics such as pyridine, N-methylindole and imidazole are not tolerated which agrees 
with findings in our previous studies. The aminium radical is highly electrophilic and the 
substrates that have failed are all electron poor or can be in the acidic conditions. In the case of 
2-methoxynapthlene where the para position (which is the more favoured position) we do 
observe some amination in the ortho position, it was due to this it was believed naproxen could 
be aminated successfully. When using chloroamines to N-arylate the methyl ester of naproxen, 
chlorination on the aromatic ring was observed whereas with the hydroxylamines we avoid this 
issue and can successfully aminate the aromatic ring selectively. Again in this case selectivity 
for the more electron rich ring is observed. 
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Table 3.30 
 
With the scope of the aromatic substrates established, investigations then focussed on different 
hydroxylamines. 
 
3.6.9 Hydroxylamine screening experiments 
 
The two hydroxylamines chosen were N-benzylhydroxylamine and N-
cyclohexylhydroxylamine both of which gave slightly lower yields with anisole than had 
previously been obtained with methylhydroxylamine (Scheme 3.41). Complete regioselectivity 
is observed for substitution in the para position, this agrees with results previously observed 
by Minisci et al that a mix of steric and electronic factors play a key role so in this case the 
Successful products Unsuccessful substrates 
 
 
N-methylindole 
 
Imidazole 
 
Benzofuran 
 
Chlorobenzene 
 
Pyridine 
 
Benzene pinacol boronate 
 
Table 3.29 
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ortho and para positions would be preferred. Also due to the bulk of the amine the para position 
would be preferred over the ortho position.44 
 
 
Scheme 3.41 
 
Further investigations are required to optimise the yields obtained and screen other substrates. 
 
3.7 Conclusions 
 
A methodology has been developed and optimised which utilises N-chloroamines and iron salts 
as the initiator in the amination of aromatic rings. The scope has been explored with variations 
in the substitution on the nitrogen, alkyl chain and the aromatic ring. A one-pot process has 
been established for the chlorination and N-arylation which alleviates the need to isolate the 
chloroamines.  
Some probes into the mechanism of the reaction have been carried out, and the competition 
reactions support the hypothesis that this reaction proceeds through a highly electrophilic 
species.  
With regards to the intermolecular reactions two sets of conditions which use either 
chloroamines or hydroxylamines have been established and trialled with a variety of aromatics. 
Late stage functionalisation of a couple of drug molecules has been achieved. There is still 
some optimisation to be carried out in regards to the yields obtained via these methodologies. 
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3.83.8 Future Work 
 
With regards to the work carried out using UV light to initiate the N-arylation reaction in flow 
an intermolecular variant of the flow N-arylation reaction should be investigated. Initial trials 
would focus on tetralin and one of the chloroamines used in the iron salt study. Investigations 
into the equivalents of each substrate that is required and whether the concentrations would be 
suitable for flow could be carried out. 
 
 
Scheme 3.42  
  
Due to the conditions established using iron salts for the N-arylation of chloroamines 
investigations into whether this would be successfully with the chloroamides could be carried 
out. If successful and the yields improved compared to the photochemical example alternative 
substitution patterns could be investigated.  It has been shown with the iron salts that substrates 
with different substituents work compared to when the UV light conditions are used when N-
arylation is carried out using N-chloroamines. 
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Scheme 3.43  
  
The hydroxylamine work has shown some initial interesting results alternative metal co-
systems could be investigated such as titanium(III) and iron(III) to investigate whether this 
would increase the yield at all. 
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O
MeNHOH.HCl
O
HN
[Co-catalyst system]
MeOH, 60 oC
 
Scheme 3.434 
 
It has been shown by Jiao et al and Morandi et al that different groups on the oxygen can 
increase the yields of amination products.1,2 As they can help stablise the negative charge 
generated on the oxygen when the N-O bond is cleaved. 
 
 
Scheme 3.45 
 
Once the best co-catalyst system has been established investigations into different substituents 
on the oxygen starting with the groups shown by Jiao and Morandi could be trialled to see 
whether this improves the yields and the range of substrates.  
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Scheme 3.46 
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Chapter 4 Experimental 
 
4.1 General Experimental 
 
All reactions were carried out under an inert, dry nitrogen atmosphere, unless otherwise stated.  
Anhydrous solvents were purified by the solvent purification system. All reagents were 
obtained from commercial suppliers and used without further purification, unless otherwise 
stated.   
Flash column chromatography was carried out using Merck silica gel (40 - 63 µm particles). 
Thin phase chromatography was carried out using pre-coated silica plates (Merck silica 
Kieselgel 150F254).  They were analysed using UV fluorescence (λmax = 254 nm) and developed 
using potassium permanganate solution. All chromatography eluents were BDH GPR grade 
and used without further purification.  
IR spectra were obtained on a Perkin Elmer Spectrum one FT-IR spectrometer, with absorption 
reported in wavenumbers (cm-1). 1H and 13C NMR spectra were recorded on a Bruker DRX 
300, a Bruker DRX 500 or a Bruker Advance 500 spectrometer with an internal deuterium 
lock. 1H chemical shifts reported in parts per million (ppm) and coupling constants (J) are 
reported in hertz (Hz). 13C{1H} NMR spectra were recorded with band proton decoupling at 
75 MHz or 126 MHz. Assignments were made on the basis of chemical shifts and coupling 
data using COSY and DEPT where necessary. High resolution mass spectra were recorded on 
a Waters-Micromass ZMD spectrometer fitted with ES ion source. Melting points were 
obtained (uncorrected) on a Reichert hot stage apparatus. 
Analytical LC-MS was performed using a system comprising of a Bruker HCT Ultra ion trap 
mass spectrometer equipped with electrospray ionization and an Agilent 1200 series LC made 
up of, a high vacuum degasser, a binary pump, a high performance autosampler, an autosampler 
thermostat, a thermostated column compartment and diode array detector. The system used a 
Phenomenex Luna C18 50 × 2 mm 5 micron column and elution was effected with a binary 
gradient of two solvent systems: MeCN/H2O + 1% TFA or MeCN/H2O. 
HPLC spectra were recorded on an Agilent C100 series HPLC using an agilent C18 column 
(4.6 x 50 mm, 1.8 µm) with a binary gradient of two solvents: MeCN/H2O + 0.1% Formic 
acid. 
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4.2 Flow Chemistry Experimental 
 
4.2.1 Chlorination flow reactor 
 
A stainless steel T-junction was attached 10 m of PTFE tubing (internal diameter 1/32nd inch, 
external diameter 1/16th inch, 5 mL reactor volume) and to the inlets PTFE tubing (internal 
diameter 1/32nd inch, external diameter 1/16th inch) was attached to connect to syringes that 
contained the reactants to the dark reactor. The flow was controlled using a dual syringe pump 
that allowed both flows to go at equal rates (0.25 mL min-1). DCM was then passed through 
the reactor (3 reactor volumes). Assuming no leaks, the reactor was covered in aluminium foil. 
The reaction mixture was collected in a conical flask and analysed appropriately. After the 
reaction was finished, DCM was passed through the reactor (5 reactor volumes) followed by 
IPA (5 reactor volumes). 
 
4.2.2 Photochemical reactor 
 
A photochemical reactor was designed based on the reactor described by Booker-Milburn et 
al.73 The photochemical reactor was constructed using FEP tubing (internal diameter 2.7 mm, 
external diameter 3.1 mm) that was wrapped around a 125W high pressure mercury quartz 
immersion well reactor (overall length 390 mm, internal diameter 38 mm, external diameter 58 
mm), with the tubing attached to the well using double-sided sticky tape and masking tape (184 
cm of FEP tubing, to give a 5 mL reactor volume + 100 cm of excess tubing). There was 50 
cm of excess tubing attached at each end of the reactor tubing, with one being placed in a 
conical flask to collect the reaction mixture and the other attached to the outlet of a stainless 
steel T-junction. Adapters were placed in the inlets of the T-junction that allowed PTFE tubing 
(internal diameter 1/32nd inch, external diameter 1/16th inch) to connect to syringes that 
contained the reactants. The flow was controlled using a dual syringe pump that allowed both 
flows to go at equal rates (0.50 mL min-1). The quickfit joint of the immersion well was 
clamped in a stand, then DCM was passed through the reactor (3 reactor volumes). Assuming 
no leaks, the reactor was covered in aluminium foil and placed in a water bath with a 
temperature of 18 ˚C and then reaction was run, with the first three column volumes discarded. 
The reaction mixture was collected in 5 mL aliquots and analysed appropriately. After the 
reaction was finished, DCM was passed through the reactor (5 reactor volumes) followed by 
IPA (5 reactor volumes).  
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General procedure A: Continous chlorination of secondary amines  
Using the continuous reactor described above, a solution of amine (0.4 M in DCM) in one 
syringe and a solution of NCS (0.4 M in DCM) in the other were pumped at a rate of 0.25 mL 
min-1. The first 10 mL of eluent was discarded, then subsequently the rest was collected in a 
conical flask. The reaction mixture was concentrated in vacuo and purified by column 
chromatography to afford the desired products. The theoretical maximum yield was calculated 
by working out the amount of substrate that would have been present in one 5 mL column 
volume, then multiplying by the collected number of column volumes. This was then compared 
to the obtained product to give the percentage yield. Reactor productivity was calculated by 
dividing the amount of purified desired product by the number of reactor volumes collected in, 
then multiplying the result by 12 to give the amount of purified material that would be obtained 
per hour.  
 
General procedure B: Continuous photochemical amination  
Using the continuous reactor described above, a solution of N-chloroamine (0.4-0.5 M in 
DCM) in one syringe and a solution of MeSO3H (6 M in DCM) in the other were pumped at a 
rate of 0.5 mL min-1. The first three reactor volumes were discarded, then subsequently 
collected in 5 mL fractions and analysed by LC-MS separately. The separate reactor volumes 
were taken up in H2O and washed with EtOAc. The aqueous phase was then basified with 2 M 
aqueous NaOH and extracted with EtOAc (× 3). The combined organic extracts were washed 
with brine, dried over Na2SO4 and concentrated in vacuo. Purification by column 
chromatography afforded the desired products. The theoretical maximum yield was calculated 
by working out the amount of substrate that would have been present in one 5 mL column 
volume, then multiplying by the collected number of column volumes. This was then compared 
to the obtained product to give the percentage yield. Reactor productivity was calculated by 
dividing the amount of purified desired product by the number of reactor volumes collected, 
then multiplying the result by 12 to give the amount of purified material that would be obtained 
per hour. 
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N-chloro-N-methyl-3-phenylpropan-1-amine 115 
 
 General procedure A was followed, using N-methyl-3-phenylpropan-1- amine (0.4 M in 
DCM) and running at 0.5 mL min-1. 50 mL of eluent was collected, then purification column 
chromatography, eluting with 10% EtOAc in hexane afforded the title compound (1.12 g, 6.09 
mmol, 61%) as a yellow gum.  
Productivity: . ! × 12 = 2.69 g h
-1
 
 
Compound data can be found in section 4.5 
 
N-chloro-N-allyl-3-phenylpropan-1-amine 239  
 
 General procedure A was followed, using N-allyl-3-phenylpropan-1- amine (0.4 M in DCM). 
50 mL of eluent was collected, purification by column chromatography, eluting with 10% 
EtOAc in hexane afforded the title compound (1.53 g, 7.29 mmol, 73%) as a yellow gum.  
Productivity: . "# ! × 12 = 0.92 g h
-1
 
 
 
Compound data can be found in section 4.5 
 
N-chloro-N-benzyl-3-phenylpropan-1-amine 240 
 
 General procedure A was followed, using N-benzyl-3-phenylpropan-1- amine (0.4 M in 
DCM). 50 mL of eluent was collected, purification by column chromatography, eluting with 
10% EtOAc in hexane afforded the title compound (1.88 g, 7.24 mmol, 72%) as a yellow gum.  
Productivity: .$$# ! × 12 = 1.13 g h
-1
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1H NMR (400 MHz, CDCl3) δ ppm 7.43 – 7.17 (10H, m, 10 × ArCH), 4.13 (2H, NClCH2Ar), 
3.00 (2H, t, J = 6.7, CH2NCl), 2.72 (2H, t, J = 7.7, ArCH2), 2.10 – 2.03 (2H, m, CH2); 13C 
NMR (101 MHz, CDCl3) δ ppm 141.8 (Cq), 137.1 (Cq), 129.2 (2 × ArCH), 128.5 (2 × ArCH), 
128.4 (2 × ArCH), 128.4 (2 × ArCH), 127.9 (ArCH), 125.8 (ArCH), 68.4 (NClCH2Ar), 62.2 
(CH2NCl), 32.7 (ArCH2), 29.5 (CH2); IR υmax (neat) / cm-1 3062, 3027, 2920, 2857, 1702, 
1602, 1495, 1453; HRMS (ESI+): C16H1935ClN [M + H]+: calculated 260.1201, found 
260.1201, ∆ = 0.0 ppm. 
 
3-(4-bromophenyl)-N-chloro-N-methylpropan-1-amine 241  
N
Cl
Br
 
General procedure A was followed, using 3-(4-bromophenyl)-N-methylpropan-1-amine (0.4 
M in DCM). 34 mL of eluent was collected, purification by column chromatography, eluting 
with 10% EtOAc in hexane afforded the title compound (1.10 mg, 4.19 mmol, 61%) as a yellow 
gum.  
Productivity: .#".% ! × 12 = 0.97 g h
-1
 
 
Compound data can be found in section 4.5 
 
3-([1,1'-biphenyl]-4-yl)-N-chloro-N-methylpropan-1-amine 242 
 
General procedure A was followed, using 3-([1,1'-biphenyl]-4-yl)-Nmethylpropan-1-amine 
(0.4 M in DCM). 28 mL of eluent was collected, purification by column chromatography, 
eluting with 10% EtOAc in hexane afforded the title compound (885 mg, 3.39 mmol, 61%) as 
a yellow gum.  
Productivity: #.$&. ! × 12 = 0.95 g h
-1
 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.63-7.22 (9H, m, 9 × ArCH), 2.96 (3H, s, NCH3), 2.95-
2.90 (2H, m, NCH2), 2.77-2.71 (2H, m, ArCH2), 2.07-1.97 (2H, m, CH2); 13C NMR (101 MHz, 
CDCl3) δ ppm 141.2 (Cq), 140.9 (Cq), 139.0 (Cq), 129.0 (2 × ArCH), 128.9 (2 × ArCH), 127.3 
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(2 × ArCH), 127.2 (ArCH), 127.1 (2 × ArCH), 65.4 (NCH2), 53.2 (NCH3), 32.5 (ArCH2), 29.8 
(CH2); IR υmax (neat) / cm-1: 3057, 3029, 2997, 2863, 1595, 1487, 1455, 1439; HRMS (ESI): 
C16H1935ClN [M+H+]: calculated 260.1201, found 260.1201, ∆ = 0.0 ppm. 
 
(R)-N-chloro-N-methyl-1-phenyloctan-3-amine 243 
 
 General procedure A was followed, using (R)-N-methyl-1-phenyloctan-3- amine (0.4 M in 
DCM). 30 mL of eluent was collected, purification by column chromatography, eluting with 
10% EtOAc in hexane afforded the title compound (777 mg, 3.06 mmol, 51%) as a yellow 
gum. 
Productivity: #.'$ ! × 12 = 0.78 g h
-1
 
 
Compound data can be found in section 4.5 
 
1-methyl-1,2,3,4-tetrahydroquinoline 116  
 
General procedure B was followed, using N-chloroamine 115 (0.5 M solution in DCM) and 
MeSO3H (6 M solution in DCM). In total, nine column volumes were collected. After work-
up, purification by column chromatography, eluting with 10% EtOAc in hexane afforded the 
title compound (930 mg, 6.32 mmol, 56%) as a pale yellow oil.  
Productivity: #.$' ! × 12 = 1.39 g h
-1
 
 
Compound data can be found in section 4.5 
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1-allyl-1,2,3,4-tetrahydroquinoline 244 
 
General procedure B was followed, using N-chloroamine 239 (0.5 M solution in DCM) and 
MeSO3H (6 M solution in DCM). In total, seven column volumes were collected. After work-
up, purification by column chromatography, eluting with 10% EtOAc in hexane afforded the 
title compound (581 mg, 3.36 mmol, 38%) as a colourless oil. 
Productivity: #. $' ! × 12 = 1.00 g h
-1
 
 
Compound data can be found in section 4.5 
 
1-benzyl-1,2,3,4-tetrahydroquinoline 245 
 
General procedure B was followed, using N-chloroamine 240 (0.45 M solution in DCM) and 
MeSO3H (6 M solution in DCM). In total, six column volumes were collected. After work-up, 
purification by column chromatography, eluting with 10% EtOAc in hexane afforded the title 
compound (648 mg, 2.90 mmol, 43%) as a colourless gum.  
Productivity: #.% % ! × 12 = 1.29 g h
-1
 
 
1H NMR (300 MHz, CDCl3) δ ppm 7.38-7.17 (5H, m, 5 × ArCH), 7.05-6.89 (2H, m, 2 × 
ArCH), 6.61-6.48 (2H, m, 2 x ArCH), 4.48 (2H, s, NCH2Ar), 3.37 (2H, t, J = 5.6, NCH2), 2.82 
(2H, t, J = 6.3, ArCH2), 2.10-1.92 (2H, m, CH2); 13C NMR (125 MHz, CDCl3) δ ppm 145.6 
(Cq), 138.9 (Cq), 129.0 (ArCH), 128.6 (2 × ArCH), 127.1 (ArCH), 126.7 (ArCH), 126.6 (2 × 
ArCH), 122.2 (Cq), 115.8 (ArCH), 110.9 (ArCH), 55.2 (NCH2Ph), 49.9 (NCH2), 28.2 (ArCH2), 
22.4 (CH2); IR υmax (neat) / cm-1: 3061, 3024, 2924, 2839, 1600, 1494, 1449, 1343; HRMS 
(ESI+): C16H18N [M+H+]: calculated 224.1434, found 224.1435, ∆ = 0.45 ppm. 
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7-bromo-1,2,3,4-tetrahydroquinoline 246 
 
General procedure B was followed, using N-chloroamine 241 (0.4 M solution in DCM) and 
MeSO3H (6 M solution in DCM). In total, seven column volumes were collected. After work-
up, purification by column chromatography, eluting with 10% EtOAc in hexane afforded the 
title compound (947 mg, 4.21 mmol, 60%) as a colourless oil.  
Productivity: #.& ' ! × 12 = 1.62 g h
-1
 
 
Compound data can be found in section 4.5 
 
7-phenyl-1,2,3,4-tetrahydroquinoline 247 
 
General procedure B was followed, using N-chloroamine 242 (0.4 M solution in DCM) and 
MeSO3H (6 M solution in DCM). In total, six column volumes were collected. After work-up, 
purification by column chromatography, eluting with 10% EtOAc in hexane afforded the title 
compound (378 mg, 1.69 mmol, 28%) as a colourless oil 
Productivity: #."$% ! × 12 = 0.76 g h
-1
 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.56-7.47 (2H, m, 2 × ArCH), 7.39-7.30 (2H, m, 2 × 
ArCH), 7.28-7.21 (1H, m, ArCH), 7.00-6.92 (1H, m, ArCH), 6.80-6.70 (2H, m, 2 × ArCH), 
3.24-3.17 (2H, m, NCH2), 2.89 (3H, s, NCH3), 2.74 (2H, t, J = 6.5, ArCH2), 2.01-1.89 (2H, m, 
CH2); 13C NMR (101 MHz, CDCl3) δ ppm 147.1 (Cq), 142.5 (Cq), 140.5 (Cq), 129.3 (ArCH), 
128.7 (2 × ArCH), 127.3 (2 × ArCH), 127.0 (ArCH), 122.2 (Cq), 115.4 (ArCH), 110.0 (ArCH), 
51.5 (NCH2), 39.3 (NCH3), 27.7 (ArCH2), 22.6 (CH2); IR υmax (neat) / cm-1: 3054, 3028, 2924, 
2837, 1678, 1605, 1561, 1515; HRMS (ESI+): C16H18N [M+H+]: calculated 224.1434, found 
224.1434, ∆ = 0.0 ppm. 
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2-pentyl-1,2,3,4-tetrahydroquinoline 248 
 
General procedure B was followed, using N-chloroamine 243 (0.25 M solution in DCM) and 
MeSO3H (6 M solution in DCM). In total, seven column volumes were collected. After 
workup, purification by column chromatography, eluting with 10% EtOAc in hexane afforded 
the title compound (378 mg, 1.74 mmol, 40%) as a yellow oil.  
Productivity: #."$' ! × 12 = 0.65 g h
-1
 
 
Compound data can be found in section 4.5 
 
4.3 Photochemical Chapter experimental 
General Procedure A: Wittig reaction 
 
 
 
Following a modified procedure by Chatfield et al,96 to a stirred solution of 
pyridinecarboxaldehyde (1.0 eq) in CH3CN (0.2 M) was added the Wittig reagent (1.1 eq) and 
the reaction mixture was stirred for 48 h at RT. The reaction mixture was concentrated in vacuo 
and the residue diluted in H2O (60 mL). The solution was acidified to pH 3 using 4 M HCl and 
extracted using DCM (3 × 80 mL). The water phase was then basified using NaHCO3 (aq) to pH 
7 and extracted using DCM (3 × 80 mL). The organic phases were dried over MgSO4 and 
concentrated in vacuo. Purification by column chromatography afforded the desired product. 
  
General Procedure B: Amide formation 
 
R
O
OEt
R
O
N
H
 
 
Following a modified procedure by Juaristi et al,78 to a stirred solution of pyridinyl ester (1.0 
eq) in MeOH (0.40 M) was added MeNH2 (8 M solution in EtOH, 8eq) and the reaction mixture 
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was heated at reflux for 16 h and then concentrated in vacuo. Purification by column 
chromatography afforded the desired products. 
 
General Procedure C: Reduction – chlorination sequence 
 
 
 
Step i: Following a modified procedure by Williamson et al,97 to a stirred suspension of LiAlH4 
(2.0 eq) in THF (1 M) at 0 oC was added a solution of pyridinyl amide (1.0 eq) in THF (1 M) 
dropwise. The reaction mixture was stirred for 5 min at 0 oC before warming to RT and then 
heated at reflux for 3 h. The reaction mixture was cooled to 0 oC and the reaction was quenched 
through the dropwise addition of H2O (12.0 eq), 2M NaOH(aq) (2.0 eq) and H2O (2.0 eq). The 
resulting slurry was dried over Na2SO4, filtered through a pad of Celite and was washed with 
EtOAc. Concentration in vacuo afforded the crude amine product which was used without 
further purification. Desired product formation was confirmed by LC-MS analysis. 
Step ii: Following a modified procedure by De Luca et al.79 To a stirred solution of the amine 
(1.0 eq) in DCM (0.5 M) in the dark was added NCS (1.0 eq) portionwise over 10 mins at RT 
and the reaction mixture was stirred for 3 h then concentrated in vacuo. Purification by column 
chromatography afforded the desired products. 
 
General Procedure D Hydrogenation  
 
 
 
To a stirred solution of ester (1.0 eq) in EtOH (0.2 M) was added 10% Pd/C (10% wt) and the 
flask was evacuated and flushed with N2 (3 ×). The flask was then evacuated and flushed with 
H2 and stirred at RT for 16 h. The flask was then evacuated and flushed with nitrogen. The 
reaction mixture was filtered through a pad of Celite and washed with EtOAc. Concentrated in 
vacuo afforded the desired product without further purification being required. 
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General Procedure E Amide coupling 
 
 
To a stirred solution of the acid (1 eq) and methylamine hydrochloride (1.5 eq) in DCM 
(0.2 M), was added TBTU (1.6 eq) and DIPEA (4 eq). The reaction mixture was stirred at RT 
for 16 hours. The reaction was quenched with saturated aqueous NaHCO3. The two phases 
were separated and the aqueous phase was extracted with DCM (3 ×). The organic phases were 
combined, dried over MgSO4 and concentrated in vacuo. Purification by column 
chromatography yielded the desired product. 
 
General Procedure F N-Chlorination 
 
 
 
Following a modified procedure by Zhong et al,80 to a stirred solution of the amide (1.0 eq) 
and tert-butanol (1.5 eq) in MTBE (0.2 M) at 0 oC, was added acetic acid (1.5 eq) and sodium 
hypochlorite (1.5 eq) dropwise. The reaction mixture was then stirred at 0 oC for 2 h. The 
organic phases were separated and the top phase was washed with H2O then brine, dried using 
MgSO4 and concentrated in vacuo. The crude material was then purified using column 
chromatography using to yield the desired product. 
 
4.4 Experimental Data 
 
Synthesis of ethyl 3-(pyridin-3-yl)prop-2-enoate 252a 
 
General procedure A was followed, using 3-pyridinecarboxaldehyde (2.00 g, 18.7 mmol) and 
Wittig reagent 251 (7.16 g, 20.5 mmol). Purification by column chromatography eluting with 
70% Et2O in hexane, afforded the title compound (1.81 g, 10.2 mmol, 54%) as a pale yellow 
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oil. The NMR data was in accordance with the literature.98 1H NMR (300 MHz, CDCl3) δ ppm 
8.67 (1H, d, J = 2.2, C2H), 8.60 (1H, dd, J = 4.8, 1.6, C6H), 7.83 (1H, dt, J = 7.9, 1.8, C4H), 
7.67 (1H, d, J = 16.1, C3CH), 7.32 (1H, dd, J = 8.4, 4.4, C5H), 6.51 (1H, d, J = 16.1, CHCO), 
4.28 (2H, q, J = 7.1, OCH2), 1.34 (3H, t, J = 7.1, CH3);   13C NMR (75 MHz, CDCl3) δ ppm 
166.3 (CO), 150.9 (C2), 149.7 (C6), 140.8 (C3CHCH), 134.2 (C4), 130.2 (C3), 123.7 (C5), 120.5 
(CHCO), 60.8 (CH2), 14.3 (CH3)  IR Vmax (neat)/cm-1: 3031, 2982, 2936, 1712 (CO), 1641, 
1586, 1477 1342; HRMS (ESI+): C10H12NO2 [M + H] +: calculated 178.0863, found 178.0867, 
∆ = +2.2 ppm. 
 
 
Synthesis of ethyl 3-(pyridin-3-yl)propanoate 253a 
 
To a stirred solution of ester 252a (1.81 g, 12.1 mmol, 1.00 eq) in toluene (0.2 M) was added 
10% Pd/C (181 mg, 10% wt). To the reaction mixture AcOH (1.40 mL, 24.3 mmol, 2.00 eq) 
and then NaBH4 (1.84 g, 48.5 mmol, 4.00 eq) were added. The reaction mixture was then 
warmed to RT and stirred for 8 h. The reaction mixture was quenched at 0 oC by addition of 4 
M HCl until the reaction mixture was at pH 2. The solution was then neutralised with saturated 
aqueous NaHCO3 to pH 7 and extracted with Et2O (3 × 100 mL). The combined organic phases 
were dried over MgSO4, filtered through a pad of Celite and concentrated in vacuo to afford 
the title compound (1.80 g, 10.1 mmol, 83%) as a yellow oil which was used without further 
purification. The NMR data was in accordance with literature.99 1H NMR (300 MHz, CDCl3) 
δ ppm 8.53 – 8.44 (2H, m, includes 1H, m, C2H; and 1H, m, C6H), 7.55 (1H, dt, J = 7.8, 2.0, 
C4H), 7.23 (1H, dd, J = 7.8, 4.8, C5H), 4.14 (2H, q, J = 7.1, OCH2), 2.97 (2H, t, J = 7.6, CH2), 
2.65 (2H, t, J = 7.6, CH2), 1.24 (3H, t, J = 7.1, CH3); 13C NMR (75 MHz, CDCl3) δ ppm 172.3 
(CO), 149.8 (C2), 147.7 (C6), 135.9 (C3), 135.8 (C4), 123.4 (C5), 60.6 (OCH2), 35.4 (CH2), 28.1 
(CH2), 14.2 (CH3); IR υmax (neat)/cm-1; 3032, 2982, 2935, 1731 (CO), 1642, 1575, 1422, 1371; 
HRMS (ESI+): C10H14NO2 [M + H] +: calculated 180.1090, found 180.1021, ∆ = -1.1 ppm. 
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Synthesis of N-methyl 3-pyridin-3-yl-propanamide 254a 
 
General procedure B was followed, using the ester 253a (1.30 g, 7.25 mmol) and MeNH2 (8 M 
in EtOH, 7.5 mL). Purification by column chromatography eluting with 2% MeOH in DCM, 
afforded the title compound (1.02 g, 6.23 mmol, 86%) as a pale yellow oil. 1H NMR  (300 
MHz, CDCl3) δ ppm 8.50 - 8.44 (2H, m, includes 1H, m, C2H; and 1H, m, C6H), 7.55 (1H, dt, 
J = 7.8, 2.0, C4H), 7.22 (1H, dd, J = 7.8, 4.8, C5H), 5.66 (1H, br. s, NH), 2.99 (2H, t, J = 7.6, 
CH2), 2.79 (3H, d, J = 4.8, CH3), 2.48 (2H, t, J = 7.6, CH2); 13C NMR (75 MHz, CDCl3) δ ppm 
172.0 (CO), 149.7 (C2), 147.7 (C6), 136.4 (C3), 136.1 (C4), 123.4 (C5), 37.7 (CH2), 28.7 (CH2), 
26.3 (CH3); IR υmax (neat)/cm-1; 3294, 3085, 2921, 1649 (CO), 1562, 1479, 1413, 1371; HRMS 
(ESI+): C9H13N2O [M + H] +: calculated 165.1022, found 165.1017, ∆ = +3.1 ppm. 
 
 Synthesis of N-chloro(N-methyl)[3-(pyridin-3-yl)propyl]amine 255a 
 
General procedure C was followed, step i, using amide 254a (430 mg, 2.64 mmol) and LiAlH4 
(200 mg, 2.28 mmol) affording the crude amine 259. Following step ii, using the crude amine 
259 (397 mg, 2.64 mmol) and NCS (180 mg, 1.35 mmol). Purification by column 
chromatography, eluting with (30% EtOAc in hexane), afforded the title compound (50 mg, 
0.27 mmol, 25%) as a brown oil. 1H NMR (300 MHz, CDCl3) δ ppm 8.50-8.46 (2H, m,  
includes 1H, m, C2H; and 1H, m, C6H), 7.54 (1H, dt, J = 7.8, 2.0, C4H), 7.24 (1H, dd, J = 7.8, 
4.8, C5H), 2.96 (3H, s, CH3), 2.92 – 2.87 (2H, m, CH2), 2.71 (2H, t, J = 7.4, CH2), 1.99 (2H, 
m, CH2), 13C NMR (75 MHz, CDCl3) δ ppm 150.0 (C2), 147.5 (C6), 136.9 (C3), 135.9 (C4), 
123.4 (C5), 64.7 (CH2N), 53.1 (CH3), 29.8 (CH2), 29.4 (CH2); IR υmax (neat)/cm-1: 3028, 2941, 
2856, 1773, 1710, 1665, 1427, 1348, HRMS (ESI+): C9H1435ClN2 [M + H] +: calculated 
185.0840, found 185.0840, ∆ = -0.2 ppm. 
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Synthesis of 3-(pyridin-4-yl)prop-2-enoate 252b 
 
General procedure A was followed, using 4-pyridinecarboxaldehyde (2.00 g, 18.7 mmol) and 
Wittig reagent 251 (7.16 g, 20.5 mmol). Purification by column chromatography, eluting with 
30% EtOAc in hexane (1% Et3N), afforded title compound (2.77 g, 15.6 mmol, 83% yield) as 
a colourless solid. A sample was crystallised from hexane to yield colourless crystals. M.p. 
67-68 oC, platelets, hexane.  The NMR data was in accordance with the literature.100 1H NMR 
(300 MHz, CDCl3) δ ppm 8.65 (2H, dd, J = 4.5, 1.6, 2 × C2H ), 7.59 (1H, d, J = 16.1, C4CH), 
7.36 (2H, dd, J = 4.6, 1.6, 2 × C3H), 6.59 (1H, d, J = 16.1, CHCO), 4.29 (2H, q, J = 7.1, 
CH2), 1.35 (3H, t, J = 7.1, CH3); 13C NMR (75 MHz, CDCl3) δ ppm 166.0 (CO), 150.6 (2 × 
C2), 149.7 (C4), 141.7 (CCH), 122.9 (CHCO), 121.8 (2 × C3), 61.0 (CH2), 14.2 (CH3); IR 
υmax (neat)/cm-1 3052, 2982, 1704 (CO), 1640, 1623, 1597, 1547, 1444; HRMS (ESI+): 
C10H12NO2 [M + H] +: calculated 178.0863, found 178.0864, ∆ = +0.8 ppm. 
 
Synthesis of ethyl 3-(pyridin-4-yl)propanoate 253b 
 
General procedure D was followed, using ester 252b (2.50 g, 14.1 mmol) and 10% Pd/C (250 
mg, 10% wt), affording the title compound (2.41 g, 13.4 mmol, 95%) as a colourless oil, which 
was characterised without further purification. The NMR data was in accordance with the 
literature.101,102 1H NMR: (300 MHz, CDCl3) δ ppm 8.51 (2H, dd, J =  4.4, 1.6, 2 × C2H), 7.14 
(2H, dd, J = 4.4, 1.6, 2 × C3H), 4.13 (2H, q, J = 7.1, OCH2), 2.95 (2H, t, J = 7.6, CH2), 2.64 
(2H, t, J = 7.6, CH2), 1.23 (3H, t, J = 7.1, CH3); 13C NMR (75 MHz, CDCl3) δ ppm 172.2 
(CO), 149.9 (2 × C2), 149.4 (C4), 123.7 (2 × C3), 60.7 (OCH2), 34.5 (CH2), 30.1 (CH2), 14.2 
(CH3); IR υmax (neat)/cm-1 3027, 2981, 2933, 1728 (CO), 1601, 1559, 1445, 1415; HRMS 
(ESI+): C10H14NO2 [M + H] +: calculated 180.1019, found 180.1017, ∆ = -0.9 ppm. 
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Synthesis of N-methyl-3-(pyridin-4-yl)propanamide 254b 
 
 General procedure B was followed, using ester 253b (2.30 g, 12.8 mmol) and MeNH2 (8 M in 
EtOH, 13 mL). Purification by column chromatography eluting with 1% MeOH in DCM (1% 
Et3N), afforded title compound (1.65 g, 10.1 mmol 78%) as a colourless solid. A small sample 
was crystallized from hexane to yield colourless crystals. M.p. 61- 62 oC, platelets, hexane. 
The NMR data was in accordance with the literature.103  1H NMR (300 MHz, CDCl3) δ ppm 
8.50 (2H, dd, J = 4.4, 1.6, 2 × C2H), 7.13 (2H, dd, J = 4.4, 1.6, 2 × C3H), 5.37 (1H, br. s, NH), 
2.98 (2H, t, J = 7.6, CH2), 2.79 (3H, d, J = 4.9, CH3), 2.47 (2H, t, J = 7.6, CH2); 13C NMR (75 
MHz, CDCl3) δ ppm 172.7 (CO), 150.0 (C4), 149.9 (2 × C2), 123.8 (2 × C3), 36.9 (CH2), 30.7 
(CH2), 26.3 (CH3);  IR υmax (neat)/cm-1 3300, 3102, 3027, 2938, 1632 (CO), 1557, 1495, 1454; 
HRMS (ESI+): C9H13N2O [M + H] +: calculated 165.1022, found 165.1019, ∆ = +1.9 ppm.  
 
Synthesis of N-chloro(N-methyl)[3-(pyridin-4-yl)propyl]amine 255b 
 
General procedure C was followed, step i, using amide 254b (1.52 g, 9.28 mmol), LiAlH4 (704 
mg, 18.6 mmol) affording the crude amine 261. Following step ii, using the crude amine 261 
(1.39 g, 8.50 mmol) and NCS (1.55 g, 11.6 mmol). Purification by column chromatography, 
eluting with 30% EtOAc in hexane, afforded the title compound (350 mg, 1.90 mmol, 20%) as 
a brown oil. 1H NMR (500 MHz, CDCl3) δ ppm 8.55 - 8.52 (2H, m, 2 × C2H), 7.20 - 7.16 (2H, 
m, 2 × C3H), 2.97 (3H, s, CH3), 2.89 (2H, t, J = 6.7, CH2), 2.76 - 2.72 (2H, m, CH2), 2.05 - 
1.98 (2H, m, CH2); 13C NMR (75 MHz, CDCl3) δ ppm 149.8 (2 × C2), 149.0 (C4), 124.0 (2 × 
C3), 64.7 (CH2N), 53.1 (CH3), 29.6 (CH2), 28.5 (CH2); IR υmax (neat) / cm-1 : 3029, 2949, 2856, 
1773, 1702, 1637 1604, 1463; HRMS (ESI+): C9H1435ClN2 [M + H] +: calculated 185.0840, 
found 185.0837, ∆ = +1.5 ppm. 
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Synthesis of ethyl (2E)-3-(6-methoxypyridin-3-yl)prop-2-enoate 266 
 
General procedure A was followed, using 5-formyl-2-methoxypyridine (5.00 g, 36.5 mmol) 
and Wittig reagent 265 (14.0 g, 40.1 mmol) followed by purification by column 
chromatography, eluting with 30% EtOAc in hexane (1% Et3N), affording the title compound 
(6.49 g, 31.3 mmol, 86% yield) as a colourless gum. The 1H NMR was in accordance with the 
literature.104 1H NMR (300 MHz, CDCl3) δ ppm 8.27 (1H, d, J = 2.4, C2H), 7.77 (1H, dd, J = 
8.7, 2.5, C4H), 7.63 (1H, d, J = 16.0, CCH), 6.77 (1H, d, J = 8.7, C5H), 6.33 (1H, d, J = 16.0, 
CHCO), 4.27 (2H, q, J = 7.1, OCH2), 3.97 (3H, s, OCH3), 1.34 (3H, t, J = 7.1, CH2CH3); 13C 
NMR (75 MHz, CDCl3) δ ppm 166.8 (CO), 165.3 (OCq), 148.3 (C2), 140.9 (CCH), 136.3 (C4), 
123.9 (Cq), 117.2 (CHCO), 111.6 (C5), 60.5 (OCH2), 53.8 (OCH3), 14.3 (CH2CH3); IR υmax 
(neat)/cm-1 3036, 2984, 2948, 1708, 1633, 1600, 1567, 1497; HRMS (ESI+): C11H14NO3 [M + 
H] +: calculated 208.0968, found 208.0964, ∆ = -2.2 ppm 
 
Synthesis of ethyl 3-(6-metho×ypyridin-3-yl)propanoate 267 
 
General procedure D was followed, using ester 266 (6.00 g, 29.0 mmol) and 10% Pd/C (600 
mg, 10% wt), affording the title compound (5.32 g, 25.4 mmol, 88%) as a colourless oil, which 
was characterised without further purification. 1H NMR (300 MHz, CDCl3) δ ppm 8.00 (1H, 
d, J =  2.0, C2H), 7.43 (1H, dd, J = 8.5, 2.5, C4H), 6.68 (1H, d, J = 8.5, C5H), 4.13 (2H, q, J = 
7.1, OCH2), 3.91 (3H, s, OCH3), 2.87 (2H, t, J = 7.6, CH2), 2.58 (2H, t, J = 7.6, CH2), 1.24 
(3H, t, J = 7.1, CH3); 13C NMR (75 MHz, CDCl3) δ ppm 172.5 (CO), 163.0 (OC6), 146.1 (C2), 
138.9 (C4), 128.5 (C3), 110.6 (C5), 60.5 (OCH2), 53.3 (OCH3), 35.9 (CH2), 27.3 (CH2), 14.2 
(CH2CH3); IR υmax (neat)/cm-1 2980, 2945, 2906, 1730, 1609, 1572, 1491, 1445; HRMS 
(ESI+): C11H16NO3 [M + H] +: calculated 210.1125, found 210.1124, ∆ = +0.7 ppm. 
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Synthesis of 3-(6-metho×ypyridin-3-yl)-N-methylpropanamide 268 
 
General procedure B was followed, using the ester 267 (5.00 g, 23.9 mmol) and MeNH2 (8 M 
in EtOH, 30 mL). Purification by crystallization from hexane, afforded the title compound (4.36 
g, 22.5 mmol, 94%) as a pale yellow crystals. M.p. 79-80 oC, platelets, hexane.   1H NMR (300 
MHz, CDCl3) δ ppm 7.99 (1H, d, J  = 2.4, C2H), 7.43 (1H, dd, J = 8.5, 2.5, C4H), 6.67 (1H, d, 
J = 8.5, C5H), 5.38 (1H, s, NH), 3.91 (3H, s, OCH3), 2.90 (2H, t, J = 7.6, CH2), 2.78 (3H, d, J 
= 4.9, NHCH3), 2.42 (2H, t, J  = 7.6, CH2); 13C NMR (75 MHz, CDCl3) δ 172.2 (CO), 162.9 
(OC6), 146.0 (C2), 139.0 (C4), 128.9 (C3), 110.6 (C5), 53.3 (OCH3), 38.2 (CH2), 27.9 (CH2), 
26.3 (CH3); IR υmax (neat)/cm-1 3311, 3107, 2949, 2932, 1638, 1609, 1566, 1492; HRMS 
(ESI+): C10H14N2NaO2 [M + Na] +: calculated 217.0947, found 217.0939, ∆ = +1.7 ppm. 
 
Synthesis of chloro[3-(6-methoxypyridin-3-yl)propyl]methylamine 263 
NO
N
Cl
 
General procedure C was followed, step i, using amide 268 (2.00 g, 10.3 mmol) and LiAlH4 
(782 mg, 20.6 mmol) afforded the crude amine 271. Following step ii, using the crude amine 
271 (1.26 g, 6.97 mmol) and NCS (1.16 g, 8.71 mmol), purification by column 
chromatography, eluting with (10% EtOAc in hexane), afforded the title compound (712 mg, 
3.33 mmol, 48%) as a colourless oil. 1H NMR (300 MHz, CDCl3) δ ppm 7.98 (1H, dd, J = 2.4, 
0.5, C2H), 7.42 (1H, dd, J = 8.5, 2.5, C4H), 6.68 (1H, d, J = 8.5, C5H), 3.91 (3H, s, CH3), 2.93 
(3H, s, CH3), 2.90 – 2.82 (2H, m, CH2), 2.65 – 2.58 (2H, m, CH2), 1.99 – 1.86 (2H, m, CH2); 
13C NMR (75 MHz, CDCl3) δ ppm 162.7 (OC6), 146.1 (C2), 138.9 (C4), 129.5 (C3), 110.5 (C5), 
64.8 (CH2), 53.3 (CH3), 53.1 (CH3), 29.6 (CH2), 28.8 (CH2); IR υmax (neat)/cm-1 2945, 2845, 
2795, 1607, 1572, 1489, 1460, 1439; HRMS (ESI+): C10H1635ClN2O [M+H]+: calculated 
215.0946, found 215.0950, ∆ = -2.1 ppm. 
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Synthesis of methyl 3-phenylpropanoate 274 
 
General procedure D was followed, using methyl trans-cinnamate (4.00 g, 24.7 mmol) and 
10% Pd/C (400 mg, 10% wt), affording the title compound (3.80 g, 23.1 mmol, 94%) as a 
colourless oil, characterised without further purification. The NMR data was in accordance 
with the literature.105 1H NMR (300 MHz, CDCl3) δ 7.37 – 7.18 (5H, m, 5 × ArCH), 3.70 (3 
H, s, CH3), 2.98 (2H, t, J = 7.8, ArCH2), 2.66 (2H, t, J = 7.8, CH2CO); 13C NMR (75 MHz, 
CDCl3) δ 173.3 (CO), 140.5 (Cq), 128.5 (ArC), 128.3 (ArC), 126.3 (ArC), 51.6 (CH3), 35.7 
(CH2), 30.9 (CH2); IR υmax (neat) / cm-1 3063, 3028, 2951, 2848, 1734 (CO), 1604, 1496, 1435. 
 
Synthesis of 3-phenylpropanoic acid 275 
 
To a stirred solution of ester 274 (3.70 g, 22.5 mmol) in MeOH (50 mL, 0.45 M) was added 
NaOH (50 mL, 0.45 M). The reaction mixture was then heated to reflux and stirred for 2 h. The 
reaction mixture was cooled to RT and quenched with 4M HCl to pH 7 and the aqueous phase 
was extracted with EtOAc (50 mL × 3), dried over Na2SO4 and concentrated in vacuo to afford 
the title compound (2.50 g, 16.6 mmol, 74%) as a colourless solid which was recrystallized in 
hexane to yield colourless crystals. M.p. 43-44 oC, needles, hexane.  The NMR data was in 
accordance with literature.106 1H NMR (300 MHz, CDCl3) δ ppm 9.00 (1H, s, OH), 7.35 – 7.15 
(5H, m, 5 × ArCH), 2.96 (2H, t, J = 7.8, CH2), 2.69 (2H, t, J = 7.7, CH2); 13C NMR (75 MHz, 
CDCl3) δ ppm 178.7 (CO), 140.2 (Cq), 128.6 (2 × ArC), 128.3 (2 × ArC),  126.4 (ArC), 35.5 
(CH2), 30.6 (CH2); IR υmax (neat) / cm-1 3058, 3028 (br OH), 2952, 2932, 2625, 1692 (CO), 
1601, 1495; HRMS (ESI+): C9H9Na2O2 [M + Na2 - H]: calculated 195.0392, found 195.0388, 
∆ = -2.5 ppm. 
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Synthesis of N-methyl-3-phenylpropanamide 276 
 
General procedure E was followed, using acid 275 (2.21 g, 14.7 mmol), NH2Me.HCl (1.49 g, 
22.1 mmol), TBTU (7.57 g, 23.6 mmol) and DIPEA (5.14 mL, 29.5 mmol). Purification by 
column chromatography, eluting with 30-40% EtOAc in hexane, afforded the title compound 
(1.74 g, 10.7 mmol, 72%) as a colourless solid which was crystallised from hexane to yield 
colourless crystals. M.p. 54-55 oC, platelets, hexane.  The NMR data was in accordance with 
literature.107 1H NMR (300 MHz, CDCl3) δ ppm 7.36 – 7.16 (5H, m, 5 × ArCH), 5.34 (1H, br. 
s, NH), 2.99 (2H, t, J = 7.6, CH2), 2.79 (3H, d, J = 4.9, CH3), 2.49 (2H, t, J = 7.7, CH2); 13C 
NMR (75 MHz, CDCl3) δ ppm 172.7 (CO), 140.9 (Cq), 128.5 (2 × ArCH), 128.3 (2 × ArCH), 
126.2 (ArCH), 38.5 (CH2), 31.7 (CH2), 26.3 (CH3); IR υmax (neat) / cm-1 3301, 3064, 3030, 
2934, 2877, 1638, 1605, 1549; HRMS (ESI+): C10H14NO [M + H] +: calculated 164.1070, 
found 164.1070, ∆ = -1.5 ppm. 
 
Synthesis of N-chloro-N-methyl-3-phenylpropanamide 278 
 
General procedure F, using amide 276 (670 mg, 4.10 mmol), tert-butanol (610 µL, 6.15 mmol), 
acetic acid (350 µL, 6.15 mmol) and sodium hypochlorite (0.75 M) (8.20 mL, 6.15 mmol), 
followed by purification by column chromatography, eluting with 20% EtOAc in hexane  
afforded the title compound (671 mg, 3.39 mmol, 83%) as a colourless oil. 1H NMR (300 MHz, 
CDCl3) δ ppm 7.35 – 7.17 (5H, m, 5 × ArCH), 3.33 (3H, s, CH3), 3.01 – 2.93 (2H, m, CH2), 
2.85 – 2.77 (2H, m, CH2); 13C NMR (126 MHz, CDCl3) δ ppm 174.0 (CO), 140.8 (Cq), 128.5 
(2 × ArC), 128.4 (2 × ArC), 126.3 (ArC), 40.9 (CH3), 35.2 (CH2), 31.1 (CH2); IR υmax (neat) / 
cm-1 3085, 3062, 3027, 2936, 2873, 1667, 1603, 1495; HRMS (ESI+): C10H1335ClNO 
[M  +  H]+: calculated 198.0680, found 198.0680, ∆ = -0.3 ppm. 
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Synthesis of 3-chloro-N-methyl-3-phenylpropanamide 280 
 
To a stirred solution of chloroamide 278 (100 mg, 0.51 mmol) in DCM (1.70 mL) was added 
methanesulfonic acid (330 µL, 5.10 mmol) and the reaction mixture was stirred and irradiated 
under UV light using a 125 W high pressure mercury lamp for 5 h. The reaction mixture was 
washed with water, dried over MgSO4 and concentrated in vacuo. The crude material was 
purified by column chromatography eluting with 20% EtOAc in hexane affording the title 
compound (52 mg, 0.26 mmol, 52%) as colourless solid. 1H NMR (300 MHz, CDCl3) δ ppm 
7.44 – 7.28 (5H, m, 5 × ArCH), 5.54 (1H, br. s, NH), 5.42 (1H, dd, J = 9.1, 5.2, CH), 2.96 – 
2.83 (2H, m, CH2), 2.81 (3H, d, J = 4.9, CH3); 13C NMR (75 MHz, CDCl3) δ ppm 169.4 (CO), 
140.7 (ArCq), 128.8 (ArCH), 128.6 (ArCH), 128.5 (ArCH), 128.3 (ArCH), 126.8 (ArCH), 59.1 
(CH), 47.3 (CH2), 26.4 (CH3); IR υmax (neat) / cm-1 3303 (NH), 3101, 3032, 2932, 2920, 1711 
(CO), 1639, 1615; HRMS (ESI+): C10H1235ClNNaO [M  +  Na]+: calculated 220.0499, found 
220.0502, ∆ = -0.9 ppm. 
 
Synthesis of N-(3-phenylpropyl)acetamide 282 
 
To a stirred solution of 3-phenylpropylamine (1.00 g, 7.40 mmol) and triethylamine (1.20 mL, 
8.51 mmol) in DCM (8 mL) at 0 oC was added a solution of acetic anhydride (800 µL, 8.51 
mmol) in DCM (2 mL) dropwise. After 15 min the reaction was warmed to RT and stirred for 
16 h. The reaction was washed with an aqueous 2M HCl solution (pH 2). The aqueous phase 
was extracted with DCM (2 × 50 mL). The organic phases were combined and washed with a 
saturated aqueous solution of NaHCO3 until neutralised, dried over MgSO4 and concentrated 
in vacuo to afford the title compound (1.31g, 7.40 mmols, 100%) as a colourless oil, 
characterised without further purification. The NMR data was in accordance with the 
literature.108 1H NMR (300 MHz, CDCl3) δ ppm 7.33 – 7.13 (5H, m, 5 × ArCH), 5.63 (1H, br. 
s, NH), 3.27 (2H, q, J = 6.5, NHCH2), 2.68 – 2.61 (2H, t, J = 7.6, ArCH2), 1.93 (3H, s, CH3), 
1.83 (2H, apparent quin, J = 7.3, CH2); 13C NMR (75 MHz, CDCl3) δ ppm 170.1 (CO), 141.5 
(ArCq), 128.5 (2 × ArCH), 128.3 (2 × ArCH), 126.0 (ArCH), 39.3 (NHCH2), 33.3 (ArCH2), 
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31.2 (CH2), 23.3 (CH3); IR υmax (neat) / cm-1 3282, 3084, 3063, 3026, 2931, 2860, 1645, 1549; 
HRMS (ESI+): C11H16NO [M + H] +: calculated 178.1226, found 178.1225, ∆ = -3.4 ppm. 
 
Synthesis N-chloro-N-(3-phenylpropyl)acetamide 283 
 
General procedure F was followed, using amide 282 (2.55 g, 14.4 mmol), tert-butanol (2.15 
mL, 21.6 mmol), acetic acid (1.25 mL, 21.6 mmol) and sodium hypochlorite (0.75 M, 29.0 mL, 
21.6 mmol). Purification by column chromatography, eluting with 20% EtOAc in hexane 
afforded the title compound (1.98 g, 9.35 mmol, 65%) as a colourless oil. 1H NMR (300 MHz, 
CDCl3) δ ppm 7.35 – 7.15 (5H, m, 5 × ArCH), 3.73 (2H, t, J = 7.1, NClCH2), 2.64 (2H, t, J = 
7.4, ArCH2), 2.20 (3H, s, CH3), 2.01 (2H, quartet, J = 7.4, CH2); 13C NMR (126 MHz, CDCl3) 
δ ppm 172.0 (CO), 141.0 (ArCq), 128.5 (2 × ArCH), 128.3 (2 × ArCH), 126.1 (ArCH), 51.8 
(CH2), 32.4 (CH2), 28.8 (CH2), 21.8 (CH3); IR υmax (neat)/cm-1 3085, 3062, 2934, 2860, 1669, 
1603, 1496, 1453; HRMS (ESI+): C11H1535ClNO [M + H] +: calculated 212.0837, found 
212.0830, ∆ = -3.4 ppm. 
 
Synthesis of N-methyl-2-phenylacetamide 287 
 
General procedure E was followed, using phenylacetic acid (2.00 g, 14.7 mmol), NH2Me.HCl 
(1.49 g, 22.0 mmol), TBTU (7.54 g, 23.5 mmol) and DIPEA (10.2 mL, 58.7 mmol). 
Purification by column chromatography, eluting with 45-55% EtOAc in hexane, afforded the 
title compound (1.62 g, 10.9 mmol, 74%) as a yellow solid which was crystallised from hexane 
to yield colourless crystals. M.p. 54-55 oC, platelets, hexane. The NMR data was in accordance 
with the literature.109 1H NMR (300 MHz, CDCl3) δ ppm 7.42 – 7.24 (5H, m, 5 × ArCH), 5.43 
(1H, br. s, NH), 3.59 (2H, s, CH2), 2.77 (3H, d, J = 4.9, CH3). 13C NMR (75 MHz, CDCl3) δ 
ppm 171.6 (CO), 134.9 (ArCq), 129.5 (2 × ArCH), 129.1 (2 × ArCH), 127.4 (ArCH), 43.8 
(CH2), 26.5 (CH3); IR υmax (neat) / cm-1 3301, 3087, 3064, 3030, 2934, 2877, 1638, 1549; 
HRMS (ESI+): C9H12NO [M + H]+: calculated 150.0913, found 150.0911, ∆ = +1.8 ppm. 
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Synthesis of N-chloro-N-methyl-2-phenylacetamide 288 
 
General procedure F was followed, using amide 287 (1.00 g, 6.70 mmol), tert-butanol (1.00 
mL, 10.1 mmol), acetic acid (580 µL, 10.1 mmol) and sodium hypochlorite (0.75 M, 13.4 mL, 
10.1 mmol) stirred for 4 h instead of 2 h. Purification by column chromatography (20% EtOAc 
in hexane) afforded the title compound (1.04 g, 5.64 mmol, 84%) as a colourless oil which 
upon storage in the freezer formed a colourless solid. The NMR data was in accordance with 
the literature.110 1H NMR (300 MHz, CDCl3) δ ppm 7.40 – 7.25 (5H, m, 5 × ArCH), 3.90 (2H, 
s, CH2), 3.38 (3H, s, CH3); 13C NMR (126 MHz, CDCl3) δ ppm 172.6 (CO), 134.1 (ArCq), 
129.2 (2 × ArCH), 128.6 (2 × ArCH), 127.1 (ArCH), 41.2 (CH3), 40.2 (CH2); IR υmax (neat) / 
cm-1 3031, 3007, 2968, 2913, 1682, 1659 (CO), 1496, 1451; HRMS (ESI+): C9H1135ClNO [M 
+ H+]: calculated 184.0524, found 184.0518, ∆ = -3.2 ppm. 
 
Synthesis of 1-methyl-2,3-dihydro-1H-indol-2-one 289 
 
To a stirred solution of chloroamide 288 (100 mg, 0.54 mmol) in DCM (1.70 mL) was added 
BF3.OEt2 (330 µL, 2.7 mmol) and the reaction mixture was stirred and irradiated under UV 
light with a 125W high pressure mercury lamp for 5 h. The reaction mixture was washed with 
water, dried over MgSO4 and concentrated in vacuo. The crude material was purified by 
column chromatography eluting with 25-30% EtOAc in hexane to afford the title compound (8 
mg, 0.05 mmol, 10%) as a colourless oil. The NMR data was in accordance with literature.111 
1H NMR (300 MHz, CDCl3) δ ppm 7.34 – 7.23 (2H, m, 2 × ArCH), 7.06 (1H, td, J = 7.6, 0.9, 
ArCH), 6.84 (1H, d, J = 7.8, ArCH), 3.55 (2H, s, CH2), 3.24 (3H, s, J = 5.1, CH3); 13C NMR 
(126 MHz, CDCl3) δ ppm 175.1 (CO), 145.3 (ArCqCH2), 127.9 (ArCH), 124.5 (ArCqN), 124.3 
(ArCH), 122.3 (ArCH), 108.1 (ArCH), 35.7 (CH2), 26.2 (CH3); IR υmax (neat) / cm-1 3056, 
2920, 2850, 1711 (CO), 1615, 1494, 1470, 1370; HRMS (ESI+): C9H10NO [M + H]+: 
calculated 148.0757, found 148.0751, ∆ = +3.9 ppm. 
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Synthesis of N-(2-phenylethyl)acetamide 291 
 
To a stirred solution of 3-phenylethylamine (2.00 g, 16.5 mmol) and triethylamine (2.65 mL 
19.0 mmol) in DCM (12 mL) at 0 oC was added a solution of acetic anhydride (1.80 mL, 19.0 
mmol) in DCM (10 mL) dropwise. After 15 min the reaction was warmed to RT and stirred 16 
hours. The RM was washed with 2 M HCl (pH 2). The aqueous phase was extracted with DCM 
(2 × 100 mL). The organic phases were combined and washed with a saturated aqueous solution 
of NaHCO3 until neutralised, dried over MgSO4 and concentrated in vacuo to afford the title 
compound (2.25 g, 13.8 mmols, 84%) as a pale yellow solid. This was crystallised from hexane 
to yield pale yellow crystals which were characterised without further purification. M.p. 46-47 
oC, platelets, hexane. The NMR data was in accordance with the literature.112 1H NMR (300 
MHz, CDCl3) δ ppm 7.40 – 7.17 (5H, m, 5 × ArCH), 5.48 (1H, br. s, NH), 3.54 (2H, q, J = 6.8, 
NHCH2), 2.84 (2H, t, J = 6.9, ArCH2), 1.96 (3H, s, CH3); 13C NMR (75 MHz, CDCl3) δ ppm 
170.0 (CO), 138.9 (ArCq), 128.7 (2 × ArCH), 128.7 (2 × ArCH), 126.5 (ArCH), 40.6 (CH2), 
35.6 (CH2), 23.3 (CH3); IR υmax (neat) / cm-1: 3285 (NH) 3086, 3065, 2930, 2871, 1642 (CO), 
1539, 1496;  HRMS (ESI+): C10H14NO [M + H]+: calculated 164.1069, found 164.1066, ∆ = -
2.4 ppm. 
 
Synthesis of N-chloro-N-(2-phenylethyl)acetamide 292 
 
General procedure F was followed, using amide 291 (500 mg, 3.06 mmol), tert-butanol (460 
µL, 4.59 mmol), acetic acid (260 µL, 4.59 mmol) and sodium hypochlorite (0.75M, 6.12 mL, 
4.59 mmol) stirred for 4 h. Purification by column chromatography 10% EtOAc in hexane  
afforded the title compound (472 mg, 2.39 mmol, 78%) as a colourless oil. The NMR data was 
in accordance with the literature.113 1H NMR (300 MHz, CDCl3) δ ppm 7.37 – 7.19 (5H, m, 5 
× ArCH), 3.93 (2H, t, J = 7.3, CH2), 3.00 (2H, t, J = 7.4, CH2), 2.12 (3H, s, CH3); 13C NMR 
(126 MHz, CDCl3) δ ppm 170.3 (CO), 137.6 (ArCq), 128.9 (2 × ArCH), 128.6 (2 × ArCH), 
126.7 (ArCH), 53.6 (CH2), 33.5 (CH2), 21.5 (CH3); IR υmax (neat) / cm-1: 3086, 3065, 2934, 
2860, 1668, 1539, 1496, 1429; HRMS (ESI+): C10H1335ClNO [M + H+]: calculated 198.0680, 
found 198.0673, ∆ = +3.5 ppm. 
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Synthesis of N-methyl-2-phenylbenzamide 165 
 
General procedure E was followed, using 2-biphenylcarboxylic acid (1.00 g, 5.04 mmol), 
NH2Me.HCl (510 mg, 7.56 mmol), TBTU (2.59 g, 20.2 mmol) and DIPEA (2.61 mL, 20.2 
mmol). Purification by column chromatography, eluting with 35-45% EtOAc in hexane 
afforded the title compound (765 mg, 3.62 mmol, 72%) as a colourless solid which was 
crystallized from EtOAc to form colourless needles. M.p. 171-172 oC, needles, EtOAc.   The 
NMR data was in accordance with literature.114 1H NMR (300 MHz, CDCl3) δ ppm 7.71 (1H, 
dd, J = 7.5, 1.5, ArCH), 7.52 – 7.33 (8H, m, 8 × ArCH), 5.15 (1H, br. s, NH), 2.68 (3H, d, J = 
4.9, CH3); 13 C NMR (75 MHz, CDCl3) δ ppm 170.2 (CO), 140.2 (ArCq), 139.3 (ArCq), 
135.7(ArCq), 130.2 (ArCH), 130.1 (2 × ArCH), 128.9 (ArCH), 128.7 (ArCH), 128.6 (2 × 
ArCH), 127.8 (ArCH), 127.6 (ArCH), 26.7 (CH3); IR υmax (neat) / cm-1 3306 (NH), 3077, 3055, 
3020, 2931, 2894, 1623 (CO), 1592; HRMS (ESI+): C14H14NO [M + H+]: calculated 212.1069, 
found 212.1066, ∆ = +1.6 ppm. 
 
Synthesis of N-chloro-N-methyl-2-phenylbenzamide 295 
 
General procedure F was followed, using amide 165 (700 mg, 3.32 mmol), tert-butanol (0.50 
mL, 5.00 mmol), acetic acid (0.30 mL, 5.00 mmol) and sodium hypochlorite (0.75 M, 6.60 mL, 
5.00 mmol) in toluene (17 mL). Purification by column chromatography, eluting with 10% 
EtOAc in hexane afforded the title compound (130 mg, 0.53 mmol, 16%) as a pale yellow oil. 
1H NMR (300 MHz, CDCl3) δ ppm 7.56 – 7.35 (9 H, m, 9 × ArCH), 2.94 (3 H, s, CH3); 13C 
NMR (126 MHz, CDCl3) δ ppm 171.1 (CO), 139.5 (ArCq), 133.4 (ArCq), 130.3 (ArCq), 130.0 
(ArCq), 129.7 (ArCq), 128.6 (ArCq), 128.4 (ArCq), 128.2 (ArCq), 127.9 (ArCq), 127.7 (ArCq), 
21.0 (CH3); IR υmax (neat) / cm-1 3057, 3024, 2977, 2944, 1656 (CO), 1596, 1565, 1475; HRMS 
(ESI+): C14H1335ClNO [M + H]+: calculated 246.0680, found 246.0680, ∆ = 0.0 ppm. 
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4.5 Chapter 3 experimental 
 
General Procedure A Reductive Amination 
 
 
 
To a stirred solution of aldehyde (1 eq) in MeOH (0.2 M) was added amine (3 ̶ 10 eq) and the 
RM was stirred for 2 h. The RM was cooled to 0 oC and NaBH4 (2 eq) was added portionwise. 
The RM was warmed to RT and stirred for 2 h then quenched with saturated aqueous NaHCO3. 
The aqueous phase was extracted with EtOAc (3 ×). The combined organic extracts were dried 
over MgSO4 and concentrated in vacuo. Purification afforded the desired products. 
 
General procedure B Reductive amination with ketones 
 
 
 
Following a modified procedure by Williamson et al, to a stirred solution of ketone (1 eq) in 
MeOH (0.2 M) was added amine (3 ̶ 10 eq) and Ti(OiPr)4 (2 eq).97 The RM was stirred for 16 
h. The RM was cooled to 0 oC and NaBH4 (2 eq) was added portionwise. The RM was warmed 
to RT and stirred for 2 h then concentrated in vacuo. The residue was taken up in EtOAc and 
ammonium hydroxide (2M, 6.0 eq) was added. The resulting mixture was dried over MgSO4, 
the filtered through Celite and concentrated in vacuo. Purification afforded the desired product. 
 
General procedure C Chlorination using NCS 
 
 
 
Following a modified procedure by De Luca et al.79, to a stirred solution of the amine (1.0 eq) 
in DCM (0.5 M) in the dark was added NCS (1.0 eq) portionwise over 10 min at RT. The RM 
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was stirred for 3 h then concentrated in vacuo. Purification by column chromatography 
afforded the desired products. 
 
General procedure D N-Arylation  
 
 
 
To a stirred solution of the amine (1.0 eq) in DCM (0.2 M) at 0 oC was added MeSO3H (10 eq) 
and FeSO4.7H2O (10 mol%). The RM was stirred at 0 oC for 1 h. The RM was basified using 
2 M NaOH (pH 9). The two phases were separated and the aqueous phase was extracted with 
DCM (3 ×). The organic phases were combined, dried over MgSO4 and concentrated in vacuo. 
Purification by column chromatography yielded the desired product. 
 
General Procedure E Amide coupling 
 
 
 
To a stirred solution of the acid (1.0 eq) and methylamine hydrochloride (1.5 eq) in DCM 
(0.2 M), was added TBTU (1.6 eq) and DIPEA (4.0 eq). The reaction mixture was stirred at 
RT for 16 h. The reaction was quenched with saturated aqueous NaHCO3. The two phases were 
separated and the aqueous phase was extracted with DCM (3 ×). The organic phases were 
combined, dried over MgSO4 and concentrated in vacuo. Purification by column 
chromatography afforded the desired product. 
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General Procedure F Rh(I)- catalysed 1,4-conjugate addition 
 
 
 
Following a modified procedure by Miyaura et al, to a stirred solution of [Rh(cod)Cl2] 
(1 mol%) and ArB(OH)2 (1.25 eq.) in degassed aqueous dioxane (0.33 M) was added a solution 
of 1,4-unsaturated carbonyl compound (1.0 eq.) in aqueous dioxane and distilled Et3N (1 eq.) 
simultaneously.88 The reaction mixture was heated at 50 oC for 6 h, after which it was cooled 
to RT, concentrated and purified by column chromatography afforded the desired product. 
 
General Procedure G Alkylation of phenols 
 
 
 
Following a modified procedure by Cuerva et al, to a stirred solution of phenol (1 eq) in acetone 
was added potassium carbonate (1 eq) and the RM was stirred at RT for 30 mins.115 
Chloroacetone (1.1 eq) was then added and the RM was heated at 50 oC for 16 h. The RM was 
filtered and concentrated in vacuo. The residue was then taken up in H2O and basified to pH 9 
using 2 M NaOH. The aqueous phase was extracted using EtOAc (3 ×). The combined organic 
extracts were dried over MgSO4 and concentrated in vacuo. Purification by column 
chromatography afforded the desired product. 
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General Procedure H N-arylation using hydroxylamines 
 
 
 
A stirred solution of the aromatic (1 eq), hydroxylamine (3 eq), FeCl2 (5 mol%) and FeCl3 (1 
eq) in MeOH was heated at 60 oC for 4 h. Hydroxylamine (3 eq) was then added to the reaction 
mixture and the reaction was heated at 60 oC for 16 h. The RM was cooled to RT and partitioned 
between H2O and EtOAc. The mixture was basified to pH 9 using 2M NaOH and the phases 
separated. The aqueous phase was extracted with EtOAc (3 ×). The combined organic extracts 
were dried over MgSO4, filtered and concentrated in vacuo. Purification by column 
chromatography afforded the desired product 
 
General Procedure I One pot process 
 
 
 
Following a modified procedure by De Luca et al.79, to a stirred solution of the amine (1.0 eq) 
in DCM (0.5 M) in the dark was added NCS (0.9 eq) portionwise over 10 min at RT. The RM 
was stirred for 1 h at RT. The RM was cooled to 0 oC. MeSO3H (10 eq) and FeSO4.7H2O (10 
mol%) were added to the RM. The RM was stirred at 0 oC for 1 h. The RM was basified using 
2 M NaOH (pH 9). The two phases were separated and the aqueous phase was extracted with 
DCM (3 ×). The organic phases were combined, dried over MgSO4 and concentrated in vacuo. 
Purification by column chromatography yielded the desired product. 
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4.6 Experimental Data 
 
Synthesis of methyl(3-phenylpropyl)amine 237 
 
General Procedure A was followed, using hydrocinnamaldehyde (4.00 g, 29.8 mmol), MeNH2 
(8 M solution in EtOH, 5.0 ml, 1.3 eq), NaBH4 (1.35 g, 35.8 mmol) Purification by SCX 
cartridge afforded the desired amine (4.42 g, 29.6 mmol, 99%) as a pale yellow oil.  The NMR 
data was in accordance with the literature.116 1H NMR (500 MHz, CDCl3) δ ppm 7.33 – 7.28 
(2H, m, 2 × ArCH), 7.24 – 7.19 (3H, m, 3 × ArCH), 2.72 – 2.62 (4H, m, include ArCH2 and 
CH2N), 2.47 (3H, s, CH3), 1.91 – 1.82 (2H, m, CH2); 13C NMR (126 MHz, CDCl3) δ ppm 
142.1 (Cq), 128.4 (2 × ArCH), 128.4 (2 × ArCH), 125.8 (ArCH), 51.5 (CH2NH), 36.3 (CH3), 
33.6 (ArCH2), 31.3 (CH2); IR υmax (neat) / cm-1 3061, 3025, 2932, 2855, 2792, 1659, 1548, 
1495; HRMS (ESI+): C10H16N [M + H]+ : calculated 150.1277, found 150.1278, ∆ = + 0.3 
ppm. 
 
Synthesis of chloro(methyl)(3-phenylpropyl)amine 115 
 
General procedure C was followed, using amine 237 (500 mg, 3.35 mmol) and NCS (559 mg, 
4.19 mmol). Purification by column chromatography, eluting with 10% EtOAc in hexane 
afforded the title compound (414 mg, 2.25 mmol, 67%) as a colourless oil. The data was in 
accordance with the literature.77 1H NMR (500 MHz, CDCl3) δ ppm 7.31 – 7.25 (2H, m, 2 × 
ArCH), 7.21 – 7.17 (3H, m, 3 × ArCH), 2.93 (3H, s, CH3), 2.88 (2H, t, J = 7.0, NCH2), 2.69 
(2H, t, J = 7.7, ArCH2), 2.01 – 1.93 (2H, m, CH2); 13C NMR (101 MHz, CDCl3) δ ppm 141.7 
(Cq), 128.5 (2 × ArCH), 128.4 (2 × ArCH), 125.9 (ArCH), 65.3 (NCH2), 53.1 (CH3), 32.8 
(ArCH2), 29.8 (CH2); IR υmax (neat) / cm-1 3027, 2949, 2866, 1603, 1496, 1454, 1439, 1172. 
HRMS data could not be obtained. 
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Synthesis of 1-methyl-1,2,3,4-tetrahydroquinoline 116 
 
General Procedure D was followed, using chloroamine 115 (100 mg, 0.54 mmol), MeSO3H 
(350 µL, 5.40 mmol) and FeSO4.7H2O (15 mg, 0.050 mmol). Purification by column 
chromatography, eluting with 10% EtOAc in hexane afforded the title compound (58 mg, 0.39 
mmol, 73%) as a colourless oil. The data was in accordance with the literature.77 
 1H NMR (500 MHz, CDCl3) δ ppm 7.11 (1H, t, J = 7.7, ArCH), 6.99 (1H, d, J = 7.1, ArCH), 
6.65 – 6.62 (2H, m, 2 × ArCH), 3.28 – 3.24 (2H, m, NCH2), 2.92 (3H, s, CH3), 2.81 (2H, t, J = 
6.4, ArCH2), 2.05 – 2.00 (2H, m, CH2); 13C NMR (126 MHz,CDCl3) 146.8 (Cq), 128.8 (ArCH), 
127.0 (ArCH), 122.9 (Cq), 116.2 (ArCH), 110.9 (ArCH), 51.3 (NCH2), 39.1 (CH3), 27.8 
(ArCH2), 22.5 (CH2); IR υmax (neat) / cm-1 3075, 3032, 2998, 2931, 2834, 1639, 1611, 1583; 
HRMS (ESI+): C10H14N [M+H+]: calculated 148.1121, found 148.1118. 
 
Synthesis of (3-phenylpropyl)(prop-2-en-1-yl)amine 301a 
 
General procedure A was followed, using hydrocinnamaldehyde (500 mg, 3.73 mmol), allyl 
amine (2.13 g, 37.3 mmol) and NaBH4 (282 mg, 7.46 mmol). Purification by SCX cartridge 
afforded the title compound (645 mg, 3.41 mmol, 91%) as a yellow oil. The data was in 
accordance with the literature.77 
1H NMR (300 MHz, CDCl3) δ ppm 7.35 – 7.16 (5H, m, 5 × ArCH), 5.86 – 5.99 (1H, m, CH), 
5.18 (1H, ddd, J = 17.2, 3.3, 1.6, CHCH2), 5.10 (1H, ddd, J = 10.2, 3.3, 1.6, CHCH2), 3.27 
(2H, dt, J = 6.0, 1.4, NCH2CH), 2.72 – 2.65 (4H, m, ArCH2 and CH2CH2N), 1.91 – 1.79 (2H, 
m, CH2CH2CH2); 13C NMR (75 MHz, CDCl3) δ ppm 142.2 (Cq), 137.0 (CH), 128.4 (2 × 
ArCH), 128.3 (2 × ArCH), 125.8 (ArCH), 115.7 (CHCH2), 52.5 (NCH2CH), 49.0 (ArCH2), 
33.7 (CH2N), 31.8 (CH2CH2CH2); IR υmax (neat) / cm-1 3082, 3062, 2928, 2857. 2814, 1642, 
1603, 1495; HRMS (ESI+): C12H18N [M + H]+: calculated 176.1434, found 176.1436, ∆ = +1.4 
ppm. 
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Synthesis of N-chloro(3-phenylpropyl)(prop-2-en-1-yl)amine 302a 
 
General procedure C was followed, using amine 301a (500 mg, 2.85 mmol) and NCS (476 mg, 
3.57 mmol). Purification by column chromatography, eluting with 10% EtOAc in hexane 
afforded the title compound (426 mg, 2.03 mmol, 71%) as a colourless oil. The data was in 
accordance with the literature.77 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.36 – 7.27 (2H, m, 2 × ArCH), 7.25 – 7.21 (3H, m, 2 × 
ArCH), 6.02 – 5.92 (1H, m, CH2CH), 5.34 – 5.24 (2H, m, CH2CH), 3.62 (2H, d, J = 6.4, 
NClCH2CH), 2.99 – 2.92 (2H, m, CH2CH2NCl), 2.75 – 2.67 (2H, m, ArCH2), 2.07 – 2.00 (2H, 
m, ArCH2CH2); 13C NMR (101 MHz, CDCl3) δ 141.7 (Cq), 133.6 (CH2CH), 128.4 (2 × ArCH), 
128.3 (2 × ArCH), 125.9 (ArCH), 119.2 (CHCH2), 66.9 (NClCH2CH), 62.2 (CH2CH2NCl), 
32.8 (ArCH2), 29.4 (ArCH2CH2); IR υmax (neat) / cm-1 3017, 3084, 2982, 2948, 1602, 1495, 
1438, 1417; HRMS (ESI+): C12H1735ClN [M + H]+ : calculated 210.1044, found 210.1042, ∆ 
= +0.9 ppm. 
 
Synthesis of 1-(prop-2-en-1-yl)-1,2,3,4-tetrahydroquinoline 303a 
 
General procedure D was followed, using chloroamine 302a (100 mg, 0.48 mmol), MeSO3H 
(315 µL, 4.80 mmol) and FeSO4.7H2O (13 mg, 0.05 mmol). Purification by column 
chromatography, eluting with 10% EtOAc in hexane afforded the title compound (57 mg, 0.33 
mmol, 69%) as a colourless oil. The data was in accordance with the literature.77 
General Procedure I was followed using amine 301a (100 mg, 0.57 mmol), NCS (68 mg, 0.51 
mmol), MeSO3H (331 µL, 5.10 mmol) and FeSO4.7H2O (14 mg, 0.05 mmol). Purification by 
column chromatography, eluting with 10% EtOAc in hexane afforded the title compound (40 
mg, 0.23 mmol, 45%) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ ppm 7.02 (1H, t, J = 7.8, ArCH), 6.94 (1H, d, J = 7.5, ArCH), 
6.58 – 6.54 (2H, m, 2 × ArCH), 5.89 – 5.80 (1H, m, CHCH2), 5.24 – 5.10 (2H, m, CHCH2), 
3.89 – 3.82 (2H, m, NCH2CH), 3.31 – 3.23 (2H, m, NCH2), 2.76 (2H, t, J = 6.3, ArCH2), 2.02 
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– 1.90 (2H, m, CH2); 13C NMR (101 MHz, CDCl3) δ 145.4 (Cq), 133.6 (ArCH), 129.0 (ArCH), 
127.1 (ArCH), 122.4 (Cq), 115.9 (CHCH2), 115.7 (ArCH), 111.0 (CHCH2), 53.9 (NCH2CH), 
49.2 (NCH2), 28.2 (ArCH2), 22.4 (CH2); IR υmax (neat) / cm-1 3065, 3022, 2928, 2841, 1725, 
1675, 1642, 1601; HRMS (ESI+): C12H16N [M + H]+: calculated 174.1277, found 174.1272, 
∆ = -2.9 ppm. 
 
Synthesis of butyl(3-phenylpropyl)amine 301b 
 
General procedure A was followed, using hydrocinnamaldehyde (500 mg, 3.73 mmol), 
butylamine (1.40 mL, 18.7 mmol) and NaBH4 (282 mg, 7.46 mmol). Purification by column 
chromatography, eluting with 20% - 100% EtOAc in hexane afforded the title compound (607 
mg, 3.17 mmol, 85%) as a yellow oil. The data was in accordance with the literature.77 1H 
NMR (300 MHz, CDCl3) δ ppm 7.32 – 7.23 (2H, m, 2 × ArCH), 7.22 – 7.12 (3H, m, 3 × 
ArCH), 2.71 – 2.54 (6H, m, include ArCH2, CbH2 and CcH2), 1.89 – 1.75 (2H, m, CaH2), 1.54 
– 1.39 (2H, m, CdH2), 1.39 – 1.26 (2H, m, CH2CH3), 0.91 (3H, t, J = 7.2, CH3); 13C NMR (75 
MHz, CDCl3) δ ppm 142.3 (Cq), 128.4 (2 × ArCH), 128.3 (2 × ArCH), 125.7 (ArCH), 49.8 
(Cc), 49.7 (ArCH2), 33.8 (Cb), 32.4 (Cd), 31.8 (Ca), 20.5 (CH2CH3), 14.0 (CH3); IR υmax (neat) 
/ cm-1 3084, 3062, 3000, 2954, 2926, 2858, 1603, 1495; HRMS (ESI+): C13H22N [M + H]+: 
calculated 192.1747, found 192.1753, ∆ = +3.4 ppm. 
 
Synthesis of butyl(N-chloro)(3-phenylpropyl)amine 302b 
 
General procedure C was followed, using amine 301b (500 mg, 2.61 mmol) and NCS (435 mg, 
3.26 mmol). Purification by column chromatography, eluting with 10% EtOAc in hexane 
afforded the title compound (410 mg, 1.82 mmol, 70%) as a colourless oil. The data was in 
accordance with the literature.77 
1H NMR (300 MHz, CDCl3) δ ppm 7.32 – 7.24 (2H, m, 2 × ArCH), 7.22 – 7.14 (3H, m, 3 × 
ArCH), 2.96 – 2.87 (4H, m, includes CbH and CcH), 2.68 (2H, t, J = 7.7, ArCH2), 2.07 – 1.94 
(2H, m, CaH), 1.69 – 1.59 (2H, m, CdH), 1.37 (2H, dq, J = 14.5, 7.3, CH2CH3), 0.93 (3H, t, J 
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= 7.3, CH3); 13C NMR (75 MHz, CDCl3) δ ppm 141.8 (Cq), 128.5 (ArCH), 128.3 (ArCH), 
125.8 (ArCH), 64.1 (Cc), 63.3 (Cb), 32.8 (ArCH2), 30.0 (Cd), 29.5 (Ca), 20.0 (CH2CH3), 13.9 
(CH3); IR υmax (neat) / cm-1 3026, 2955, 2933, 2864, 1495, 1454, 1366, 1352; HRMS (ESI+): 
C13H2135ClN [M + H]+: calculated 226.1357, found 226.1360, ∆ = -1.1 ppm. 
 
Synthesis of 1-butyl-1,2,3,4-tetrahydroquinoline 303b 
 
General Procedure D was followed, using chloroamine 302b (100 mg, 0.44 mmol), MeSO3H 
(285 µL, 4.40 mmol) and FeSO4.7H2O (12 mg, 0.04 mmol). Purification by column 
chromatography, eluting with 10% EtOAc in hexane afforded the title compound (36 mg, 0.19 
mmol, 43%) as a pale yellow oil. The data was in accordance with the literature.77 
General Procedure I was followed using amine (100 mg, 0.52 mmol), NCS (63 mg, 0.47 mmol), 
MeSO3H (305 µL, 4.70 mmol) and FeSO4.7H2O (14 mg, 0.05 mmol). Purification by column 
chromatography, eluting with 10% EtOAc in hexane afforded the title compound (51 mg, 0.27 
mmol, 57%) as a colourless oil. 
1H NMR (300 MHz, CDCl3) δ ppm 7.08 – 6.98 (1H, m, ArCH), 6.98 – 6.86 (1H, m, ArCH), 
6.60 – 6.49 (2H, m, 2 × ArCH), 3.34 – 3.15 (4H, m, CbH2 and CcH2), 2.80 – 2.68 (2H, m, 
ArCH2), 2.02 – 1.86 (2H, m, CaH2), 1.64 – 1.48 (2H, m, CdH2), 1.42 – 1.26 (2H, m, CH2CH3), 
0.95 (3H, t, J = 7.3, CH3); 13C NMR (75 MHz, CDCl3) δ ppm 145.4 (Cq), 129.1 (ArCH), 127.0 
(ArCH), 122.1 (Cq), 115.1 (ArCH), 110.5 (ArCH), 51.2 (NCH2), 49.5 (NCH2), 28.4 (Cd), 28.2 
(ArCH2), 22.3 (Ca), 20.5 (CH2CH3), 14.1 (CH3); IR υmax (neat) / cm-1 3064, 3020, 2954, 2929, 
2860, 1676, 1601, 1503; HRMS (ESI+): C13H20N [M + H]+: calculated 190.1590, calculated 
190.1593, ∆ = +1.5 ppm. 
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Synthesis of N-(3-phenylpropyl)hexan-1-amine 301c 
 
General Procedure A was followed using hydrocinnamaldehyde (1.00 g, 7.45 mmol), 
hexylamine (4.90 mL, 37.3 mmol) and NaBH4 (423 mg, 11.2 mmol). Purification by column 
chromatography, eluting with 20-100% EtOAc in hexane afforded the title compound (512 mg, 
2.33 mmol,31 %) as a colourless oil. The data was in accordance with the literature.77 
1H NMR (300 MHz CDCl3) δ ppm 7.32-7.23 (2H, m, 2 × ArCH), 7.21-7.16 (3H, m, 3 × ArCH), 
2.70-2.54 (6H, m, includes ArCH2, CbH2 and CcH2), 1.88-1.74 (2H, m, CaH2), 1.51-1.41 (2H, 
m, CdH2), 1.37-1.21 (6H, m, includes CH2CH3, CeH2 and CfH2), 0.93-0.83 (3H, m, CH3); 13C 
NMR (75 MHz, CDCl3) δ ppm 142.2 (Cq), 128.4 (2 × ArCH), 128.3 (2 × ArCH), 125.7 (ArCH), 
50.1 (Cc), 49.6 (Cb), 33.7 (Cd), 31.8 (ArCH2 and Ca), 30.2 (Ce), 27.1 (Cf), 22.6 (CH2), 14.0 
(CH3); IR υmax (neat)/cm-1: 3026, 2925, 2855, 1603, 1495, 1454, 1129, 687; HRMS (ESI+): 
C15H26N [M+H]+ : calculated 220.2060, found 220.2063, ∆ = +1.4 ppm. 
 
Synthesis of N-chloro-N-(3-phenylpropyl)hexan-1-amine 302c 
 
General procedure C was followed, using amine 301c (500 mg, 2.61 mmol) and NCS (435 mg, 
3.26 mmol). Purification by column chromatography, eluting with 10% EtOAc in hexane 
afforded the title compound (410 mg, 1.82 mmol, 70%) as a colourless oil. The data was in 
accordance with the literature.77 
1H NMR (300 MHz, CDCl3) δ ppm 7.30 (2H, m, 2 x ArCH), 7.25-7.13 (3H, m, 3 x ArCH), 
2.92 (4H, m, includes 2H, m, CbH2 and CcH2), 2.75-2.61 (2H, m, ArCH2), 2.09-1.95 (2H, m, 
CaH2), 1.75-1.60 (2H, m, CdH2), 1.43-1.22 (6H, m, includes CeH2, CfH2 and CH2CH3 ), 0.91 
(3H, t, J = 6.8, CH3); 13C NMR (75 MHz, CDCl3) δ ppm 142.0 (Cq), 128.6 (2 × ArCH), 128.5 
(2 × ArCH), 126.0 (ArCH), 64.6 (CH2), 63.4 (CH2), 32.9 (CH2), 31.8 (CH2), 29.6 (CH2), 28.0 
(CH2), 26.7 (CH2), 22.7 (CH2), 14.2 (CH3); IR υmax (neat)/cm-1: 3085, 3027, 2928, 1063, 1496, 
1454, 1347, 1302; HRMS (ESI+): C15H2535ClN [M+H]+ : calculated 254.1670, found 
254.1675, ∆ = +2.0 ppm. 
 
166 
 
Synthesis of 1-hexyl-1,2,3,4-tetrahydroquinoline 303c 
 
General Procedure D was followed, using chloroamine 302c (100 mg, 0.39 mmol), MeSO3H 
(255 µL, 3.90 mmol) and FeSO4.7H2O (11 mg, 0.04 mmol). Purification by column 
chromatography, eluting with 10% EtOAc in hexane afforded the title compound (41 mg, 0.19 
mmol, 48%) as a colourless oil. The data was in accordance with the literature.77 
1H NMR (300 MHz, CDCl3) δ ppm 7.09-6.99 (1H, m, ArCH), 6.97-6.89 (1H, m, ArCH), 6.63-
6.47 (2H, m, includes 2 × ArCH), 3.34-3.15 (4H, m, includes CH2c and CH2b), 2.75 (2H, t, J = 
6.4, ArCH2), 2.02-1.88 (2H, m, CH2a), 1.66-1.51 (2H, m, CH2d), 1.40-1.24 (6H, m, includes 
CH2e, CH2f and CH2CH3), 0.98-0.81 (3H, m, CH3); 13C NMR (125 MHz, CDCl3) δ ppm 145.5 
(Cq), 129.3 (ArCH), 127.2 (ArCH), 122.3 (Cq), 115.3 (ArCH), 110.6 (ArCH), 51.7 (Cc), 49.6 
(Cb), 31.9 (Cd), 28.4 (ArCH2), 27.1 (Ca), 26.3 (Ce), 22.8 (Cf), 22.4 (CH2), 14.2 (CH3); IR υmax 
(neat)/cm-1: 3066, 2925, 2855, 1601, 1574, 1504, 1456, 1369; HRMS (ESI): C15H24N [M+H]+: 
calculated 218.1903, found 218.1902, ∆ = -0.5 ppm. 
 
Synthesis of 1-(but-3-en-1-yl)-4-methylbenzene 308a 
 
4-Methylbenzyl bromide (800 mg, 4.32 mmol) was flushed with N2 and THF (11 mL) was 
added. The solution was cooled to 0 oC and allylmagnesium bromide (2.0 M in THF, 4.3 mL, 
8.64 mmol) was added dropwise. The RM was stirred at 0 oC for 2 h. The reaction was 
quenched with saturated aqueous NH4Cl. The aqueous phase was extracted using EtOAc (3 × 
70 mL). The combined organic layers were dried over MgSO4 and concentration in vacuo 
afforded the title compound x (588 mg, 4.02 mmol, 93%) as a colourless oil without further 
purification being required. The NMR data is in accordance with the literature.117 
1H NMR (300 MHz, CDCl3) δ ppm 7.12 (4H, s, 4 × ArCH), 5.96 – 5.83 (1H, m, CHCH2), 5.10 
– 4.99 (2H, m, CHCH2), 2.70 (2H, t, J = 7.6, ArCH2), 2.40 (2H, t, J = 7.6, CH2), 2.35 (3H, s, 
CH3); 13C NMR (75 MHz, CDCl3) δ 138.8 (Cq), 138.2 (CH), 135.2 (Cq), 128.9 (2 × ArCH), 
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128.3 (2 × ArCH), 114.8 (CHCH2), 35.6 (ArCH2CH2), 34.9 (ArCH2), 21.0 (CH3); IR υmax 
(neat) / cm-1 3077, 3048, 3003, 2978, 2923, 2856, 1640, 1515. HRMS data could not be 
obtained. 
 
Synthesis of 3-(4-methylphenyl)propanal 309a 
 
A stirred solution of alkene 308a (500 mg, 3.42 mmol) in DCM (17 mL) was cooled to ˗78 oC 
and a flow of oxygen was bubbled through the solution for 5 min. Ozone was then bubbled 
through the RM for 20 min (colour change observed from colourless to bright blue). Oxygen 
was then bubbled through the RM for a further 5 min and triphenylphosphine (943 mg, 3.59 
mmol) was added. The reaction was stirred at ˗78 oC for 10 min and the starch iodine test 
showed no peroxides were present. The reaction mixture was warmed to RT and concentrated 
in vacuo. Purification by column chromatography 10% EtOAc in hexane afforded the title 
compound (364 mg, 2.46 mmol, 72%) as a colourless oil. The NMR data is in accordance with 
the literature.118  
1H NMR (400 MHz, CDCl3) δ ppm 9.86 (1H, t, J = 1.3, CHO), 7.40 – 7.35 (1H, m, ArCH), 
7.28 – 7.25 (1H, m, ArCH), 7.24 – 7.15 (2H, m, ArCH), 3.09 (2H, t, J = 7.5, ArCH2), 2.83 (2H, 
td, J = 7.6, 1.2, CH2CHO), 2.35 (3H, s, CH3).; 13C NMR (126 MHz, CDCl3) δ ppm 201.8 
(CHO), 137.2 (Cq), 135.9 (Cq), 129.3 (2 × ArCH), 128.2 (2 × ArCH), 45.4 (CH2), 27.7 (ArCH2), 
21.0 (CH3). IR υmax (neat) / cm-1 3050, 3011, 2923, 2862, 1722, 1515, 1435, 1407. HRMS data 
could not be obtained. 
 
Synthesis of methyl[3-(4-methylphenyl)propyl]amine 310a 
 
General procedure A was followed, using aldehyde 309a (300 mg, 2.02 mmol), MeNH2 (8M 
solution in EtOH, 300 µL) and NaBH4 (153 mg, 4.04 mmol). Purification by SCX cartridge 
afforded the title compound (320 mg, 1.96 mmol, 97%) as a yellow oil. The 1H NMR data is 
in accordance with the literature.119  
1H NMR (500 MHz, CDCl3) δ ppm 7.08 (4H, s, 4 × ArCH), 2.62 (4H, t, J = 7.3, include ArCH2 
and CH2NH), 2.43 (3H, s, NHCH3), 2.31 (3H, s, ArCH3), 1.85 – 1.79 (2H, m, CH2); 13C NMR 
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(126 MHz, CDCl3) δ ppm 138.9 (Cq), 135.3 (Cq), 129.1 (2 × ArCH), 128.3 (2 × ArCH), 51.4 
(CH2NH), 36.2 (NHCH3), 33.1 (ArCH2), 31.3 (CH2), 21.0 (ArCH3); IR υmax (neat) / cm-1 3046, 
3016, 2925, 2853, 2789, 1514, 1470, 1445; HRMS (ESI+): C11H18N [M + H]+: calculated 
164.1434, found 164.1432, ∆ = +1.0 ppm. 
 
Synthesis of N-chloro(methyl)[3-(4-methylphenyl)propyl]amine 311a 
 
General procedure C was followed, using amine 310a (250 mg, 1.53 mmol) and NCS (255 mg, 
1.91 mmol). Purification by column chromatography, eluting with 10% EtOAc in hexane 
afforded the title compound (219 mg, 1.11 mmol, 73%) as a colourless oil. 
1H NMR (300 MHz, CDCl3) δ ppm 7.09 (4H, s, ArCH), 2.92 (3H, s, NClCH3), 2.87 (2H, t, 
J = 6.8, CH2N), 2.64 (2H, t, J = 7.8, ArCH2), 2.32 (3H, s, ArCH3), 2.00 – 1.89 (2H, m, 
ArCH2CH2); 13C NMR (75 MHz, CDCl3) δ 138.6 (Cq), 135.3 (Cq), 129.1 (2 × ArCH), 128.3 
(2 × ArCH), 65.3 (CH2N), 53.0 (NCH3), 32.3 (ArCH2), 29.8 (CH2), 21.0 (ArCH3); IR υmax 
(neat) / cm-1 3046, 3018, 2995, 2948, 1514, 1437, 1375, 1169; HRMS (ESI+): C11H1735ClN 
[M + H]+ : calculated 198.1044, found 198.1042, ∆ = ˗0.8 ppm. 
 
Synthesis of 1,7-dimethyl-1,2,3,4-tetrahydroquinoline 324 
 
General Procedure D was followed, using chloroamine 311a (100 mg, 0.51 mmol), MeSO3H 
(335 µL, 5.10 mmol) and FeSO4.7H2O (14 mg, 0.051 mmol). Purification by column 
chromatography, eluting with 10% EtOAc in hexane afforded the title compound (64 mg, 0.40 
mmol, 78%) as a colourless oil. The NMR data was in accordance with the literature.120 
1H NMR (400 MHz, CDCl3) δ ppm 6.76 (1H, d, J = 7.3, ArCH), 6.36 (2H, m, 2 × ArCH), 3.16 
– 3.08 (2H, m, NCH2), 2.80 (3H, s, NCH3), 2.65 (2H, t, J = 6.5, ArCH2), 2.20 (3H, s, ArCH3), 
1.93 – 1.84 (2H, m, CH2); 13C NMR (101 MHz, CDCl3) δ 146.6 (Cq), 136.6 (Cq), 128.7 
(ArCH), 112.0 (Cq), 117.0 (ArCH), 111.8 (ArCH), 51.4 (NCH2), 39.2 (NCH3), 27.5 (ArCH2), 
22.7 (CH2), 21.6 (ArCH3); IR υmax (neat) / cm-1 3041, 3022, 2924, 2856, 2839, 2812, 1611, 
1575; HRMS (ESI+): C11H16N [M + H]+: calculated 162.1277, found 162.1280, ∆ = -1.9 ppm. 
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Synthesis of 1-(but-3-en-1-yl)-3,5-dimethylbenzene 308b 
 
3,5-Methylbenzyl bromide (800 mg, 4.02 mmol) was flushed with N2 in a round bottom flask 
and THF (10 mL) was added. The solution was cooled to 0 oC and allylmagnesium bromide 
(2.0 M in THF, 4.0 mL, 8.04 mmol) was added dropwise. The RM was stirred at 0 oC for 2 h 
The reaction was quenched with saturated aqueous NH4Cl. The solution was extracted using 
EtOAc (3 × 70 mL). The combined organic extracts were dried over MgSO4 and concentration 
in vacuo afforded the title compound (613 mg, 3.83 mmol, 95%) as a yellow oil without further 
purification being required. 
1H NMR (500 MHz, CDCl3) δ ppm 6.84 – 6.81 (3H, m, 3 × ArCH), 5.96 – 5.79 (1H, m, CH), 
5.08 – 4.96 (2H, m, CHCH2), 2.66 – 2.61 (2H, m, CH2), 2.41 – 2.32 (2H, m, CH2), 2.30 (6H, 
s, CH3); 13C NMR (126 MHz, CDCl3) δ ppm 141.9 (Cq), 138.4 (CHCH2), 137.8 (2 × Cq), 127.5 
(ArCH), 126.3 (2 × ArCH), 114.7 (CHCH2), 35.6 (CH2), 35.3 (CH2), 21.3 (2 × ArCH3); IR 
υmax (neat) / cm-1 3026, 2955, 2933, 2864, 2835, 1495, 1454, 1366. HRMS data could not be 
obtained. 
  
Synthesis of [3-(3,5-dimethylphenyl)propyl](methyl)amine 309b 
 
Step i) A stirred solution of alkene 308b (500 mg, 3.12 mmol) in DCM (16 mL) was cooled to 
-78 oC and oxygen was bubbled through the solution for 5 min. Ozone was bubbled through 
the reaction mixture for 20 min (colour change observed from colourless to bright blue). 
Oxygen was then bubbled through the mixture for a further 5 min after which 
triphenylphosphine (862 mg, 3.28 mmol) was added. The reaction was stirred at -78 oC for 10 
min and the starch iodine test showed no peroxides were present. The reaction mixture was 
concentrated in vacuo. Purification by column chromatography 10% EtOAc in hexane afforded 
the title compound (370 mg, 2.28 mmol, 73%) as a colourless oil. 
Step ii) General procedure A was followed, using aldehyde x (300 mg, 1.85 mmol), MeNH2 
(8M solution in EtOH, 300 µL) and NaBH4 (140 mg, 3.70 mmol). Purification by SCX cartridge 
afforded the title compound (311 mg, 1.75 mmol, 95%) as a pale yellow oil. 
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1H NMR (300 MHz, CDCl3) δ ppm 6.84 – 6.80 (3H, m, 3 × ArCH), 2.66 – 2.54 (4H, m, ArCH2, 
CH2NH), 2.43 (3H, s, NCH3), 2.28 (6H, s, 2 × ArCH3), 1.86 – 1.76 (2H, m, CH2); 13C NMR 
(75 MHz, CDCl3) δ ppm 142.0 (Cq), 137.8 (2 × Cq), 127.4 (ArCH), 126.2 (2 × ArCH), 51.6 
(CH2), 36.3 (CH3), 33.5 (CH2), 31.4 (CH2), 21.3 (2 × ArCH3); IR υmax (neat) / cm-1 3300, 3012, 
2918, 2855, 2788, 1605, 1545, 1469; HRMS (ESI+) C12H19N [M + H]+: calculated 178.1590, 
found 178.1592, ∆ = +1.2 ppm. 
 
Synthesis of N-chloro[3-(3,5-dimethylphenyl)propyl]methylamine 310b 
 
General procedure C was followed, using amine 309b (250 mg, 1.41 mmol) and NCS (235 mg, 
1.76 mmol). Purification by column chromatography, eluting with 10% EtOAc in hexane 
afforded the title compound (196 mg, 0.93 mmol, 66%) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ ppm 6.95 – 6.80 (3H, m, ArCH), 2.97 – 2.95 (3H, s, CH3), 2.91 
(2H, t, J = 7.0, CH2NCl), 2.66 – 2.60 (2H, t, J = 7.3, ArCH2), 2.32 (6H, s, 2 × CH3), 2.01 – 
1.90 (2H, m, CH2); 13C NMR (101 MHz, CDCl3) δ ppm 141.6 (Cq), 137.9 (2 × Cq), 127.5 
(ArCH), 126.3 (2 × ArCH), 65.4 (CH2NCl), 53.1 (CH3), 32.6 (ArCH2), 29.8 (CH2), 21.3 (2 × 
ArCH3); IR υmax (neat) / cm-1 2948, 2917, 2858, 1605, 1456, 1437, 1375, 1191; HRMS (ESI+): 
C12H1935ClN [M + H]+: calculated 212.1201, found 212.1205, ∆ = +2.1 ppm. 
 
 Synthesis of 1,6,8-trimethyl-1,2,3,4-tetrahydroquinoline 321 
 
General Procedure D was followed, using chloroamine 310b (100 mg, 0.47 mmol), MeSO3H 
(305 mL, 4.70 mmol) and FeSO4.7H2O (13 mg, 0.047 mmol). Purification by column 
chromatography, eluting with 10% EtOAc in hexane afforded the title compound (22 mg, 0.13 
mmol, 28%) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ ppm 6.81 (1H, s, ArCH), 6.72 (1H, s, ArCH), 3.14 – 3.06 (2H, 
m, NCH2), 2.75 (2H, t, J = 6.7, ArCH2), 2.68 (3H, s, CH3), 2.27 (3H, s, ArCH3), 2.22 (3H, s, 
ArCH3), 1.88 – 1.78 (2H, m,CH2); 13C NMR (101 MHz, CDCl3) δ ppm 131.3 (Cq), 131.1 (Cq), 
130.5 (Cq), 129.7 (ArCH), 128.8 (Cq), 127.9 (ArCH), 52.2 (NCH2), 43.0 (CH3), 27.7 (ArCH2), 
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20.6 (ArCH3), 18.4 (ArCH3), 16.7 (CH2); IR υmax (neat) / cm-1 2997, 2933, 2853, 1722, 1678, 
1605, 1479. 1439; HRMS (ESI+): C12H18N [M + H]+: calculated 176.1453, found 176.1455, 
∆ = +2.0 ppm. 
 
Synthesis of 1-(but-3-en-1-yl)-3-chlorobenzene 308c 
 
3-chlorobenzyl bromide (1.50 g, 7.30 mmol) was flushed with N2 and THF (18 mL) was added. 
The solution was cooled to 0 oC and the allyl Grignard (2.0 M in THF, 7.30 mL, 14.6 mmol) 
was added dropwise. The reaction mixture was stirred at 0oC for 2 h, it was then quenched with 
NH4Cl. The solution was extracted using EtOAc (3 x 100 mL) The combined organic layers 
were dried over MgSO4 and concentrated. Purification by column chromatography 10% EtOAc 
in hexane afforded the title compound (1.20 g, 7.20 mmol, 99%) as a colourless oil. The NMR 
data was in accordance with the literature.121 
1H NMR (400 MHz, CDCl3) δ ppm 7.26 – 7.17 (3H, m, 3 × ArCH), 7.09 (1H, d, J = 7.2, 
ArCH), 5.92 – 5.80 (1H, m, CHCH2), 5.12 – 4.98 (2H, m, CHCH2), 2.72 (2H, t, J = 7.7, ArCH2), 
2.39 (2H, m, CH2); 13C NMR (101 MHz, CDCl3) δ ppm 143.9 (Cq), 137.5 (CH), 134.1 (Cq), 
129.5 (ArCH), 128.6 (ArCH), 126.7 (ArCH), 126.0 (ArCH), 115.3 (CHCH2), 35.2 (CH2), 35.0 
(ArCH2); IR υmax (neat) / cm-1  3077, 2978, 2928, 2857, 1640, 1598, 1573, 1476; HRMS data 
could not be obtained. 
 
Synthesis of 3-(3-chlorophenyl)propanal 309c 
 
A stirred solution of alkene 308c (1.00 g, 6.00 mmol) in DCM (30 mL) was cooled to -78 oC 
and oxygen was bubbled through it for 5 mins after which ozone was bubbled through the 
reaction mixture for 20 mins (colour change observed colourless to bright blue). Oxygen was 
then bubbled through the mixture for a further five mins after which triphenylphosphine (1.66 
g, 6.30 mmol) was added. The reaction was stirred at -78 oC for 10 mins and the starch iodine 
test showed no peroxides were present. The reaction mixture was concentrated in vacuo. 
Purification by column chromatography 10% EtOAc in hexane afforded the title compound 
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(766 mg, 4.54 mmol, 76%) as a colourless oil. The NMR data was in accordance with the 
literature.122 
1H NMR (400 MHz, CDCl3) δ ppm 9.84 (1H, s, CHO), 7.30 – 7.18 (3H, m, 3 ArCH), 7.10 
(1H, d, J = 7.1, ArCH), 2.96 (2H, t, J = 7.4, CH2), 2.81 (2 H, t, J = 7.5, ArCH2); 13C NMR 
(101 MHz, CDCl3) δ ppm 200.9 (CHO), 142.4 (Cq), 134.3 (Cq), 129.9 (ArCH), 128.5 (ArCH), 
126.6 (ArCH), 126.5 (ArCH), 45.0 (CH2), 27.7 (ArCH2); IR υmax (neat) / cm-1 3019, 2928, 
2894, 2824, 2724, 1721 (CO),  1598, 1573; HRMS data could not be obtained. 
 
Synthesis of [3-(3-chlorophenyl)propyl](methyl)amine 310c 
 
General Procedure A was followed, using aldehyde 309c (700 mg, 4.15 mmol), MeNH2 (8M 
in EtOH, 1.50 mL, 12.0 mol) and NaBH4 (236 mg, 6.23 mmol). Purification by SCX cartridge 
afforded the title compound (672 mg, 3.66 mmol, 88%) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ ppm 7.26 – 7.15 (3H, m, 3 × ArCH), 7.08 (1H, d, J = 7.2, 
ArCH), 2.70 – 2.61 (4H, m, includes ArCH2 and CH2NH), 2.47 (3H, s, CH3), 1.91 – 1.80 (2H, 
m, CH2); 13C NMR (101 MHz, CDCl3) δ ppm 144.0 (Cq), 134.1 (Cq), 129.6 (ArCH), 128.5 
(ArCH), 126.6 (ArCH), 126.1 (ArCH), 51.1 (CH2N), 36.1 (CH3), 33.2 (ArCH2), 30.8 (CH2); 
IR υmax (neat) / cm-1 3059, 2935, 2858, 2796, 1596, 1571, 1536, 1473; HRMS (ESI+): 
C10H1535ClN [M + H]+: calculated 184.0888, found 184.0886, ∆ = + 1.0 ppm. 
 
Synthesis of N-chloro[3-(3-chlorophenyl)propyl]methylamine 311c 
 
General procedure C was followed, using chloroamine 310c (300 mg, 1.64 mmol), NCS (274 
mg, 2.05 mmol). Purification by column chromatography eluting with 10% EtOAc in hexane 
afforded the title compound (300 mg, 1.38 mmols, 85%) as a colourless oil 
1H NMR (400 MHz, CDCl3) δ ppm 7.26 – 7.17 (3H, m, 3 × ArCH), 7.10 (1H, d, J = 7.2, 
ArCH), 2.96 (3H, s, CH3), 2.89 (2H, t, J = 6.8, CH2), 2.69 (2H, t, J = 7.7 CH2), 2.01 – 1.94 
(2H, m, CH2); 13C NMR (101 MHz, CDCl3) δ ppm 143.8 (Cq), 134.1 (Cq), 129.7 (ArCH), 
128.6 (ArCH), 126.7 (ArCH), 126.1 (ArCH), 64.9 (CH2N), 53.1 (CH3), 32.4 (ArCH2), 29.5 
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(CH2): IR υmax (neat) / cm-1 3061, 2992, 2950, 2919, 2867, 1597, 1572, 1475; HRMS (ESI+): 
C10H1435Cl2N [M + H]+: calculated 218.0498, found 218.0492, ∆ = - 2.5 ppm. 
 
Synthesis of 6-chloro-1-methyl-1,2,3,4-tetrahydroquinoline and 8-chloro-1-methyl-
1,2,3,4-tetrahydroquinoline 325a and 325b 
 
General Procedure D was followed, using chloroamine 311c (100 mg, 0.46 mmol), MeSO3H 
(300 µL, 4.60 mmol) and FeSO4.7H2O (13 mg, 0.046 mmol). Purification by column 
chromatography, eluting with 10% EtOAc in hexane afforded the regioisomeric 325a and 325b 
as an inseperable mixture (1.4 : 1, 40 mg, 0.22 mmol, 48%) as a colourless oil. The NMR data 
for 325b was in accordance with the literature.123 
General Procedure I was followed using amine 310c (100 mg, 0.54 mmol), MeSO3H (318 µL, 
4.90 mmol) and FeSO4.7H2O (14 mg, 0.05 mmol). Purification by column chromatography, 
eluting with 10% EtOAc in hexane afforded the title compound (37 mg, 0.20 mmol, 42%) as a 
colourless oil.  
1H NMR (400 MHz, CDCl3, peaks for 325a) δ ppm 7.02 (1H, dd, J = 8.7, 2.6, ArCH), 6.93 
(1H, d, J = 2.6, ArCH), 6.50 (1H, d, J = 8.7, ArCH), 3.25 – 3.19 (2H, m, CH2NMe), 2.88 (3H, 
s, CH3), 2.75 (2H, t, J = 6.5, ArCH2), 1.99 (2H, m, CH2), 13C NMR (101 MHz, CDCl3, peaks 
for 325a) δ ppm 145.3 (Cq), 131.2 (Cq), 128.4 (ArCH), 126.6 (ArCH), 124.4 (Cq), 111.9 
(ArCH), 51.1 (CH2NMe), 39.2 (CH3), 27.7 (ArCH2), 22.2 (CH2); 1H NMR (400 MHz, CDCl3, 
peaks for 325b) δ ppm 7.19 (1H, d, J = 7.8, ArCH), 6.97 (1H, d, J = 7.8), 6.85 (1 H, t, J = 7.8, 
ArCH), 3.19 – 3.14 (2H, m, CH2NMe), 2.91 (3H, s, CH3), 2.82 (2H, t, J = 6.7, ArCH2), 1.91 – 
1.85 (2H, m, CH2);  13C NMR (101 MHz, CDCl3, peaks for 325b) δ ppm 146.0 (Cq), 128.3 
(ArCH), 128.2 (ArCH), 127.5 (Cq), 122.0 (ArCH), 120.7 (Cq), 52.0 (CH2NMe), 42.8 (CH3), 
27.9 (ArCH2), 17.2 (CH2); IR υmax (neat) / cm-1 3040, 2934, 2861, 2841, 1596, 1560, 1499, 
1463; HRMS data could not be obtained. 
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Synthesis of 1-(but-3-en-1-yl)-4-chlorobenzene 308d 
 
Step i) To a stirred solution of 4-chlorobenzyl alcohol (1.30 g, 9.12 mmol) in DCM (23 mL) 
at 0 oC was added Et3N (1.40 mL, 10.0 mmol). MsCl (770 mL, 7.96 mmol) was added dropwise 
and the RM was stirred at 0 oC for 2 h. The reaction was quenched with saturated aqueous 
NaHCO3. The two phases were separated and the aqueous phase was extracted with DCM (2 
× 60 mL). The combined organic phases were dried over MgSO4 and concentrated to afford 
the desired crude mesylate as a yellow oil. 
Step ii) The crude oil was flushed with N2 and THF (23 mL) was added. The solution was 
cooled to 0 oC and allylmagnesium bromide (2.0 M in THF, 9.10 mL, 18.2 mmol) was added 
dropwise. The reaction mixture was stirred at 0 oC for 2 h. The reaction was quenched with 
saturated aqueous NH4Cl. The phases were separated and the aqueous phase was extracted 
using EtOAc (3 × 60 mL), the combined organic layers were dried over MgSO4 and 
concentrated. Purification by column chromatography with 10% EtOAc in hexane afforded the 
title compound (640 mg, 3.84 mmol, 42%) as a colourless oil. The data was in accordance with 
the literature.77  
1H NMR (400 MHz, CDCl3) δ ppm 7.24 (2H, d, J = 8.6, 2 × ArCH), 7.11 (2H, d, J = 8.6, 2 × 
ArCH), 5.88 – 5.77 (1H, m, CHCH2), 5.06 – 4.95 (2H, m, CHCH2), 2.68 (2H, t, J = 7.7, ArCH2), 
2.39 – 2.30 (2H, m, ArCH2CH2); 13C NMR (75 MHz, CDCl3) δ ppm 140.3 (Cq), 137.6 
(CHCH2), 131.5 (Cq), 129.8 (2 × ArCH), 128.4 (2 × ArCH), 115.3 (CHCH2), 35.4 (CH2), 34.7 
(CH2); IR υmax (neat) / cm-1 3078, 3027, 2978, 2928, 2856, 1641, 1491, 1439. HRMS data 
could not be obtained. 
 
Synthesis of 3-(4-chlorophenyl)propanal 309d 
 
A stirred solution of alkene 308d (550 mg, 3.30 mmol) in DCM (17 mL) was cooled to -78 oC 
and oxygen was bubbled through the solution for 5 min. Ozone was bubbled through the RM 
for 20 min (colour change observed from colourless to bright blue). Oxygen was then bubbled 
through the mixture for a further 5 min after which triphenylphosphine (912 mg, 3.47 mmol) 
was added. The reaction was stirred at -78 oC for 10 mins and the starch iodine test showed no 
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peroxides were present. The RM was concentrated in vacuo. Purification by column 
chromatography 10% diethyl ether in hexane afforded the title compound (481 mg, 2.85 mmol, 
87%) as a colourless oil. The data was in accordance with the literature.77 
1H NMR (500 MHz, CDCl3) δ ppm 9.84 (1H, t, J = 1.2, CHO), 7.32 – 7.26 (2H, m, 2 × ArCH), 
7.16 (2H, d, J = 8.2, 2 × ArCH), 2.96 (2H, t, J = 7.5, ArCH2), 2.83 – 2.78 (2H, m, CH2CHO); 
13C NMR (126 MHz, CDCl3) δ ppm 201.0 (CHO), 138.8 (Cq), 132.1 (Cq), 129.7 (2 × ArCH), 
128.7 (2 × ArCH), 45.1 (CH2CHO), 27.4 (ArCH2); IR υmax (neat) / cm-1 3028, 2929, 2894, 
2725, 1720, 1492, 1447, 1408. HRMS data could not be obtained. 
 
Synthesis of [3-(4-chlorophenyl)propyl](methyl)amine 310d 
 
General procedure A was followed, using aldehyde 309d (300 mg, 1.78 mmol), MeNH2 (8 M 
solution in EtOH, 500 µL) and NaBH4 (101 mg, 2.67mmol). Purification by SCX cartridge, 
afforded the title compound (288 mg, 1.57 mmol, 88%) as a yellow oil no further purification 
was required. The data was in accordance with the literature.77 
 
1H NMR (400 MHz, CDCl3) δ ppm 7.30 – 7.22 (2H, m, 2 × ArCH), 7.17 – 7.10 (2H, m, 2 × 
ArCH), 2.69 – 2.60 (2H, m, ArCH2), 2.45 (3H, s, CH3), 2.16 – 1.96 (2H, m, NHCH2), 1.90 – 
1.76 (2H, m, CH2); 13C NMR (101 MHz, CDCl3) δ ppm 140.5 (Cq), 131.5 (Cq), 129.7 (2 × 
ArCH), 128.5 (2 ArCH), 51.3 (ArCH2), 36.3 (CH3), 32.9 (NHCH2), 31.2 (CH2); IR υmax (neat) 
/ cm-1
 
3025, 2933, 2857, 2793, 1632, 1538, 1490, 1383; HRMS (ESI+): C10H15ClN [M + H]+: 
calculated 184.0888, found 184.0892, ∆ = -2.4 ppm. 
 
Synthesis of N-chloro[3-(4-chlorophenyl)propyl]methylamine 311d 
 
General procedure C was followed, using amine 310d (200 mg, 1.09 mmol) and NCS (182 mg, 
1.36 mmol). Purification by column chromatography, eluting with 10% EtOAc in hexane 
afforded the title compound (160 mg, 0.73 mmol, 67%) as a colourless oil. The data was in 
accordance with the literature.77 
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1H NMR (400 MHz, CDCl3) δ ppm 7.25 (2H, d, J = 8.3, 2 × ArCH), 7.12 (2H, d, J = 8.3, 2 × 
ArCH), 2.92 (3H, s, CH3), 2.85 (2H, t, J = 6.8, CH2NCl), 2.64 (2H, t, J = 7.6, ArCH2), 1.98 – 
1.90 (2H, m, CH2); 13C NMR (101 MHz, CDCl3) δ ppm 140.1 (Cq), 131.6 (Cq), 129.8 (2 × 
ArCH), 128.5 (2 × ArCH), 65.0 (CH2NCl), 53.1 (CH3), 32.0 (ArCH2), 29.6 (CH2); IR υmax 
(neat) / cm-1 2950, 2866, 1491, 1455, 1437, 1407, 1365, 1129. HRMS data could not be 
obtained. 
 
Synthesis of 7-chloro-1-methyl-1,2,3,4-tetrahydroquinoline 320 
 
General Procedure D was followed, using chloroamine 311d (100 mg, 0.46 mmol), MeSO3H 
(300 µL, 4.40 mmol) and FeSO4.7H2O (13 mg, 0.046 mmol). Purification by column 
chromatography, eluting with 10% EtOAc in hexane afforded the title compound (37 mg, 0.20 
mmol, 42%) as a colourless oil. The data was in accordance with the literature.77 
1H NMR (400 MHz, CDCl3) δ ppm 6.83 (1H, d, J = 7.8, ArCH), 6.56 – 6.49 (2H, m, 2 × 
ArCH), 3.25 – 3.19 (2H, m, NCH3CH2), 2.86 (3H, s, CH3), 2.70 (2H, t, J = 6.4, ArCH2), 1.99 
– 1.90 (2H, m, CH2); 13C NMR (101 MHz, CDCl3) δ ppm 147.5 (Cq), 132.5 (Cq), 129.5 
(ArCH), 121.0 (Cq), 115.5 (ArCH), 110.5 (ArCH), 50.9 (NCH3CH2), 38.9 (CH3), 27.3 
(ArCH2), 22.2 (CH2); IR υma× (neat) / cm-1 3022, 2929, 2890, 2840, 1599, 1564, 1502, 1466; 
HRMS (ESI+): C10H1335ClN [M+H]+: calculated 182.0731, found 182.0723. HRMS data could 
not be obtained. 
 
Synthesis of 1-(but-3-en-1-yl)-2-chlorobenzene 308e 
 
 
 
Step i) To a stirred solution of 2-chlorobenzyl alcohol (1.30 g, 9.12 mmol) in DCM (23 mL) 
at 0 oC was added Et3N (1.40 mL, 10.0 mmol) then MsCl (780 µL, 10.0 mmol) was added 
dropwise and the RM was stirred at 0 oC for 2 h. The RM was quenched with saturated aqueous 
NaHCO3. The two phases were separated and the aqueous phase was extracted with DCM (2 
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× 60 mL). The combined organic extracts were dried over MgSO4 and concentrated in vacuo 
to afford the desired crude mesylate as a yellow oil. 
Step ii) The crude oil was flushed with N2 in a round bottom flask and THF (23 mL) was added. 
The solution was cooled to 0 oC and allylmagnesium bromide (2.0 M in THF, 9.10 mL, 18.2 
mmol) was added dropwise. The RM was stirred at 0 oC for 2 h. The reaction was quenched 
with saturated aqueous NH4Cl. The phases were separated and the aqueous phase was extracted 
using EtOAc (3 × 60 mL). The combined organic extracts were dried over MgSO4 and 
concentrated. Purification by column chromatography with 10% EtOAc in hexane afforded the 
title compound (940 mg, 5.64 mmol, 62%) as a colourless oil. The NMR data is in accordance 
with the literature.124 
1H NMR (400 MHz, CDCl3) δ ppm 7.33 (1H, m, ArCH), 7.17 (3H, m ArCH), 5.95 – 5.80 (1H, 
m, CHCH2), 5.11 – 4.96 (2H, m, CHCH2), 2.86 – 2.79 (2H, m, ArCH2), 2.42 – 2.33 (2H, m, 
CH2); 13C NMR (101 MHz, CDCl3) δ ppm 139.4 (Cq), 137.8 (CHCH2), 134.0 (Cq), 130.4 
(ArCH), 129.5 (ArCH), 127.3 (ArCH), 126.7 (ArCH), 115.2 (CHCH2), 33.7 (ArCH2), 33.1 
(CH2); IR υmax (neat) / cm-1 3075, 2999, 2978, 2931, 1640, 1572, 1473, 1442. HRMS data 
could not be obtained. 
 
Synthesis of 3-(2-chlorophenyl)propanal 309e 
 
A stirred solution of alkene 308e (550 mg, 3.30 mmol) in DCM (17 mL) was cooled to -78 oC 
and oxygen was bubbled through the solution for 5 min. Ozone was bubbled through the 
reaction mixture for 20 min (colour change observed from colourless to bright blue). Oxygen 
was then bubbled through the mixture for a further 5 min after which triphenylphosphine (912 
mg, 3.47 mmol) was added. The reaction was stirred at -78 oC for 10 min and the starch iodine 
test showed no peroxides were present. The RM was concentrated in vacuo. Purification by 
column chromatography 10% diethyl ether in hexane afforded the title compound (377 mg, 
2.24 mmol, 68%) as a colourless oil. The NMR data is in accordance with the literature.125 
1H NMR (500 MHz, CDCl3) δ ppm 9.86 (1H, t, J = 1.2, CHO), 7.37 –  7.33 (1H, m, ArCH), 
7.31 – 7.26 (1H, m, ArCH), 7.25 – 7.17 (2H, m, 2 × ArCH), 3.10 (2H, t, J = 7.6, ArCH2), 2.83 
(2 H, td, J = 7.6, 1.2, CH2); 13C NMR (126 MHz, CDCl3) δ 201.1 (CO), 138.0 (Cq), 133.9 (Cq), 
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130.5 (ArCH), 129.7 (ArCH), 127.9 (ArCH), 127.0 (ArCH), 43.5 (CH2CHO), 26.2 (ArCH2); 
IR υmax (neat) cm-1 3069, 2935, 2896, 2823, 2723, 1722 (CO), 1474, 1444. HRMS data could 
not be obtained. 
 
Synthesis of [3-(2-chlorophenyl)propyl](methyl)amine 310e 
 
General procedure A was followed, using aldehyde 309e (300 mg, 1.78 mmol), MeNH2 (8M 
solution in EtOH, 500 µL) and NaBH4 (101 mg, 2.67 mmol). Purification by SCX cartridge 
afforded the title compound (273 mg, 1.49 mmol, 72%) as a yellow oil no further purification 
was required. The 1H NMR data is in accordance with the literature.119 
1H NMR (300 MHz, CDCl3) δ ppm 7.37 – 7.29 (1H, m, ArCH), 7.24 – 7.06 (3H, m, 3 × ArCH), 
2.80 – 2.72 (2H,m, CH2NH), 2.69 – 2.60 (2H, m, ArCH2), 2.45 (3H, s, CH3), 1.89 – 1.73 (2H, 
m, CH2); 13C NMR (75 MHz, CDCl3) δ ppm 139.8 (Cq), 133.9 (Cq), 130.3 (ArCH), 129.5 
(ArCH), 127.3 (ArCH), 126.8 (ArCH), 51.6 (ArCH2), 36.5 (CH3), 31.4 (CH2NH), 29.9 (CH2); 
IR υmax (neat) / cm-1 2948, 2871, 2791, 1567, 1451, 1379, 1304, 1263; HRMS (ESI+): 
C10H1535ClN [M+H]+: calculated 184.0888, found 184.0885. 
 
Synthesis of N-chloro[3-(2-chlorophenyl)propyl]methylamine 311e 
 
General procedure C was followed, using amine 310e (200 mg, 1.09 mmol) and NCS (182 mg, 
1.36 mmol). Purification by column chromatography, eluting with 10% EtOAc in hexane 
afforded the title compound (141 mg, 0.65 mmol, 59%) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ ppm 7.34 (1H, dd, J = 7.7, 1.5, ArCH), 7.25 – 7.12 (3H, m, 3 × 
ArCH), 2.95 (3H, s, CH3), 2.92 (2H, t, J = 6.9, CH2NCl), 2.80 (2H, t, J = 7.8, ArCH2), 2.02 – 
1.93 (2H, m, CH2); 13C NMR (101 MHz, CDCl3) δ 139.3 (Cq), 134.0 (Cq), 130.5 (ArCH), 
129.5 (ArCH), 127.4 (ArCH), 126.8 (ArCH), 65.3 (CH2NCl), 53.0 (CH3), 30.6 (ArCH2), 28.1 
(CH2); IR υmax (neat) cm-1 3063, 2952, 2868, 2844, 1473, 1439, 1365, 1274; HRMS (ESI)+: 
C10H1435Cl2N [M+H]+: calculated 218.0498, found 218.0494. 
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Synthesis of 1-(but-3-en-1-yl)-4-bromobenzene 308f 
 
Step i) To a stirred solution of 4-bromobenzyl alcohol (3.00 g, 16.0 mmol) in DCM (40 mL) 
at 0 oC was added Et3N (2.50 mL, 17.6 mmol) then MsCl (1.40 mL, 17.6 mmol) was added 
dropwise and the RM was stirred at 0 oC for 2 h. The RM was quenched with saturated aqueous 
NaHCO3. The two phases were separated and the aqueous phase was extracted with DCM (2 
× 60 mL). The combined organic extracts were dried over MgSO4 and concentrated in vacuo 
to afford the desired crude mesylate as a yellow oil. 
Step ii) The crude oil was flushed with N2 in a round bottom flask and THF (40 mL) was added. 
The solution was cooled to 0 oC and allylmagnesium bromide (2.0 M in THF, 16.1 mL, 32.1 
mmol) was added dropwise. The RM was stirred at 0 oC for 2 h. The reaction was quenched 
with saturated aqueous NH4Cl. The phases were separated and the aqueous phase was extracted 
using EtOAc (3 × 60 mL). The combined organic extracts were dried over MgSO4 and 
concentrated. Purification by column chromatography with 10% EtOAc in hexane afforded the 
title compound (2.31 g, 10.9 mmol, 68%) as a colourless oil. The data was in accordance with 
the literature.126  
1H NMR (500 MHz, CDCl3) δ ppm 7.40 (2H, d, J = 8.4, 2 × ArCH), 7.06 (2H, d, J = 8.4, 2 × 
ArCH), 5.83 (1H, ddt, J = 17.0, 10.2, 6.6, CH=CH2), 5.04 (1H, ddd, J = 17.0, 3.4, trans-
CHCH2), 4.99 (1H, dd, J = 10.2, 1.9, cis- CHCH2), 2.71-2.61 (2H, m, ArCH2), 2.35 (2H, app. 
dtt, J = 9.0, 7.8, 1.3, CH2); 13C NMR (125 MHz, CDCl3) δ ppm 140.9 (Cq), 137.7 (CH=CH2), 
131.5 (2 × ArCH), 130.4 (2 ×  ArCH), 119.7 (Cq), 115.4 (CH=CH2), 35.4 (CH2), 34.9 (ArCH2); 
IR υmax (neat)/cm-1: 3078, 3024, 2978, 2929, 2857, 1641, 1487, 1439. HRMS data could not 
be obtained. 
 
Synthesis of 3-(4-bromophenyl)propanal 309f 
 
A stirred solution of alkene 308f (2.00 g, 9.47 mmol) in DCM (47 mL) was cooled to -78 oC 
and oxygen was bubbled through the solution for 5 min. Ozone was bubbled through the 
reaction mixture for 20 min (colour change observed from colourless to bright blue). Oxygen 
was then bubbled through the mixture for a further 5 min after which triphenylphosphine (2.61 
180 
 
g, 9.94 mmol) was added. The reaction was stirred at -78 oC for 10 min and the starch iodine 
test showed no peroxides were present. The RM was concentrated in vacuo. Purification by 
column chromatography 10% diethyl ether in hexane afforded the title compound (1.60 g, 7.55 
mmol, 80%) as a colourless oil. The data was in accordance with the literature.127  
1H NMR (400 MHz, CDCl3) δ ppm 9.80 (1H, t, J = 1.4, CHO), 7.40 (2H, d, J = 8.3, 2 × ArCH), 
7.07 (2H, d, J = 8.3, 2 × ArCH), 2.90 (2H, t, J = 7.4, ArCH2), 2.78 – 2.74 (2H, m, CH2); 13C 
NMR (100 MHz, CDCl3) δ ppm 201.1 (CO), 139.5 (Cq), 131.8 (2 × ArCH), 130.2 (2 × ArCH), 
120.2 (Cq), 45.1 (CH2), 27.6 (ArCH2); IR υmax  (neat)/cm- 1: 2930, 2823, 2724, 1719 (C=O), 
1591, 1487, 1438, 1404. HRMS data could not be obtained. 
 
Synthesis of [3-(4-bromophenyl)propyl](methyl)amine 310f 
 
General procedure A was followed, using aldehyde 309f (1.60 g, 7.50 mmol), MeNH2 (8M 
solution in EtOH, 4.70 mL) and NaBH4 (426 mg, 11.3 mmol). Purification by SCX cartridge 
afforded the title compound (1.47 g, 6.47 mmol, 86%) as a yellow oil no further purification 
was required. The data was in accordance with the literature.128  
1H NMR (400 MHz, CDCl3) δ ppm 7.38 (2H, d, J = 8.3, 2 × ArCH), 7.05 (2H, d, J = 8.3, 2 × 
ArCH), 2.64-2.55 (4H, m, includes ArCH2 and CH2N), 2.41 (3H, s, NCH3), 1.83-1.73 (2H, m, 
CH2); 13C NMR (101 MHz, CDCl3) δ 141.1 (Cq), 131.5 (2 × ArCH), 130.2 (2 × ArCH), 119.6 
(Cq), 51.3 (CH2N), 36.4 (NCH3), 33.1 (ArCH2), 31.2 (CH2); IR υmax (neat)/cm-1: 3310 (NH), 
3023, 2932, 2857, 2798, 1537, 1487, 1452; HRMS (ESI)+ : C10H1579BrN [M+H]+: calculated 
228.0382, found 228.0376. 
 
Synthesis of [3-(4-bromophenyl)propyl](chloro)methylamine 311f 
 
General procedure C was followed, using [3-(4-bromophenyl)propyl](methyl)amine 310f (300 
mg, 1.32 mmol) and NCS (220 mg, 1.65 mmol). Purification by column chromatography, 
eluting with 10% EtOAc in hexane afforded the title compound (260 mg, 0.99 mmol, 75%) as 
a colourless oil.  
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1H NMR (300 MHz, CDCl3) δ ppm 7.43 – 7.37 (2H, m, 2 × ArCH), 7.10 – 7.04 (2H, m, 2 × 
ArCH), 2.93 (3H, s, CH3), 2.85 (2H, t, J = 6.9, CH2NCl), 2.64 (2H, t, J = 7.6, ArCH2), 2.00 – 
1.88 (2H, m, CH2); 13C NMR (101 MHz, CDCl3) δ ppm 140.6 (Cq), 131.5 (2 × ArCH), 130.2 
(2 × ArCH), 119.7 (Cq), 64.9 (CH2NCl), 53.1 (CH3), 32.1 (ArCH2), 29.6 (CH2); IR υmax (neat) 
cm-1  2991, 2949, 2919, 2864, 1487, 1455, 1437, 1403; HRMS (ESI+): C10H1479Br35ClN [M + 
H]+ calculated 261.9992, found 261.9989, ∆ = +1.0 ppm. 
 
Synthesis of 7-bromo-1-methyl-1,2,3,4-tetrahydroquinoline 322 
 
General Procedure D was followed, using [3-(4-bromophenyl)propyl](chloro)methylamine 
311f (100 mg, 0.38 mmol), MeSO3H (250 µL, 3.80 mmol) and FeSO4.7H2O (11 mg, 0.038 
mmol). Purification by column chromatography, eluting with 10% EtOAc in hexane afforded 
the title compound (62 mg, 0.27 mmol, 72%) as a colourless oil. The NMR data is in accordance 
with literature.129 
1H NMR (300 MHz, CDCl3) δ ppm 6.78 (1H, d, J = 7.7, ArCH), 6.70 – 6.65 (2H, m, 2 × 
ArCH), 3.26 – 3.18 (2H, m, CH2NMe), 2.86 (3H, s, CH3), 2.68 (2H, t, J = 6.4, ArCH2), 2.00 – 
1.88 (2H, m, CH2); 13C NMR (75 MHz, CDCl3) δ ppm 147.7 (Cq), 129.8 (ArCH), 121.5 (Cq), 
120.6 (Cq), 118.5 (ArCH), 113.2 (ArCH), 50.9 (CH2NMe), 38.9 (CH3), 27.4 (ArCH2), 22.1 
(CH2); IR υmax (neat) / cm-1 3015, 2928, 2886, 2837, 1593, 1557, 1497, 1464; HRMS (ESI+): 
C10H1379Br35ClN [M + H]+ calculated 226.1583, found 226.1583, ∆ = 0 ppm. 
 
Synthesis of 1-(but-3-en-1-yl)-4-methoxybenzene 308g 
 
 Step i: To a stirred solution of 4-methoxybenzyl alcohol (1.00 g, 7.24 mmol) in DCM (18 mL) 
at 0 oC was added Et3N (1.10 mL, 7.96 mmol) then MsCl (0.60 mL, 7.96 mmol) was added 
dropwise and the RM was stirred at 0 oC for 2 h. The reaction was quenched with saturated 
aqueous NaHCO3. The two phases were separated, and the aqueous phase was extracted with 
DCM (2 × 100 mL). The combined organic extracts were dried over MgSO4 and concentrated 
to afford the desired crude mesylate as a yellow oil. 
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Step ii: The crude oil was flushed with N2 in a round bottom flask and THF (18 mL) was added. 
The solution was cooled to 0 oC and allylmagnesium bromide (2.0 M in THF, 7.25 mL, 14.48 
mmol) was added dropwise. The RM was stirred at 0 oC for 2 h. The reaction was quenched 
with saturated aqueous NH4Cl. The aqueous phase was extracted with EtOAc (3 × 100 mL), 
the combined organic extracts were dried over MgSO4 and concentrated in vacuo. Purification 
by column chromatography, eluting with 10% EtOAc in hexane afforded the title compound 
(744 mg, 4.59 mmol, 63%) as a colourless oil. The NMR data is in accordance with literature.117 
1H NMR (400 MHz, CDCl3) δ ppm 7.10 (2H, d, J = 8.4, 2 × ArCH), 6.83 (2H, d, J = 8.5, 2 × 
ArCH), 5.90 – 5.80 (1H, m, CH), 5.05 – 4.95 (2H, m, CHCH2), 3.78 (3H, s, CH3), 2.65 (2H, t, 
J = 7.8 ArCH2), 2.37 – 2.31 (2H, m, CH2); 13C NMR (101 MHz, CDCl3) δ ppm 157.8 (Cq), 
138.2 (CH), 134.0 (Cq), 129.3 (2 × ArCH), 114.8 (CH2CH), 113.7 (2 × ArCH), 55.3 (CH3), 
35.8 (CH2), 34.5 (ArCH2); IR υmax (neat) / cm-1 3075, 3031, 2997, 2931 1639, 1611, 1583, 
1510. HRMS data could not be obtained. 
 
Synthesis of 4-(4-methoxyphenyl)butane-1,2-diol 315 
 
To a stirred solution of alkene 308g (500 mg, 3.08 mmol) in acetone/water (10:1, 15 mL) was 
added NMO (542 mg, 4.62 mmol) and potassium osmate (IV) dihydrate (57 mg, 0.15 mmol). 
The RM was stirred at RT for 48 h. The reaction was quenched using solid sodium hydrosulfate 
and the mixture was filtered through a pad of Celite, washed with acetone and concentrated in 
vacuo. Purification by column chromatography, eluting with 4% MeOH in DCM afforded the 
title compound (604 mg, 3.08 mmol, 76%) as a white solid. The NMR data was in accordance 
with the literature.130 
1H NMR (400 MHz, CDCl3) δ ppm 7.16 – 7.13  (2H, m, 2 × ArCH), 6.89 – 6.83 (2H, m, 2 × 
ArCH), 3.81 (3H, s, CH3), 3.77 – 3.65 (2H, m, CH2OH), 3.53 – 3.45 (1H, m, CHOH), 2.81 – 
2.59 (2H, m, ArCH2), 1.85 – 1.72 (2H, m, ArCH2CH2); 13C NMR (126 MHz, CDCl3) δ ppm 
157.9 (Cq), 133.7 (Cq), 129.3 (2 × ArCH), 113.9 (2 × ArCH), 71.5 (CH2OH), 66.9 (CHOH), 
55.3 (CH3), 34.9 (CH2), 30.9 (ArCH2); IR υmax (neat) / cm-1 3317 (br. OH), 3003, 2922, 2857, 
1610, 1510, 1453, 1419. HRMS data could not be obtained. 
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Synthesis of 3-(4-methoxyphenyl)propanal 316 
 
To a stirred solution of diol 315 (400 mg, 2.04 mmol) in H2O/MeOH (10:1, 10 mL) was added 
sodium periodate (654 mg, 3.06 mmol). The RM was stirred at RT for 2 h. The RM was diluted 
with brine and extracted with DCM (3 × 50 mL). The combined organic extracts were dried 
over MgSO4 and concentrated to afford the title compound (330 mg, 2.01 mmol, 99%) as a 
colourless oil without further purification being required. The NMR data is in accordance with 
the literature.131  
1H NMR (400 MHz, CDCl3) δ ppm 9.81 (1H, t, J = 1.4, CHO), 7.11 (2H, d, J = 8.6, ArCH), 
6.83 (2H, d, J = 8.6, ArCH), 3.79 (3H, s, CH3), 2.91 (2H, t, J = 7.4, ArCH2), 2.77 – 2.72 (2H, 
m, CH2); 13C NMR (101 MHz, CDCl3) δ ppm 201.8 (CO), 158.1 (Cq), 132.3 (Cq), 129.2 
(2 × ArCH), 114.0 (2 × ArCH), 55.3 (CH3), 45.5 (CH2), 27.3 (ArCH2); IR υmax (neat) / cm-1 
3031, 2996, 2934, 2834, 1719, 1611, 1510, 1463. HRMS data could not be obtained. 
  
Synthesis of [3-(4-methoxyphenyl)propyl](methyl)amine 317 
 
General procedure A was followed, using aldehyde 316 (300 mg, 1.83 mmol), MeNH2 (8 M 
solution in EtOH, 300 µL, 1.3 eq.) and NaBH4 (83 mg, 2.20 mmol). Purification by SCX 
cartridge afforded the title compound (303 mg, 1.69 mmol, 92%) as a yellow oil. The NMR 
data was in accordance with the literature.132  
1H NMR (500 MHz, CDCl3) δ ppm 7.10 (2H, d, J = 8.6, 2 × ArCH), 6.85 – 6.80 (2H, m, 2 × 
ArCH), 3.78 (3H, s, OCH3), 2.65 – 2.57 (4H, m, includes ArCH2 and CH2NH), 2.44 (3H, s, 
CH3), 1.85 – 1.80 (2H, m, CH2); 13C NMR (126 MHz, CDCl3) δ ppm 157.8 (Cq), 133.9 (Cq), 
129.2 (2 × ArCH), 113.8 (2 × ArCH), 55.3 (OCH3), 51.2 (CH2NH), 36.0 (NCH3), 32.6 
(ArCH2), 31.2 (CH2); IR υmax (neat) / cm-1 3040, 2996, 2933, 2855, 2799, 1611, 1510, 1463; 
HRMS (ESI+): C11H18NO [M + H]+: calculated 180.1383, found 180.1383, ∆ = + 0.2 ppm. 
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Synthesis of chloro[3-(4-methoxyphenyl)propyl]methylamine 317 
 
Following a modified procedure by Zhong et al,80 to a stirred solution of the amine 316 (200 
mg, 1.12 mmol) and tert-butanol (28 µL, 0.28 mmol) in MTBE (6 mL) at 0 oC, was added 
acetic acid (65 µL, 1.12 mmol) and sodium hypochlorite (0.75 M, 1.5 mL, 1.12 mmol) 
dropwise. The reaction mixture was then stirred at 0 oC for 2 h. The phases were separated and 
the etheral phase was washed with H2O (10 mL) then brine (10 mL), dried over MgSO4 and 
concentrated in vacuo. Purification by column chromatography, eluting with 10% EtOAc in 
hexane afforded the title compound (157 mg, 0.73 mmol, 66%) as a pale yellow oil. 
1H NMR (400 MHz, CDCl3) δ ppm 7.06 – 7.01 (2H, m, 2 × ArCH), 6.78 – 6.73 (2H, m, 2 ×  
ArCH), 3.72 (3H, s, OCH3), 2.85 (3H, s, CH3), 2.83 (2H, t, J = 6.9, CH2N), 2.58 (2H, t, J = 7.6, 
ArCH2), 1.91 – 1.81 (2H, m, CH2); 13C NMR (101 MHz, CDCl3) δ ppm 157.8 (Cq), 133.7 (Cq), 
129.3 (2 × ArCH), 113.8 (2 × ArCH), 65.2 (ArCH2), 55.3 (OCH3), 53.0 (CH3), 31.8 (CH2N), 
29.9 (CH2); IR νmax (neat)/cm-1: 2994, 2955, 2870, 2835, 1611, 1583, 1511, 1457. HRMS data 
could not be obtained. 
 
Synthesis of N-methyl-1-phenoxypropan-2-amine 328 
 
General procedure B was followed, using ketone 327 (0.50 g, 3.37 mmol), MeNH2 (8 M 
solution in EtOH, 8.00 mL, 26.0 mmol), Ti(OiPr)4 (2.00 mL, 6.75 mmol) and NaBH4 (255 mg, 
6.25 mmol). Purification by SCX cartridge afforded the title compound (300 mg, 1.84 mmol, 
55%) as a pale yellow oil.  
1H NMR (500 MHz, CDCl3) δ ppm 7.32 – 7.24 (2H, m, 2 × ArCH), 7.22 – 7.14 (3H, m, 3 ×  
ArCH), 2.72 – 2.50 (3H, m, includes ArCH2 and NCH), 2.40 (3H, s, NCH3), 1.84 – 1.72 (1H, 
m, CH2), 1.68 – 1.54 (1H, m, CH2), 1.09 (3H, d, J = 6.2, CHCH3); 13C NMR (125 MHz, CDCl3) 
δ ppm 142.4 (Cq), 128.3 (2 × ArCH), 128.2 (2 × ArCH), 125.7 (ArCH), 54.4 (CH), 38.5 
(ArCH2), 33.8 (NCH3), 32.3 (CH2) 19.9(CHCH3) ; IR νmax (neat)/cm-1: 3304, 3062, 2930, 2857, 
2792, 1541, 1495, 1453; HRMS (ESI+):C11H18N [M + H]+ : calculated 164.1434, found 
164.1432,  ∆ = - 1.2 ppm. 
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Synthesis of [3-(4-bromophenyl)propyl](chloro)methylamine 329 
 
General procedure C was followed, using [3-(4-bromophenyl)propyl](methyl)amine 328 (200 
mg, 1.23 mmol) and NCS (204 mg, 1.53 mmol). Purification by column chromatography, 
eluting with 10% EtOAc in hexane afforded the title compound (176 mg, 0.99 mmol, 72%) as 
a colourless oil. The data was in accordance with the literature.76  
1H NMR (500 MHz, CDCl3) δ ppm 7.31 – 7.26 (2H, m, 2 × ArCH), 7.23 – 7.16 (3H, m, 3 ×  
ArCH), 2.93 – 2.84 (4H, m, includes NCH3 and CH), 2.73 – 2.66 (2H, m, ArCH2), 1.98 (1H, 
m, CH2) 1.73 – 1.63 (1H, m, CH2), 1.16 (3H, d, J = 6.3, CHCH3); 13C NMR (125 MHz, CDCl3) 
δ ppm 142.1 (Cq), 128.4 (2 × ArCH), 128.3 (2 × ArCH), 125.8 (ArCH), 64.5 (CH), 48.1 
(NCH3), 36.3 (ArCH2), 32.3 (CH2) 14.2 (CHCH3) ; IR νmax (neat)/cm-1: 3026, 2970, 2951, 
2865, 1605, 1496, 1453, 1442; HRMS (ESI+):C11H1735ClN [M + H]+ : calculated 198.1044, 
found 198.1038,  ∆ = - 3.0 ppm. 
 
Synthesis of 7-bromo-1-methyl-1,2,3,4-tetrahydroquinoline 329 
 
General Procedure D was followed, using [3-(4-bromophenyl)propyl](chloro)methylamine 
330 (100 mg, 0.50 mmol), MeSO3H (330 µL, 5.10 mmol) and FeSO4.7H2O (14 mg, 0.051 
mmol). Purification by column chromatography, eluting with 10% EtOAc in hexane afforded 
the title compound (65 mg, 0.40 mmol, 79%) as a colourless oil. The NMR data is in accordance 
with literature.76 
1H NMR (500 MHz, CDCl3) δ ppm 7.13 (1H, t, J = 7.7, ArCH), 7.02 (1H, d, J = 7.3, ArCH), 
6.64 (1H, t, J = 7.3, ArCH), 6.60 (1H, d, J = 8.2, ArCH), 3.52 – 3.44 (1H, m, CH), 2.94 (3H, 
s, NCH3), 2.93 – 2.84 (1H, m, ArCH2), 2.75 – 2.72 (1H, m, ArCH2) 2.07 – 1.99 (1H, m, CH2), 
1.84 – 1.76 (1H, m, CH2), 1.18 (3H, d, J = 6.5, CH3); 13C NMR (125 MHz, CDCl3) δ ppm 
145.4 (Cq), 128.5 (ArCH), 127.1 (ArCH), 122.1 (Cq), 115.4 (ArCH), 110.6 (ArCH), 53.8 (CH), 
37.0 (NCH3), 28.1 (CH2), 23.8 (ArCH2) 17.6 (CHCH3) ; IR νmax (neat)/cm-1: 3068, 3021, 2962, 
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2925, 2843, 2790, 1603, 1575; HRMS (ESI+):C11H16N [M + H]+ : calculated 162.1277, found 
162.1273,  ∆ = - 2.5 ppm. 
 
Synthesis of [3-(4-bromophenyl)propyl](chloro)methylamine 329 
 
General procedure C was followed, using [3-(4-bromophenyl)propyl](methyl)amine 328 (300 
mg, 1.32 mmol) and NCS (220 mg, 1.65 mmol). Purification by column chromatography, 
eluting with 10% EtOAc in hexane afforded the title compound (260 mg, 0.99 mmol, 75%) as 
a colourless oil. The data was in accordance with the literature.76  
1H NMR (400 MHz, CDCl3) δ ppm 7.33 – 7.26 (2H, m, 2 × ArCH), 7.24 – 7.16 (3H, m, 3 ×  
ArCH), 2.89 (3H, s, CH3), 2.79 – 2.61 (3H, m, includes ArCH2 and CH), 2.01 – 1.89 (1H, m, 
CH2), 1.81 – 1.65 (2H, m, includes CH2 and CaH2) 1.51 – 1.38 (1H, m, CaH2), 1.37 – 1.23 (6H, 
m, includes CbH2 and CcH2), 0.91 (3H, t, J = 6.9, CH3) ; 13C NMR (100 MHz, CDCl3) δ ppm 
142.9 (Cq), 128.5 (4 × ArCH), 125.8 (ArCH), 58.9 (CH), 35.5 (ArCH2), 33.7 (CaH2), 32.3 
(ArCH2CH2), 32.2 (CH2), 25.5 (CH2), 22.8 (CH2), 14.2 (CH3) ; IR νmax (neat)/cm-1: 3062, 3026, 
2926, 2856, 2788, 1603, 1495, 1454; HRMS (ESI+):C15H2635ClN [M + H]+ : calculated 
254.1670, found 254.1674,  ∆ = 1.8 ppm. 
 
Synthesis of 7-bromo-1-methyl-1,2,3,4-tetrahydroquinoline 329 
 
General Procedure D was followed, using [3-(4-bromophenyl)propyl](chloro)methylamine 
330 (100 mg, 0.39 mmol), MeSO3H (260 µL, 3.90 mmol) and FeSO4.7H2O (11 mg, 0.039 
mmol). Purification by column chromatography, eluting with 10% EtOAc in hexane afforded 
the title compound (45 mg, 0.21 mmol, 53%) as a colourless oil. The NMR data is in accordance 
with literature.76  
1H NMR (400 MHz, CDCl3) δ ppm 7.07 (1H, t, J = 7.7, ArCH), 6.96 (1H, d, J = 7.3, ArCH), 
6.57 (1H, t, J = 7.3, ArCH), 6.51 (1H, d, J = 8.2, ArCH),  3.29 – 3.17 (1H, m, CH), 2.92 (3H, 
s, CH3), 2.86 – 2.73 (1H, m, ArCH2), 2.71 – 2.58 (1H, m, ArCH2 ) 1.94 – 1.82 (2H, m, CH2), 
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1.65 – 1.53 (1H, m, CaH2), 1.44 – 1.19 (7H, m, includes CaH2, CbH2, CcH2 and CdH2) 0.98 – 
0.81 (3H, m, CH3) ; 13C NMR (100 MHz, CDCl3) δ ppm 145.7 (Cq), 128.8 (ArCH), 127.2 
(ArCH), 122.0 (Cq), 115.3 (ArCH), 110.5 (ArCH), 59.1 (CH), 38.1 (NCH3), 32.2 (ArCH2), 
31.3 (CaH2), 25.9 (CH2), 24.6 (ArCH2CH2), 23.7 (CH2), 22.8 (CH2), 14.2 (CH3) ; IR νmax 
(neat)/cm-1: 3020, 2926, 2856, 1602, 1575, 1498, 1479, 1455; HRMS (ESI+):C15H24N [M + 
H]+ : calculated 218.1903, found 218.1903,  ∆ = 0.0 ppm. 
 
Synthesis of 1-phenoxypropan-2-one 337 
 
General procedure G was followed, using phenol (1.50 g, 15.9 mmol), potassium carbonate 
(2.20 g, 15.9 mmol) and chloroacetone (1.40 mL, 17.5 mmol). Purification by column 
chromatography, eluting with 10% EtOAc in hexane afforded the title compound (1.56 g, 10.4 
mmol, 65%) as a colourless oil. The NMR data was in accordance with the literature.133  
1H NMR (400 MHz, CDCl3) δ ppm 7.36 – 7.30 (2H, m, 2 × ArCH), 7.03 (1H, t, J = 7.4 Hz, 
ArCH), 6.91 (2H, d, J = 7.8 Hz, 2 × ArCH), 4.56 (2H, s, CH2), 2.31 (3H, s, CH3); 13C NMR 
(75 MHz, CDCl3) δ ppm 206.0 (Cq), 157.7 (Cq), 129.7 (2 × ArCH), 121.8 (ArCH), 114.5 (2 × 
ArCH), 73.1 (CH2), 26.7 (CH3); IR υmax (neat) / cm-13063, 3043, 2903, 1720, 1589, 1493, 1432, 
1357. HRMS data could not be obtained. 
 
Synthesis of N-methyl-1-phenoxypropan-2-amine 338 
 
General procedure B was followed, using ketone 337 (1.50 g, 9.99 mmol), MeNH2 (8 M 
solution in EtOH, 12.0 mL, 94.0 mmol), Ti(OiPr)4 (5.90 mL, 20.0 mmol) and NaBH4 (567 mg, 
15.0 mmol). Purification by SCX cartridge afforded the title compound (743mg, 4.50 mmol, 
45%) as a pale yellow oil.  
1H NMR (300 MHz, CDCl3) δ ppm 7.34 – 7.26 (2H, m, 2 × ArCH), 7.00 – 6.89 (3H, m, 3 × 
ArCH), 3.88 (2H, m, CH2), 3.02 (1H, m, CH), 2.50 (3H, s, NHCH3), 1.16 (3H, d, J = 6.5, 
CHCH3); 13C NMR (101 MHz, CDCl3) δ ppm 158.9 (Cq), 129.5 (2 × ArCH), 120.8 (ArCH), 
114.6 (2 × ArCH), 71.6 (CH2), 54.1 (CH), 33.8 (NHCH3), 16.8 (CH3); IR υma× (neat) / cm-1 
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3062, 3039, 2968, 2930, 2872, 2795, 1676, 1599; HRMS (ESI+): C10H16NO [M + H] +: 
calculated 166.1226, found 166.1220, ∆ = 3.8 ppm. 
 
Synthesis of N-chloro-N-methyl-1-phenoxypropan-2-amine 339 
 
Following a modified procedure by Zhong et al, to a stirred solution of the amine 338 (300 mg, 
1.82 mmol) and tert-butanol (44 µL, 0.46 mmol) in MTBE (9 mL) at 0 oC, was added acetic 
acid (105 µL, 1.82 mmol) and sodium hypochlorite (0.75 M, 2.45 mL, 1.82 mmol) dropwise 
simultaneously. The reaction mixture was stirred at 0 oC for 2 h. the organic phases were 
separated and the top phase was washed with H2O (20 mL) then brine (20 mL), dried over 
MgSO4 and concentrated in vacuo. Purification by column chromatography, eluting with 10% 
EtOAc in hexane afforded the title compound (250 mg, 1.25 mmol, 69%) as a pale yellow oil. 
1H NMR (300 MHz, CDCl3) δ ppm 7.37 – 7.24 (2H, m, 2 × ArCH), 7.05 – 6.91 (3H, m, 3 × 
ArCH), 4.24 (1 H, dd, J = 9.8, 5.6, CH2), 3.93 (1H, dd, J = 9.8, 5.6, CH2), 3.46 – 3.30 (1H, m, 
CH), 3.04 (3H, s, NHCH3), 1.32 (3H, d, J = 6.5, CH3); 13C NMR (101 MHz, CDCl3) δ ppm 
158.6 (Cq), 129.5 (2 × ArCH), 121.0 (ArCH), 114.7 (2 × ArCH), 69.9 (CH2), 64.7 (CH), 49.5 
(NHCH3), 13.1 (CH3); IR υmax (neat) / cm-1 3063, 3040, 2960, 2940, 2872, 1599, 1585, 1495; 
HRMS data could not be obtained. 
 
Synthesis of 3,4-dimethyl-3,4-dihydro-2H-benzo[b][1,4]oxazine 340 
 
General Procedure D was followed, using chloroamine 339 (150 mg, 0.75 mmol), MeSO3H 
(490 µL, 7.50 mmol) and FeSO4.7H2O (21 mg, 0.075 mmol). Purification by column 
chromatography, eluting with 10% EtOAc in hexane afforded the title compound (25 mg, 0.15 
mmol, 20%) as a colourless oil. The NMR data is in accordance with the literature.134 
1H NMR signals for the major product reported 340a (300 MHz, CDCl3) δ ppm 6.92 – 6.84 
(1H, m, ArCH), 6.83 – 6.77 (1H, m, ArCH), 6.69 – 6.61 (2H, m, 2 × ArCH), 4.21 (1H, dd, J = 
10.5, 2.6, CH2), 4.04 (1H, dd, J = 10.5, 2.6, CH2), 3.44 – 3.33 (1H, m, CH), 2.89 (3H, s, NCH3), 
1.22 (3H, d, J = 6.5, CH3); 13C NMR signals for the major product reported 340a (101 MHz, 
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CDCl3) δ ppm 144.2 (Cq), 126.6 (Cq), 121.8 (ArCH), 116.6 (ArCH), 116.4 (ArCH), 111.7 
(ArCH), 69.2 (CH2), 52.1 (CH), 36.1 (NCH3), 14.1 (CH3); IR υma× (neat) / cm-1 3065, 3039, 
2972, 2929, 2875, 2820, 1604, 1499; LCMS (ESI+): C10H14NO [M+H]+; calculated 164.22, 
measured 164.41. HRMS data could not be obtained. 
 
Synthesis of N-(1-phenoxypropan-2-yl)prop-2-en-1-amine 341b 
 
General procedure B was followed, using ketone 337 (500mg, 3.33 mmol), allylamine (2.50 
mL, 33.3 mmol), Ti(OiPr)4 (2.00 mL, 6.66 mmol) and NaBH4 (189 mg, 5.00 mmol). 
Purification by SCX cartridge afforded the title compound (705mg, 3.69 mmol, 83%) as a pale 
yellow oil.  
1H NMR (300 MHz, CDCl3) ppm δ 7.35 – 7.25 (2H, m, 2 × ArCH), 7.00 – 6.89 (3H, m, 3 × 
ArCH), 5.95 (1H, ddt, J = 16.2, 10.2, 6.0, CH=CH2), 5.36 – 5.04 (2H, m, CH=CH2), 3.98 – 
3.80 (2H, m, CH2), 3.48 – 3.24 (2H, m, CH2), 3.22 – 3.09 (1H, m, CHNH), 1.19 (3H, d, J = 
6.5, CH3); 13C NMR (75 MHz, CDCl3) δ ppm 158.9 (Cq), 137.0 (CH=CH2), 129.5 (2 × ArCH), 
120.8 (ArCH), 115.9 (CH=CH2), 114.6 (2 × ArCH), 72.0 (OCH2), 51.8 (CHNH), 49.8 
(NHCH2), 17.4 (CH3); IR υmax (neat) / cm-1 3071, 3039, 2975, 2926, 2872, 2833, 1587, 1496; 
HRMS (ESI+): C12H18NO [M + H] +: calculated 192.1383, found 192.1384, ∆ = -0.6 ppm. 
 
Synthesis of N-chloro-N-(1-phenoxypropan-2-yl)prop-2-en-1-amine 342b 
 
General Procedure C was followed, using amine 341b (200 mg, 1.05 mmol) and NCS (140 mg, 
1.05 mmol). Purification by column chromatography, eluting with 10% EtOAc in hexane 
afforded the title compound (123 mg, 0.54 mmol, 52%) as a colourless oil. 
1H NMR (300 MHz, CDCl3) δ ppm 7.35 – 7.27 (2H,m, 2 × ArCH), 7.02 – 6.91 (3H, m, 3 × 
ArCH), 5.97 (1H, ddt, J = 16.7, 10.2, 6.4, CH=CH2), 5.39 – 5.21 (2H, m, CH=CH2), 4.29 (1H, 
dd, J = 9.8, 5.9, CH2), 3.95 (1H, dd, J = 9.8, 5.9, CH2), 3.85 – 3.66 (2H, m, CH2), 3.62 – 3.44 
(1H, m, CHNCl), 1.33 (3H, d, J = 6.4, CH3); 13C NMR (75 MHz, CDCl3) δ ppm 158.6 (Cq), 
134.1 (CH=CH2), 129.5 (2 × ArCH), 121.0 (ArCH), 119.0 (CH=CH2), 114.7 (2 × ArCH), 69.9 
(OCH2), 63.7 (CHNCl), 62.2 (NClCH2), 13.3 (CH3); IR υmax (neat) / cm-1 3078, 3040, 2979, 
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2935, 2881, 1598, 1587, 1495; HRMS (ESI+): C12H1635ClNNaO [M + Na] +: calculated 
248.0813, found 248.0810, ∆ = 1.3 ppm. 
 
Synthesis of N-(1-phenoxypropan-2-yl)butan-1-amine 341c 
 
General procedure B was followed, using ketone 337 (500mg, 3.33 mmol), butylamine (2.20 
mL, 16.7 mmol), Ti(OiPr)4 (2.00 mL, 6.66 mmol) and NaBH4 (189 mg, 5.00 mmol). 
Purification by column chromatography eluting with 90% EtOAc in hexane, afforded the title 
compound (500mg, 2.41 mmol, 72%) as a pale yellow oil.  
1H NMR (300 MHz, CDCl3) δ ppm 7.34 – 7.25 (2H, m, 2 × ArCH), 7.00 – 6.88 (3H, m, 2 × 
ArCH), 3.96 – 3.80 (2H, m, CH2), 3.17 – 3.04 (1H, m, CH), 2.79 – 2.59 (2H, m, CH2), 1.58 – 
1.30 (4H, m, 2 × CH2), 1.18 (3H, d, J = 6.5, CHCH3), 0.99 – 0.91 (3H, m, CH3); 13C NMR 
(101 MHz, CDCl3) δ ppm 158.9 (Cq), 129.5 (2 × ArCH), 120.8 (ArCH), 114.6 (2 × ArCH), 
72.0 (OCH2), 52.5 (CH), 47.1 (NHCH2), 32.6 (NHCH2CH2), 20.6 (CH2CH3), 17.5 (CH3CH), 
14.3 (CH3CH2); IR υmax (neat) / cm-1 3062, 3039, 2958, 2927, 2871, 1667, 1599, 1495; HRMS 
(ESI+): C13H22NO [M + H] +: calculated 208.1696, found 208.1695, ∆ = 0.5 ppm. 
 
Synthesis of N-chloro-N-(1-phenoxypropan-2-yl)butan-1-amine 342c 
 
General Procedure C was followed, using amine 341c (100 mg, 0.52 mmol) and NCS (69 mg, 
0.52 mmol). Purification by column chromatography, eluting with 10% EtOAc in hexane 
afforded the title compound (100 mg, 0.41 mmol, 80%) as a colourless oil. 
1H NMR (300 MHz, CDCl3) δ ppm 7.35 – 7.25 (2H, m, 2 × ArCH), 7.03 – 6.89 (3H, m, 3 × 
ArCH), 4.32 – 4.25 (1H, m, CH2 ), 4.00 – 3.91 (1H, m, CH2), 3.54 – 3.41 (1H, m, CH), 3.18 – 
2.96 (2H, m, CH2), 1.67 (2H, dt, J = 14.6, 7.2, CH2), 1.48 – 1.34 (2H, m, CH2), 1.32 (3H, d, J 
= 6.5, CH3), 1.01 – 0.91 (3H, m, CH3); 13C NMR (75 MHz, CDCl3) δ ppm 158.7 (Cq), 129.5 
(2 × ArCH), 120.9 (ArCH), 114.7 (2 × ArCH), 70.0 (OCH2), 63.3 (CH), 60.7 (NClCH2), 30.3 
(NClCH2CH2), 20.0 (CH2CH3), 14.0 (CH3CH), 13.3 (CH3CH2); IR υmax (neat) / cm-1 3063, 
3040, 2958, 2934, 2872, 1599, 1587, 1495; HRMS (ESI+): C13H2135ClNO [M + H] +: calculated 
242.1306, found 242.1302, ∆ = 1.8 ppm. 
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Synthesis of 4-butyl-3-methyl-3,4-dihydro-2H-benzo[b][1,4]oxazine 344 
N
O
 
General Procedure D was followed, using chloroamine 342c (100 mg, 0.41 mmol), MeSO3H 
(270 µL, 4.10 mmol) and FeSO4.7H2O (11 mg, 0.04 mmol). Purification by column 
chromatography, eluting with 10% EtOAc in hexane afforded the title compound (13 mg, 0.06 
mmol, 15%) as a colourless oil. 
1H NMR (300 MHz, CDCl3) δ ppm 6.93 – 6.77 (2H, m, 2 × ArCH), 6.68 – 6.55 (2H, m, 2 × 
ArCH), 4.13 – 3.97 (2H, m, OCH2), 3.54 – 3.41 (1H, m, CH), 3.40 – 3.27 (1H, m, CH2), 3.21 
– 3.04 (1H, m, CH2), 1.71 – 1.52 (2H, m, CH2), 1.47 – 1.32 (2H, m, CH2), 1.22 (3H, d, J = 6.5, 
CHCH3), 1.04 – 0.94 (3H, m, CH3); 13C NMR (101 MHz, CDCl3) δ ppm 143.4 (Cq), 134.5 
(Cq), 121.8 (ArCH), 116.3 (ArCH), 116.1 (ArCH), 111.8 (ArCH), 69.1 (OCH2), 50.9 (CH), 
48.7 (NCH2), 29.5 (CH2), 20.4 (CH2), 15.9 (CH3), 14.0 (CHCH3); IR υmax (neat) / cm-1 3065, 
3039, 2958, 2930, 2872, 1605, 1578, 1502; HRMS (ESI+): C13H20NO [M + H] +: calculated 
206.1539, found 206.1538, ∆ = +0.7 ppm. 
 
Synthesis of 1-(4-chlorophenoxy)propan-2-one 347a 
 
General procedure G was followed, using 4-chlorophenol (1.50 g, 11.7 mmol), potassium 
carbonate (1.61 g, 11.7 mmol) and chloroacetone (1.02 mL, 12.8mmol). Purification by column 
chromatography, eluting with 10% EtOAc in hexane afforded the title compound (1.26 g, 6.82 
mmol, 59%) as a colourless oil. The NMR data is in accordance with the literature.135 
1H NMR (400 MHz, CDCl3) δ ppm 7.28 (2H, d, J= 9.0, 2 × ArCH), 6.84 (2H, d, J = 9.0, 2  
ArCH), 4.54 (2H, s, CH2), 2.30 (3H, s, CH3); 13C NMR (101 MHz, CDCl3) δ ppm 205.1 (CO), 
156.4 (Cq), 129.6 (2 × ArCH), 126.8 (Cq), 115.9 (2 × ArCH), 73.3 (CH2), 26.6 (CH3); IR υma× 
(neat) / cm-1 3099, 3071, 3011, 2914, 2839, 1721, 1584, 1488. HRMS data could not be 
obtained. 
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Synthesis of 1-(4-chlorophenoxy)-N-methylpropan-2-amine 348a 
 
General procedure B was followed, using ketone 347a (1.00g, 5.42 mmol), MeNH2 (8 M 
solution in EtOH, 7.00 mL, 56.0 mmol), Ti(OiPr)4 (3.20 mL, 10.8 mmol) and NaBH4 (308 mg, 
8.13 mmol). Purification by SCX cartridge afforded the title compound (986mg, 4.94 mmol, 
91%) as a pale yellow oil.  
1H NMR (300 MHz, CDCl3) δ ppm 7.23 (2H, d, J = 9.0, 2 × ArCH), 6.85 (2H, d, J = 9.0, 2 × 
ArCH), 3.97 – 3.84 (2H, m, OCH2), 3.19 – 3.03 (1H, m, CH), 2.53 (3H, s, NCH3), 1.22 (3H, 
d, J = 6.5, CH3); 13C NMR (101 MHz, CDCl3) δ ppm 156.9 (Cq), 129.4 (2 × ArCH), 116.9 
(Cq), 116.0 (2 × ArCH), 70.0 (OCH2), 53.9, 32.0, 14.9 (CHCH3); IR υmax (neat) / cm-1 3061, 
2962, 2930, 2872, 1596, 1493, 1380, 1274; HRMS (ESI+): C10H1535ClNO [M + H] +: calculated 
200.0837, found 200.0835, ∆ = 1.0 ppm. 
 
Synthesis of N-chloro-1-(4-chlorophenoxy)-N-methylpropan-2-amine 345a 
 
General Procedure C was followed, using amine 348a (300 mg, 1.50 mmol) and NCS (220 mg, 
1.65 mmol). Purification by column chromatography, eluting with 10% EtOAc in hexane 
afforded the title compound (200 mg, 0.85 mmol, 57%) as a colourless oil. 
1H NMR (300 MHz, CDCl3) δ ppm 7.27 – 7.22 (2H, m, 2 × ArCH), 6.93 – 6.77 (2H, m, 2 × 
ArCH), 4.20 (1H, dd, J = 9.8, 5.8, CH2), 3.89 (1H, dd, J = 9.8, 5.8, CH2), 3.42 – 3.29 (1H, m, 
CH), 3.03 (3H, s, NCH3), 1.30 (3H, d, J = 6.5, CH3); 13C NMR (75 MHz, CDCl3) δ ppm 156.1 
(Cq), 129.5 (2 × ArCH), 125.9 (Cq), 116.1 (2 × ArCH), 110.2 (Cq), 70.3 (OCH2), 64.6 (CH), 
49.5 (NCH3), 12.9 (CH3); IR υmax (neat) / cm-1 2979, 2935, 2882, 1596, 1491, 1471, 1285, 
1241; HRMS (ESI+): C10H1435Cl2NO [M + H] +: calculated 234.0447, found 234.0442, ∆ = 2.0 
ppm. 
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Synthesis of 1-(3-bromophenoxy)propan-2-one 347b 
 
General procedure G was followed, using 3-bromophenol (1.50 g, 8.67 mmol), potassium 
carbonate (1.20 g, 8.67 mmol) and chloroacetone (0.76 mL, 9.54mmol). Purification by column 
chromatography, eluting with 10% EtOAc in hexane afforded the title compound (1.35 g, 5.89 
mmol, 68%) as a colourless oil. The NMR data is in accordance with the literature.135 
1H NMR (300 MHz, CDCl3) δ ppm 7.23 – 7.12 (2H, m, 2 × ArCH), 7.10 – 7.05 (1H, m, ArCH), 
6.88 – 6.81 (1H, m, ArCH), 4.55 (2H, s, CH2), 2.30 (3H, s, CH3); 13C NMR (75 MHz, CDCl3) 
δ ppm 204.8 (Cq), 158.5 (Cq), 130.8 (ArCH), 125.0 (ArCH), 123.0 (Cq), 118.1 (ArCH), 113.4 
(ArCH), 73.1 (CH2), 26.6 (CH3); IR υmax (neat) / cm-1 3066, 2970, 2919, 2897, 1732, 2589, 
1575, 1475. HRMS data could not be obtained. 
 
Synthesis of 1-(3-bromophenoxy)-N-methylpropan-2-amine 348b 
 
General procedure B was followed, using ketone 347b (1.00g, 4.37 mmol), MeNH2 (8 M 
solution in EtOH, 5.50 mL, 44 mmol), Ti(OiPr)4 (2.50 mL, 8.74 mmol) and NaBH4 (248 mg, 
6.56 mmol). Purification by SCX cartridge afforded the title compound (983mg, 4.04 mmol, 
92%) as a pale yellow oil.  
1H NMR (300 MHz, CDCl3) δ ppm 7.20 – 6.98 (3H, m, 3 × ArCH), 6.88 – 6.82 (1H, m, ArCH), 
3.93 – 3.73 (2H, m, CH2), 3.06 – 2.97 (1H, m, CH), 2.49 (3H, s, NCH3), 1.17 (3H, d, J = 6.5, 
CH3);13C NMR (101 MHz, CDCl3) δ ppm 159.6 (Cq), 130.6 (ArCH), 124.0 (ArCH), 122.8 
(Cq), 117.9 (ArCH), 113.5 (ArCH), 71.7 (OCH2), 53.9 (CH), 33.6 (NCH3), 16.5 (CH3); IR υmax 
(neat) / cm-1 3065, 2970, 2930, 2876, 2795, 1671, 1574, 1473; HRMS (ESI+): C10H15BrNO 
[M + H] +: calculated 244.0332, found 244.0329, ∆ = 1.0 ppm. 
 
 
 
 
 
194 
 
Synthesis of 1-(3-bromophenoxy)-N-chloro-N-methylpropan-2-amine 345b 
 
General Procedure C was followed, using amine 348b (300 mg, 1.23 mmol) and NCS (180 mg, 
1.35 mmol). Purification by column chromatography, eluting with 10% EtOAc in hexane 
afforded the title compound (214 mg, 0.77 mmol, 62%) as a colourless oil. 
1H NMR (300 MHz, CDCl3) δ ppm 7.20 – 7.08 (3H, m, 3 × ArCH), 6.88 (1H, ddd, J = 7.9, 
2.4, 1.5, ArCH), 4.24 – 4.17 (1H, m, CH2), 3.94 – 3.88 (1H, m, CH2), 3.43 – 3.29 (1H, m, CH), 
3.03 (3H, s, NCH3), 1.31 (3H, d, J = 6.5, CH3); 13C NMR (101 MHz, CDCl3) δ ppm 159.4 
(Cq), 130.6 (ArCH), 124.1 (ArCH), 122.8 (Cq), 118.0 (ArCH), 113.7 (ArCH), 70.1 (OCH2), 
64.5 (CH), 49.5 (NCH3), 12.9 (CH3); IR υmax (neat) / cm-1 3067, 2979, 2937, 2884, 2791, 1589, 
1574, 1470; HRMS (ESI+): C10H13Br35ClNNaO [M + Na] +: calculated 299.9761, found 
299.9762, ∆ = -0.1 ppm. 
 
Synthesis of 7-bromo-3,4-dimethyl-3,4-dihydro-2H-benzo[b][1,4]oxazine 350 
 
General Procedure D was followed, using chloroamine 345b (100 mg, 0.36 mmol), MeSO3H 
(240 µL, 3.60 mmol) and FeSO4.7H2O (10 mg, 0.036 mmol). Purification by column 
chromatography, eluting with 10% EtOAc in hexane afforded the title compound (10 mg, 0.040 
mmol, 11%) as a colourless oil. 
1H NMR (300 MHz, CDCl3) δ ppm 6.90 – 6.80 (2H, m, 2 × ArCH), 6.38 (1H, d, J = 8.4, 
ArCH), 4.09 (1H, dd, J = 10.5, 2.5, CH2), 3.93 (1H, dd, J = 10.6, 3.2, CH2), 3.33 – 3.21 (1H, 
m, CH), 2.76 (3H, s, CH3), 1.10 (3H, d, J = 6.5, CH3); IR υmax (neat) / cm-1 3429, 3074, 2975. 
2934, 2877, 2809, 1588, 1467; HRMS data could not be obtained. 
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Synthesis of N-(2-bromoethyl)-4-methyl-N-phenylbenzenesulfonamide 356 
 
 
 
Following a modified procedure by Barluenga et al, a stirred solution of 4-methyl-N-
phenylbenzenesulfonamide (500 mg, 2.02 mmol), K2CO3 (558 mg, 4.04 mmol) and 
dibromoethane (350 µL, 4.04 mmol) in MeCN (4 mL) was heated at reflux for 16 h.136 The 
RM was cooled to RT. The RM was partitioned between ethyl acetate (30 mL) and water (40 
mL). The two phases were separated and the aqueous phase was re-extracted with EtOAc (2 × 
30 mL). The organic extracts were combined and dried over MgSO4. Purification by column 
chromatography, eluting with 10% EtOAc in hexane afforded the title compound x (476 mg, 
1.34 mmol, 66%) as an amorphous white solid 
1H NMR (300 MHz, CDCl3) δ ppm 7.51 (2H, d, J = 8.3, 2 × ArCH), 7.39 – 7.32 (3H, m, 3 × 
ArCH), 7.27 (2H, d, J = 8.0, 2 × ArCH), 7.13 – 7.04 (2H, m, 2 × ArCH), 3.90 (2H, t, J = 7.5, 
CH2), 3.42 (2H, t, J = 7.5, CH2), 2.45 (3H, s, CH3); 13C NMR (75 MHz, CDCl3) δ ppm 143.8 
(Cq), 139.0 (Cq), 135.2 (Cq), 129.5 (2 × ArCH), 129.3 (2 × ArCH), 129.0 (2 × ArCH), 128.4 
(ArCH), 127.7 (2 × ArCH), 52.6 (NCH2), 28.8 (CH2Br), 21.6 (CH3); IR υmax (neat) / cm-1 3065, 
3979, 2963, 2923, 2870, 1593, 1490, 1453; HRMS (ESI+): C15H16BrNNaO2S [M + Na] +: 
calculated 375.9977, found 375.9973, ∆ = 1.0 ppm. 
 
Synthesis of 4-methyl-N-(2-(methylamino)ethyl)-N-phenylbenzenesulfonamide 357 
 
 
 
A stirred solution of alkylbromo compound 356 (200 mg, 0.57 mmol) in MeNH2 (8M in EtOH, 
2.8 mL) was heated at 100 oC in a sealed tube for 16 h. The RM was concentrated in vacuo to 
afforded title compound (174 mg, 0.57 mmol, quant) as a colourless oil. 
1H NMR (300 MHz, CDCl3) δ ppm 7.43 (2H, d, J = 8.3, 2 × ArCH), 7.28 – 7.22 (3H, m, 3 × 
ArCH), 7.19 (2H, d, J = 8.3, 2 × ArCH), 7.10 – 7.02 (2H, m, 2 × ArCH), 3.87 (2H, t, J = 5.9, 
CH2), 2.95 (2H, t, J = 5.9, CH2), 2.62 (3H, s, CH3), 2.36 (3H, s, CH3); 13C NMR (101 MHz, 
CDCl3) δ ppm 144.4 (Cq), 138.8 (Cq), 133.6 (Cq), 129.8 (2 × ArCH), 129.5 (2 × ArCH), 128.8 
(2 × ArCH), 128.7 (ArCH), 128.1 (2 × ArCH), 48.1 (NCH2), 47.5 (CHNH), 33.8 (NCH3), 21.6 
(CH3); IR υmax (neat) / cm-1 2962, 2920, 2875, 2859, 2719, 2423, 1593, 1490; HRMS (ESI+): 
C16H21N2O2S [M + H] +: calculated 305.1318, found 305.1315, ∆ = 0.3 ppm. 
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Synthesis of N-(2-(chloro(methyl)amino)ethyl)-4-methyl-N-phenylbenzenesulfonamide 
358 
 
Following a modified procedure by Zhong et al, to a stirred solution of the amine 357 (100 mg, 
0.33 mmol) and tert-butanol (10 µL, 0.08 mmol) in MTBE (2 mL) at 0 oC, was added acetic 
acid (20 µL, 0.33 mmol) and sodium hypochlorite (0.75 M, 0.50 mL, 0.33 mmol) dropwise 
simultaneously. The reaction mixture was stirred at 0 oC for 2 h. the organic phases were 
separated and the top phase was washed with H2O (20 mL) then brine (20 mL), dried over 
MgSO4 and concentrated in vacuo. Purification by column chromatography, eluting with 10% 
EtOAc in hexane afforded the title compound (68 mg, 0.20 mmol, 61%) as a pale yellow oil. 
1H NMR (501 MHz, CDCl3) δ ppm 7.53 – 7.47 (4H, m, 4 × ArCH), 7.46 – 7.41 (1H, m, ArCH), 
7.34 – 7.29 (1H, m, ArCH), 7.08 (1H, m, ArCH), 6.99 – 6.93 (2H, m, 2 × ArCH), 3.85 – 3.74 
(2H, m, CH2), 3.06 – 3.00 (2H, m, NClCH2), 2.90 (3H, s, CH3), 2.44 (3H, s, CH3); 13C NMR 
(101 MHz, CDCl3) δ ppm 144.4 (Cq) 132.3 (Cq), 130.4 (Cq), 129.6 (2 × ArCH), 129.5 (2 × 
ArCH), 129.1 (2 × ArCH), 128.8 (ArCH3), 127.8 (2 × ArCH), 64.1 (NClCH2), 53.3 (NCH2), 
49.4 (NClCH3), 22.7 (ArCH3); IR υmax (neat) / cm-1 3059, 3024, 2998, 2967, 2916, 1597, 1487, 
1439; HRMS (ESI+): C16H1935ClN2NaO2S [M + Na] +: calculated 361.0748, found 361.0747, 
∆ = 0.1 ppm. 
 
Synthesis of 3-(2,6-dimethylphenyl)-N-methylbutanamide 363 
 
General procedure F was followed, using crotonamide (700 mg, 7.06 mmol), 2,6-
dimethylboronic acid (1.32 g, 8.83 mmol, 1.25 eq.), [Rh(cod)Cl2] (35 mg, 0.071 mmol) and 
Et3N (990 µL, 7.06 mmol). Purification by column chromatography, eluting with 50% EtOAc 
in hexane afforded the title compound (990 mg, 4.82 mmol, 68%) colourless solid. 1H NMR 
(300 MHz, CDCl3) δ ppm 7.00 – 6.97 (3H, m, 3 × ArCH), 5.21 (1H, s, NH), 3.93 – 3.81 (1H, 
m, CHCH2), 2.73 (3H, d, J = 4.9, NHCH3), 2.56 (2H, d, J = 7.3, CH2CO), 2.40 (6H, s, 2 × 
ArCH3), 1.36 (3H, d, J = 7.3, CHCH3); 13C NMR (75 MHz, CDCl3) δ ppm 172.8 (CO), 143.1 
(ArCH), 136.5 (Cq), 130.3 (Cq), 128.5 (Cq)  126.1 (2 × ArCH), 42.4 (CH2), 31.9 (CHCH2), 26.3 
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(NHCH3), 21.6 (ArCH3), 19.1 (CHCH3); IR υmax (neat) / cm-1 3091, 2961, 2938, 2912, 2877, 
1636, 1569, 1510; HRMS (ESI+): C13H20NO [M + H]+: calculated 206.1539, found 206.1547, 
∆ = +3.4 ppm. 
 
Synthesis of [3-(2,6-dimethylphenyl)butyl](methyl)amine 364 
 
Following a modified procedure by Williamson et al,97 to a stirred suspension of LiAlH4 (443 
mg, 11.7 mmol) in THF (12 mL) at 0 oC was added a solution of amide 363 (600 mg, 2.92 
mmol) in THF (3 mL) dropwise. The reaction mi×ture was stirred for 5 min at 0 oC before 
warming to RT and then heated at reflux for 3 h. The reaction mixture was cooled to 0 oC and 
the reaction was quenched through the dropwise addition of H2O (12.0 eq), aqueous NaOH (2 
M, 2.0 eq) and H2O (2.0 eq). The resulting slurry was dried over Na2SO4, filtered through a 
pad of Celite and was washed with EtOAc. Concentration in vacuo afforded the title compound 
(452 mg, 2.36 mmol, 81%) as a colourless oil 
1H NMR (300 MHz, CDCl3) δ ppm 6.99 – 6.95 (3H, m, 3 × ArCH), 3.39 – 3.26 (1H, m, 
CHCH2), 2.69 – 2.26 (10H, m, includes 2 × ArCH3, NHCH3 and CH2), 2.11 – 1.83 (2H, m, 
CH2NH), 1.37 – 1.28 (3H, d, J = 7.36, CHCH3); 13C NMR (75 MHz, CDCl3) δ ppm 142.5 
(ArCH), 136.2 (Cq), 128.3 (Cq) 125.7 (3 × ArCH), 50.9 (NCH2), 36.2 (CH2), 35.2 (NCH3), 33.0 
(CH), 21.6 (2 × ArCH3), 19.1 (CHCH3); IR υmax (neat) / cm-1 3017, 2930, 2871, 2790, 1466, 
1369, 1309, 1256; HRMS (ESI+): C13H21NNa [M + Na]+: calculated 214.1566, found 
214.1564, ∆ = +1.0 ppm. 
 
Synthesis of N-chloro[3-(2,6-dimethylphenyl)butyl]methylamine 365 
 
General procedure C was followed, using amine 364 (200 mg, 1.05 mmol) and NCS (175 mg, 
1.31 mmol). Purification by column chromatography, eluting with 10% EtOAc in hexane 
afforded the title compound (200 mg, 0.89 mmol, 85%) as a colourless oil. 
1H NMR (300 MHz, CDCl3) δ ppm 6.98 (3H, d, J = 4.2, 3 × ArCH), 3.47 – 3.31 (1H, m, CH), 
2.87 (3H, s, NCH3), 2.80 – 2.69 (2H, m, NCH2), 2.49 – 2.30 (6H, br.s, 2 × ArCH3), 2.22 – 1.95 
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(2H, m, CH2), 1.37 – 1.27 (3H, m, CH3); 13C NMR (101 MHz, CDCl3) δ ppm 142.1 (Cq), 136.4 
(Cq), 130.4 (Cq), 128.1 (Cq), 125.6 (2 × ArCH), 125.6, 64.9 (NCH2), 53.2 (NCH3), 33.7 (CH2), 
32.2 (CH), 21.6 (2 × ArCH3), 19.1 (CH3); IR υmax (neat) / cm-1 3017, 2954, 2930, 1463, 1437, 
1368, 1175, 1076; HRMS (ESI)+: C13H2135ClN [M+H]+: calculated 226.1357, found 226.1353, 
∆ = -1.8 ppm. 
 
Synthesis of 1,4,5,8-tetramethyl-1,2,3,4-tetrahydroquinoline 366 
 
General Procedure D was followed, using chloroamine 365 (100 mg, 0.44 mmol), MeSO3H 
(285 µL, 4.40 mmol) and FeSO4.7H2O (12 mg, 0.44 mmol). Purification by column 
chromatography, eluting with 10% EtOAc in hexane afforded the title compound (27 mg, 0.14 
mmol, 33%) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ ppm 6.91 (1H, d, J = 7.6, ArCH), 6.70 (1H, d, J = 7.6, ArCH), 
3.24 –  3.18 (2H, m, NCH2), 3.12 – 3.02 (1H, m, CH), 2.71 (3H, s, NCH3), 2.28 (3H, s, ArCH3), 
2.27 (3H, s, ArCH3), 2.10 – 1.99 (1H, m, CHCH2), 1.56 – 1.46 (1H, m, CHCH2), 1.17 (3H, d, 
J = 7.0, CHCH3); 13C NMR (101 MHz, CDCl3) δ ppm 147.3 (Cq), 133.7 (Cq), 132.5 (Cq), 128.9 
(ArCH), 128.1 (Cq), 123.5 (ArCH), 47.4 (NCH2), 44.0 (NCH3), 28.2 (CH), 25.1 (CH2), 21.3 
(CHCH3), 19.2 (ArCH3), 19.0 (ArCH3); IR υmax (neat) / cm-1 2929, 2864, 2787, 1737, 1578, 
1460, 1397, 1370;  HRMS (ESI+): C13H20N [M + H]+: calculated 190.1590, found 190.1593, 
∆ = +1.3 ppm. 
 
Synthesis of methyl 3-(4-methylphenyl)-3-phenylpropanoate 391a 
 
General procedure F was followed, using methyl trans-cinnamate (1.50 g, 9.25 mmol), p-
tolylboronic acid (1.57 g, 11.6 mmol, 1.25 eq.), [Rh(cod)Cl2] (46 mg, 0.093 mmol) and Et3N 
(1.30 mL, 9.25 mmol). Purification by column chromatography, eluting with 10% EtOAc in 
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hexane afforded the title compound (2.15 g, 8.44 mmol, 91%) pale yellow oil. The NMR data 
is in accordance with the literature.137 
1H NMR (300 MHz, CDCl3) δ ppm 7.31 – 7.16 (5H, m, 5 × ArCH), 7.12 – 7.07 (4H, m, 4 × 
ArCH), 4.52 (1H, t, J = 8.0, CHCH2), 3.57 (3H, s, OCH3), 3.04 (2H, d, J = 8.0, CHCH2), 2.29 
(3H, s, ArCH3); 13C NMR (75 MHz, CDCl3) δ ppm 172.4 (CO), 143.7 (Cq), 140.5 (Cq), 136.1 
(Cq), 129.3 (2 × ArCH), 128.6 (2 × ArCH), 127.6 (2 × ArCH), 127.5 (2 × ArCH), 126.5 (ArCH), 
51.7 (OCH3), 46.6 (CHCH2), 40.7 (CHCH2), 21.0 (ArCH3); IR υmax (neat) / cm-1  3057, 3026, 
2950, 2920, 1734 (CO), 1637, 1600, 1513; HRMS (ESI+): C17H19O2 [M + H]+: calculated 
255.1380, found 255.1380, ∆ = 0.0 ppm. 
 
Synthesis of 3-(4-methylphenyl)-3-phenylpropanoic acid 392a 
OH
O
 
To a stirred solution of ester 391a (2.00 g, 7.86 mmol) in MeOH (26 mL, 0.3 M) was added 
aqueous 2 M NaOH (26 mL, 0.3 M). The RM was then heated to reflux and stirred for 2 h. The 
RM was cooled to RT and the reaction was quenched with 4 M HCl to pH 7. The aqueous 
phase was extracted with EtOAc (50 mL × 3). The combined organic phases were dried over 
Na2SO4 and concentrated in vacuo to afford the title compound (1.50 g, 6.24 mmol, 79%) as a 
colourless solid which was crystallized in 19 : 1 (EtOAc : hexane) to yield colourless micro-
crystals. The NMR data is in accordance with the literature.137  
1H NMR (400 MHz, CDCl3) δ ppm 7.16– 6.96 (9H, m, 9 × ArCH), 4.35 (1H, t, J = 7.6, CH), 
2.81 (2H, s, CH2), 2.21 (3 H, s, ArCH3); 13C NMR (126 MHz, CDCl3) δ ppm 177.0 (CO), 
144.3 (Cq), 141.1 (Cq), 135.8 (Cq), 129.2 (2 × ArCH), 128.5 (2 × ArCH),  127.6 (2 × ArCH),  
127.5 (2 × ArCH), 126.3 (ArCH), 46.8 (CH), 41.7 (CH2), 21.0 (CH3); IR υmax (neat) / cm-1 
3055, 3025, 3003, 2920, 2858, 1697, 1577, 1512; HRMS (ESI+): C16H15Na2O2 [M + Na2]+: 
calculated 285.0862, found 285.0867, ∆ = +1.6 ppm. 
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Synthesis of N-methyl-3-(4-methylphenyl)-3-phenylpropanamide 393a 
 
General procedure E was followed, using acid 392a (800 mg, 3.33 mmol), NH2Me.HCl (338 
mg, 5.00 mmol), TBTU (1.71 g, 5.33 mmol) and DIPEA (1.72 mL, 13.3 mmol). Purification 
by column chromatography, eluting with 50-60% EtOAc in hexane, afforded the title 
compound (640 mg, 2.53 mmol, 78%) as a colourless solid which was crystallised from EtOAc 
to yield colourless crystals. The data is in accordance with the literature.76  
1H NMR (400 MHz, CDCl3) δ ppm 7.30 – 7.14 (5H, m, 5 × ArCH), 7.13 – 7.06 (4H, m, 4 × 
ArCH), 5.19 (1H, s, NH), 4.53 (1H, t, J = 7.8, CH), 2.86 (2H, d, J = 7.8, CH2), 2.65 (3H, d, J 
= 4.9, NCH3), 2.29 (3H, s, ArCH3). 13C NMR (101 MHz, CDCl3) δ ppm 171.8 (CO), 144.0 
(Cq), 140.8 (Cq), 136.1 (Cq), 129.3 (2 × ArCH), 128.6 (2 × ArCH), 127.7 (2 × ArCH), 127.6 (2 
× ArCH), 126.5 (ArCH), 47.0 (CH), 43.4 (CH2), 26.3 (NCH3), 21.0 (ArCH3); IR υmax (neat) / 
cm-1 3271, 3097, 3061, 2966, 2929, 1635, 1566, 1512; HRMS (ESI+): C17H20NO [M + H]+: 
calculated 254.1539, found 254.1548, ∆ = -3.4 ppm. 
 
Synthesis of methyl[3-(4-methylphenyl)-3-phenylpropyl]amine 394 
 
Following a modified procedure by Williamson et al,97 to a stirred suspension of LiAlH4 (299 
mg, 7.88 mmol) in THF (8 mL) at 0 oC was added a solution of  amide 393a (500 mg, 1.97 
mmol) in THF (2 mL) dropwise. The reaction mixture was stirred for 5 min at 0 oC before 
warming to RT and then heated at reflux for 3 h. The reaction mixture was cooled to 0 oC and 
the reaction was quenched through the dropwise addition of H2O (12.0 eq.), aqueous NaOH (2 
M, 2.0 eq.) and H2O (2.0 eq.). The resulting slurry was dried over Na2SO4, filtered through a 
pad of Celite and was washed with EtOAc. Concentration in vacuo afforded the title compound 
(420 mg, 1.75 mmol, 89%) as a pale yellow oil. The data is in accordance with the literature.76 
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1H NMR (300 MHz, CDCl3) δ ppm 7.31 – 7.20 (4H, m, 4 × ArCH), 7.19 – 7.05 (5H, m, 5 × 
ArCH), 3.97 (1H, t, J = 7.8, CHCH2), 2.56 (2H, t, J = 7.3, CH2NH), 2.39 (3H, s, NHCH3), 2.30 
(3H, s, ArCH3), 2.26 – 2.14 (2H, m, CHCH2); 13C NMR (75 MHz, CDCl3) δ ppm 145.0 (Cq), 
141.7 (Cq), 135.7 (Cq), 129.2 (2 × ArCH), 128.5 (2 × ArCH), 127.7 (2 × ArCH), 127.7 (2 × 
ArCH), 126.1 (ArCH), 50.4 (CH2NH), 48.7 (CHCH2), 36.3 (NHCH3), 35.5 (CH2), 21.0 
(ArCH3); IR υmax (neat) / cm-1 3083, 3056, 2925, 2861, 2792, 1599, 1511, 1493; HRMS (ESI+): 
C17H21NNa [M + Na]+: calculated 262.1566, found 262.1568, ∆ = -0.8 ppm. 
 
Synthesis of N-chloro(methyl)[3-(4-methylphenyl)-3-phenylpropyl]amine 388 
 
General procedure C was followed, using amine 394 (200 mg, 0.84 mmol) and NCS (140 mg, 
1.05 mmol). Purification by column chromatography, eluting with 10% EtOAc in hexane 
afforded the title compound (181 mg, 0.66 mmol, 79%) as a colourless oil. The data is in 
accordance with the literature.76 
1H NMR (400 MHz, CDCl3) δ ppm 7.30 – 7.22 (4H, m, 4 × ArCH), 7.19 – 7.06 (5H, m, 5 × 
ArCH), 4.03 (1H, t, J = 7.9, CHCH2), 2.88 (3H, s, NCH3), 2.83 – 2.77 (2H, m, CH2N), 2.40 – 
2.35 (2H, m, CHCH2), 2.29 (3H, s, ArCH3); 13C NMR (101 MHz, CDCl3) δ ppm 144.7 (Cq), 
141.4 (Cq), 135.8 (Cq), 129.2 (2 × ArCH), 128.5 (2 × ArCH), 127.8 (2 × ArCH), 127.7 (2 × 
ArCH), 126.2 (ArCH), 64.3 (CH2N), 53.2 (NCH3), 47.7 (CH), 34.0 (CHCH2), 21.0 (ArCH3); 
IR υmax (neat) / cm-1 3058, 3024, 2983, 2952, 2920, 1598, 1511, 1493; HRMS (ESI+): 
C17H2135ClN [M + H]+ : calculated 274.1357, found 274.1359, ∆ = -0.2 ppm.  
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Synthesis of 1,7-dimethyl-4-phenyl-1,2,3,4-tetrahydroquinoline 396a and 396b 
 
General Procedure D was followed, using chloroamine 388 (100 mg, 0.37 mmol), MeSO3H 
(240 µL, 3.70 mmol) and FeSO4.7H2O (10 mg, 0.037 mmol). Purification by column 
chromatography, eluting with 10% EtOAc in hexane afforded an inseperable mixture of the 
regioisomeric title compounds (64 mg, 0.27 mmol, 73%) as a colourless oil. The data is in 
accordance with the literature.76 
1H NMR signals for the major product reported 396a (400 MHz, CDCl3) δ ppm 7.30 – 7.25 
(2H, m, 2 × ArCH), 7.21 – 7.17 (1H, m, ArCH), 7.12 – 7.09 (2H, m, 2 × ArCH), 6.62 (1H, d, 
J = 7.6, ArCH), 6.49 (1H, s, ArCH), 6.39 (1H, d, J = 7.6, ArCH), 4.09 (1H, t, J = 6.2, CHCH2), 
3.23 – 3.11 (2H, m, NCH2), 2.93 (3H, s, NCH3), 2.29 (3H, s, ArCH3), 2.26 – 2.19 (1H, m, 
CHCH2), 2.12 – 2.02 (1H, m, CHCH2); 13C NMR signals for the major product reported 396a 
(101 MHz, CDCl3) δ ppm 146.8 (2 × Cq), 137.2 (Cq), 129.8 (ArCH), 128.7 (2 × ArCH), 128.3 
(2 × ArCH), 126.1 (ArCH), 122.1 (Cq), 117.1 (ArCH), 111.8 (ArCH), 48.7 (NCH2), 43.2 
(NCH3), 39.3 (CHCH2), 31.3 (CHCH2), 21.7 (ArCH3); IR υmax (neat) / cm-1  3076, 3063, 2975, 
2950, 1640, 1568, 1452, 1415; HRMS (ESI+): C17H20N [M + H]+: calculated 238.1590, found 
238.1585, ∆ = -2.1 ppm. 
 
Synthesis of methyl 3-phenyl-3-[3-(trifluoromethyl)phenyl]propanoate 391b 
 
General procedure F was followed, using methyl trans-cinnamate (1.50 g, 9.25 mmol), 3-
(trifluoromethyl)phenylboronic acid (2.20 g, 11.6 mmol, 1.25 eq.), [Rh(cod)Cl2] (46 mg, 0.093 
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mmol) and Et3N (1.30 mL, 9.25 mmol). Purification by column chromatography, eluting with 
EtOAc in hexane afforded the title compound (2.74 g, 8.88 mmol, 96%) as a pale yellow oil. 
The data is in accordance with the literature.76 
1H NMR (300 MHz, CDCl3) δ ppm 7.52 – 7.36 (4H, m, 4 × ArCH), 7.34 – 7.18 (5H, m, 5 × 
ArCH), 4.62 (1H, t, J = 8.0, CHCH2), 3.59 (3H, s, CH3), 3.07 (2H, d, J = 8.0, CH2CO); 13C 
NMR (101 MHz, CDCl3) δ 171.9 (CO), 144.4 (Cq), 142.5 (Cq), 131.2 (ArCH), 130.9 (q, 
J = 32.1, CqCF3), 129.1 (ArCH), 128.8 (2 × ArCH), 127.6 (2 × ArCH), 127.0 (ArCH), 124.4 
(q, J = 3.7, ArCHCqCF3), 124.1 (q, J = 272.4, CF3), 123.6 (q, J = 3.7, ArCHCqCF3), 51.8 (CH3), 
46.8 (CH), 40.4 (CH2); IR υmax (neat) / cm-1 3063, 3029, 2953, 2922, 1735 (CO), 1637, 1495, 
1436; HRMS (ESI+): C17H15F3NaO2 [M + Na]+: calculated 331.0916, found 331.0916, ∆ = 
+0.1 ppm. 
 
Synthesis of 3-phenyl-3-[3-(trifluoromethyl)phenyl]propanoic acid 392b 
OH
O
CF3
 
To a stirred solution of ester 391b (2.00 g, 6.49 mmol) in MeOH (22 mL) was added aqueous 
2 M NaOH (22 mL, 0.30 M). The RM was then heated to reflux and stirred for 2 h. The RM 
was cooled to RT and the reaction was quenched with addition of 4 M HCl until pH 7. The 
aqueous phase was extracted with EtOAc (3 × 50 mL). The combined organic extracts were 
dried over Na2SO4 and concentrated in vacuo. Crystalisation from hexane : EtOAc (9:1) to to 
afford the title compound (1.40 g, 4.77 mmol, 73%) as a colourless crystalline solid. The data 
is in accordance with the literature.76  
1H NMR (400 MHz, CDCl3) δ ppm 7.58 – 7.36 (4H, m, 4 × ArCH), 7.35 – 7.17 (5H, m, 5 × 
ArCH), 4.59 (1H, t, J = 7.9, CHCH2), 3.12 (2H, dd, J = 7.9, 2.0, CH2); 13C NMR (101 MHz, 
CDCl3) δ ppm 176.5 (CO), 147.2 (Cq), 144.2 (Cq), 142.2 (Cq), 131.1 (ArCH), 131.0 (q, J = 
32.1, Cq), 129.2 (ArCH), 128.9 (2 × ArCH), 127.6 (2 × ArCH), 127.1 (ArCH), 124.4 (q, J = 
3.8, ArCHCqCF3), 124.1 (q, J = 272.3, CF3), 123.7 (q, J = 3.8, ArCHCqCF3), 46.5 (CH), 40.1 
(CH2); IR υmax (neat) / cm-1 3064(Br.OH), 3027, 2958, 2910, 1696, 1628, 1496, 1448; HRMS 
(ESI+): C16H13F3NaO2 [M + Na]+: calculated 317.0760, found 317.0759, ∆ = -0.2ppm. 
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Synthesis of N-methyl-3-phenyl-3-[3-(trifluoromethyl)phenyl]propanamide 393b 
 
General procedure E was followed, using acid 392b (800 mg, 2.72 mmol), NH2Me.HCl (275 
mg, 4.08 mmol), TBTU (1.40 g, 4.35 mmol) and DIPEA (1.90 mL, 10.9 mmol). Purification 
by column chromatography, eluting with 30-40% EtOAc in hexane, afforded the title 
compound (430 mg, 1.40 mmol, 34%) as a colourless oil. The data is in accordance with the 
literature.76  
1H NMR (300 MHz, CDCl3) δ ppm 7.57 – 7.34 (4H, m, 4 × ArCH), 7.34 – 7.12 (5H, m, 5 × 
ArCH), 5.27 (1H, s, NH), 4.68 (1H, t, J = 7.7, CHCH2), 2.88 (2H, d, J = 7.8, CH2CO), 2.67 
(3H, d, J = 4.8, CH3). 13C NMR (101 MHz, CDCl3) δ 171.0 (CO), 144.8 (Cq), 142.8 (Cq), 131.4 
(ArCH), 130.8 (q, J = 32.1, CqCF3), 129.0 (ArCH), 128.8 (2 × ArCH), 127.7 (2 × ArCH), 126.9 
(ArCH), 124.2 (q, J = 3.8, ArCHCCF3), 124.1 (q, J = 272.4, CF3), 123.5 (q, J = 3.7, 
ArCHCCF3), 47.0 (CH), 43.1 (CH2), 26.3 (CH3); IR υmax (neat) / cm-1 3296, 3088, 3066, 2942, 
1642, 1562, 1494, 1446; HRMS (ESI+): C17H16F3NNaO [M + Na]+: calculated 330.1076, 
found 330.1087, ∆ = +3.3 ppm. 
 
Synthesis of methyl({3-phenyl-3-[3-(trifluoromethyl)phenyl]propyl})amine 395 
 
To a stirred solution of amide 393b (310 mg, 1.01 mmol) in THF (5 mL) at 0 oC was added 
dropwise a solution of BH3 (4 mL of a 1 M solution in THF, 4.0 eq.) dropwise. The reaction 
mi×ture was stirred at 0 oC for 15 min, then heated to reflux and stirred for 6 h. The reaction 
mixture was cooled to 0 oC and the reaction was quenched with 4 M NaOH (6 mL) dropwise. 
The phases were separated and the aqueous phase was extracted with EtOAc (3 × 20 mL). The 
combined organic phases were dried over MgSO4 and concentrated in vacuo. Purification by 
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SCX cartridge afforded the title compound (134 mg, 0.46 mmol, 45%) as a yellow oil. The data 
is in accordance with the literature.76 
1H NMR (400 MHz, CDCl3) δ ppm 7.50 (1H, s, ArCH), 7.46 – 7.34 (3H, m, 3 × ArCH), 7.33 
– 7.16 (5H, m, 5 × ArCH), 4.09 (1H, t, J = 7.8, CHCH2), 2.54 (2H, t, J = 7.3, CH2NH), 2.39 
(3H, s, CH3), 2.31 – 2.21 (2H, m, CHCH2); 13C NMR (101 MHz, CDCl3) δ 145.6 (Cq), 143.4 
(Cq), 131.2 (ArCH), 130.7 (d, J = 32.0, CqCF3), 129.0 (ArCH), 128.8 (2 × ArCH), 127.9 (2 × 
ArCH), 126.7 (ArCH), 124.4 (q, J = 3.7, ArCHCqCF3), 124.2 (q, J = 272.3, CF3) 123.2 (q, J 
3.8, ArCHCqCF3), 49.7 (NCH2), 48.6 (CH), 36.3 (NCH3), 34.6 (CH2) ; IR υmax (neat) / cm-1 
3062,3029, 2936, 2850, 2797, 1599, 1493, 1473; HRMS (ESI+): C17H18F3NNa [M + Na]+: 
calculated 294.1391, found 294.1492, ∆ = -0.8 ppm. 
 
Synthesis of N-chloro(methyl){3-phenyl-3-[3-(trifluoromethyl)phenyl]propyl}amine 389 
 
General procedure C was followed, using amine 395 (120 mg, 0.41 mmol) and NCS (68 mg, 
0.51 mmol). Purification by column chromatography, eluting with 10% EtOAc in hexane 
afforded the title compound (110 mg, 0.34 mmol, 82%) as a colourless oil. The data is in 
accordance with the literature.76 
1H NMR (400 MHz, CDCl3) δ ppm 7.51 (1H, s, ArCH), 7.46 – 7.37 (3H, m, 3 × ArCH), 7.32 
– 7.19 (5H, m, 5 × ArCH), 4.20 – 4.10 (1H, t, J = 7.9, CH), 2.88 (3H, s, CH3), 2.78 (2H, t, J = 
6.8, CH2NCl), 2.46 – 2.36 (2H, m, CHCH2); 13C NMR (126 MHz, CDCl3) δ 145.5 (Cq), 143.3 
(Cq), 131.3 (ArCH), 130.8 (q, J = 32.0, CqCF3), 129.0 (ArCH), 128.8 (ArCH), 127.9 (ArCH), 
126.7 (ArCH), 124.6 (q, J = 3.8, ArCHCCF3), 124.2 (q, J = 272.4, CF3). 123.3 (q, J = 3.8, 
ArCHCCF3), 63.7 (NCH2), 53.2 (NCH3), 47.7 (CH), 33.8 (CH2); IR υmax (neat) / cm-1 3062, 
3028, 2952, 2881, 1599, 1494, 1445, 1326; HRMS (ESI+): C17H1835ClF3N [M + H] +: 
calculated 328.1074, found 338.1069, ∆ = -2.1 ppm. 
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Synthesis of 1-methyl-4-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydroquinoline 397b 
 
General procedure D was followed, using chloroamine 389 (100 mg, 0.31 mmol), MeSO3H 
(200 µL, 3.10 mmol) and FeSO4.7H2O (9 mg, 0.031 mmol). Purification by column 
chromatography, eluting with 10% EtOAc in hexane afforded the title compound (69 mg, 0.24 
mmol, 77%) as a colourless oil. The data is in accordance with the literature.76 
1H NMR (300 MHz, CDCl3) δ ppm 7.50 – 7.35 (3H, m, 3 × ArCH), 7.25 (1H, d, J = 7.6, 
ArCH), 7.18 – 7.10 (1H, m, ArCH), 6.70 – 6.67 (2H, m, 2 × ArCH), 6.57 (1H, td, J =7.3, 1.1, 
ArCH), 4.24 – 4.15 (1H, m, CHCH2), 3.31 – 3.07 (2H, m, CH2N), 2.94 (3H, s, CH3), 2.35 – 
2.01 (2H, m, CHCH2); 13C NMR (101 MHz, CDCl3) δ ppm 147.5 (Cq), 146.8 (Cq), 132.2 
(ArCH), 130.7 (q, J = 32.0, CqCF3), 129.8 (ArCH), 128.8 (ArCH), 128.0 (ArCH), 125.3 (q, J 
= 3.8, ArCHCCF3), 124.3 (q, J = 272.3, CF3), 123.8 (Cq), 123.1 (q, J = 3.8, ArCHCCF3), 116.5 
(ArCH), 111.3 (ArCH), 48.4 (NCH2), 43.4 (CHCH2), 39.2 (CH3), 31.1 (CH2); IR υmax (neat) / 
cm-1 3066, 3026 2945, 2927, 1602, 1503, 1444, 1322; HRMS (ESI+): C17H17F3N [M + H]+: 
calculated 292.1308, found 292.1313, ∆ = -1.7ppm. 
 
Synthesis of 4-benzoyl-1-chloropiperidine 401 
 
A solution of benzoyl piperidine HCl (1.00 g, 4.33 mmol) was dissolved in H2O (10 mL) and 
basified to pH 9 using aqueous NaOH (2 M, 15 mL). The aqueous phase was extracted with 
EtOAc (3 × 50 mL). The combined organic extracts were dried over MgSO4 and concentrated 
in vacuo which afforded the crude amine. To a solution of the crude amine in DCM (22 mL) 
was added NCS (722 mg, 5.41 mmol) and the RM was stirred for 3 h at RT. Purification by 
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column chromatography, eluting with 10% EtOAc in hexane afforded the title compound (790 
mg, 3.53 mmol, 82%) as a white solid. 
1H NMR (500 MHz, CDCl3) δ ppm 7.95 (2H, dd, J = 8.3, 1.1, 2 × ArCH), 7.64 – 7.58 (1H, m, 
ArCH), 7.51 (2H, t, J = 7.7, 2 × ArCH), 3.56 (2H, d, J = 9.5, NCH2), 3.37 (1H, t, J = 10.7, CH), 
3.11 – 3.00 (2H, m, NCH2), 2.14 – 2.02 (2H, m, CHCH2), 1.97 (2H, d, J = 14.1, CHCH2); 13C 
NMR (101 MHz, CDCl3) δ 201.5 (CO), 135.7 (Cq), 133.2 (ArCH), 128.8 (2 × ArCH), 128.3 
(2 × ArCH), 62.0 (2 × NCH2), 42.0 (CH), 29.8 (2 × CH2CH); IR υmax (neat) / cm-1 3047, 2960, 
2940, 2921, 2836, 1673, 1593, 1577; HRMS (ESI+): C12H15ClNO [M + H]+: calculated 
224.0837, found 224.0835, ∆ = +0.6 ppm. 
 
Synthesis of 4-benzoyl-1-(5,6,7,8-tetrahydronaphthalen-2-yl)piperidine 403 
 
To a stirred solution of the chloroamine 401 (100 mg, 0.45 mmol) in DCM (0.45 mL) at 0 oC 
was added tetralin (610 µL, 4.50 mmol) MeSO3H (295 µL, 4.50 mmol) and FeSO4.7H2O (12 
mg, 0.045). The RM was stirred at 0 oC for 1 h. The RM was basified using 2 M NaOH (pH 
9). The two phases were separated and the aqueous phase was extracted with DCM (3 × 15 
mL). The organic phases were combined, dried over MgSO4 and concentrated in vacuo. 
Purification by column chromatography, eluting with DCM in hexane afforded the title 
compound x (48 mg, 0.15 mmol, 33%) as a colourless oil. 
1H NMR (500 MHz, CDCl3) δ ppm 8.00 – 7.93 (2H, m, 2 × ArCH), 7.60 – 7.54 (1H, m, ArCH), 
7.48 (2H, t, J = 7.6, 2 × ArCH), 6.97 (1H, d, J = 8.3, ArCH), 6.76 (1H, d, J = 7.7, ArCH), 6.68 
(1H, s, ArCH), 3.69 (2H, dt, J = 6.1, 2.8, NCH2), 3.42 – 3.31 (1H, m, CHCO), 2.88 – 2.77 (2H, 
m, NCH2), 2.73 – 2.68 (4H, m, 2 × CbH2), 2.04 – 1.91 (4H, m, 2 × CH2CH), 1.82 – 1.74 (4H, 
m, 2 × CaH2); 13C NMR (126 MHz, CDCl3) δ ppm 202.5 (CO), 137.6 (Cq), 136.1 (2 × Cq), 
133.0 (ArCH), 129.7 (2 × ArCH), 128.9 (Cq), 128.8 (2 × ArCH), 128.3 (ArCH), 117.4 (ArCH), 
115.1 (ArCH), 50.2 (2 × NCH2), 43.6 (CH), 29.9 (2 × CH2CH), 28.7 (CbH2), 28.6 (CbH2), 23.5 
(CaH2), 23.4 (CaH2); IR υmax (neat) / cm-1 3057, 3013, 2854, 2834, 2801, 1679, 1609, 1597; 
HRMS (ESI+): C22H25NNaO [M + Na]+: calculated 342.1828, found 342.1825, ∆ = -0.9 ppm. 
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Synthesis of 405 
 
To a stirred solution of the chloroamine 401 (100 mg, 0.45 mmol) in DCM (0.45 mL) at 0 oC 
was added toluene (480 µL, 4.50 mmol) MeSO3H (295 µL, 4.50 mmol) and FeSO4.7H2O (12 
mg, 0.045). The RM was stirred at 0 oC for 1 h. The RM was basified using 2 M NaOH  (pH 
9). The two phases were separated and the aqueous phase was extracted with DCM (3 × 15 
mL). The organic phases were combined, dried over MgSO4 and concentrated in vacuo. 
Purification by column chromatography, eluting with DCM in hexane afforded the title 
compound as inseparable regioisomers, o : m : p, 3.6 : 7.2 : 5.5 (42 mg, 0.13 mmol, 29%) as a 
colourless oil. NMRs reported as a mixture of the three regioisomers. 
1H NMR (400 MHz, CDCl3) δ ppm 7.99 – 7.93 (2H, m), 7.57 (1H, ddd, J = 7.9, 2.3, 1.1), 7.48 
(2H, dd, J 11.6, 4.2), 7.18 (0.22H, d, J = 8.8, ArCH, o), 7.15 (0.44H, t, J = 7.7, ArCH, m), 7.07 
(0.68H, d, J = 8.2, 2 × ArCH, p), 6.88 (0.68H, d, J = 8.2, 2 × ArCH,p), 6.83 – 6.65 (1.98H, m, 
6 ArCH, o and m), 3.79 – 3.65 (2H, m, NCH2), 3.43 – 3.32 (1H, m, CH), 2.85 (2H, m, NCH2), 
2.33 (0.66H, s, CH3, o), 2.32 (1.32H, s, CH3, m), 2.27 (1.02H, s, CH3, p), 2.01 – 1.92 (4H, m, 
2 × CH2CH); 13C NMR (101 MHz, CDCl3) δ ppm 202.5 (CO), 151.7 (Cq), 150.3 (Cq), 149.6 
(Cq), 138.8 (Cq), 136.3 (Cq), 136.1 (ArCH), 136.0 (Cq), 133.1 (ArCH), 133.0 (ArCH), 129.7 
(ArCH), 129.4 (Cq), 129.0 (ArCH), 128.8 (ArCH), 128.3 (ArCH), 120.6 (ArCH), 119.2 
(ArCH), 117.6 (ArCH), 117.1 (ArCH), 115.5 (ArCH), 113.8 (ArCH), 50.1 (NCH2), 49.6 
(NCH2), 43.6 (CH), 28.7 (ArCH3, o), 28.7 (ArCH3, m), 28.5 (ArCH3, p), 21.8 (CH2CH), 20.5 
(CH2CH); IR υmax (neat) / cm-1 3057, 3026, 2948, 2921, 2807, 2748, 1678, 1595 LCMS (ESI+): 
C19H22NO [M + H]+: calculated 279.2, found 280.4. 
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Synthesis of 1-chloro-4-phenylpiperidine 410 
 
General procedure B was followed, using 4-phenylpiperidine (190 mg, 1.18 mmol) and NCS 
(198 mg, 1.48 mmol). Purification by column chromatography, eluting with 10% EtOAc in 
hexane afforded the title compound (212 mg, 1.08 mmol, 92%) as a white solid. 
1H NMR (500 MHz, CDCl3) δ ppm 7.35 (2H, dd, J = 10.5, 4.5, 2 × ArCH), 7.28 – 7.21 (3H, 
m, 3 × ArCH), 3.60 (2H, d, J = 11.2, NCH2), 3.04 (2 H, t, J = 11.2, NCH2), 2.71 – 2.60 (1H, 
m, CH), 2.12 – 1.98 (2H, m, CH2CH), 1.92 (2 H, d, J = 13.1, CH2CH); 13C NMR (126 MHz, 
CDCl3) δ ppm 144.9 (Cq), 128.6 (2 × ArCH), 126.8 (2 × ArCH), 126.5 (ArCH), 63.4 (2 × 
NCH2), 41.2 (CH), 35.0 (2 × CH2CH); IR υmax (neat) / cm-1 3026, 2936, 2918, 2902, 2826, 
1493, 1468, 1451; HRMS (ESI+): C11H15ClN [M + H]+: calculated 196.0888, found 196.0890, 
∆ -1.3 ppm. 
 
Synthesis of 4-phenyl-1-(5,6,7,8-tetrahydronaphthalen-2-yl)piperidine 411 
 
To a stirred solution of the chloroamine 410 (100 mg, 0.51 mmol) in DCM (0.51 mL) at 0 oC 
was added tetralin (695 µL, 5.10 mmol) MeSO3H (330 µL, 5.10 mmol) and FeSO4.7H2O (14 
mg, 0.051). The RM was stirred at 0 oC for 1 h. The RM was basified using 2 M NaOH (pH 
9). The two phases were separated and the aqueous phase was extracted with DCM (3 × 15 
mL). The organic phases were combined, dried over MgSO4 and concentrated in vacuo. 
Purification by column chromatography, eluting with DCM in hexane afforded the title 
compound xx (39 mg, 0.13 mmol, 26%) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ ppm 7.38 – 7.15 (5H, m, 5 × ArCH), 6.97 (1H, d, J = 8.1, 
ArCH), 6.78 (1H, d, J = 8.1, ArCH), 6.70 (1H, s, ArCH), 3.72 (2H, d, J = 11.4, 2 × NCH2), 
2.79 – 2.66 (7H, m, includes CH, 2 × CbH2, 2 CH2CH), 1.92 (4 H, s, 2 × CHCH2), 1.77 (4H, s, 
J = 2.0, 2 × CaH2); 13C NMR (101 MHz, CDCl3) δ ppm 149.9 (Cq), 146.3 (Cq), 137.6 (Cq), 
129.7 (ArCH), 128.7 (Cq), 128.5 (2 × ArCH), 126.9 (2 × ArCH), 126.3 (ArCH), 117.4 (ArCH), 
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115.1 (ArCH), 51.3 (2 × NCH2), 42.6 (CH), 33.5 (2 × CH2CH), 29.9 (CbH2), 28.6 (CbH2), 23.6 
(CaH2), 23.4 (CaH2); IR υma× (neat) / cm-1 3058, 3025, 2923, 2852, 2798, 1736, 1681, 1609; 
LCMS C21H26N [M+H]+ calculated 292.2, measured 292.2. 
 
Synthesis of 412 
 
To a stirred solution of the chloroamine 410 (100 mg, 0.51 mmol) in DCM (0.45 mL) at 0 oC 
was added toluene (545 µL, 5.10 mmol) MeSO3H (330 µL, 5.10 mmol) and FeSO4.7H2O (14 
mg, 0.051). The RM was stirred at 0 oC for 1 h. The RM was basified using 2 M NaOH (pH 
9). The two phases were separated and the aqueous phase was extracted with DCM (3 × 15 
mL). The organic phases were combined, dried over MgSO4 and concentrated in vacuo. 
Purification by column chromatography, eluting with DCM in hexane afforded the title 
compound as inseperable regioisomers, o : m : p, 3.5 : 4.7 : 5.0 (39 mg, 0.14 mmol, 39%) as a 
colourless oil. All data reported as a mixture of the three regioisomers. 
1H NMR (400 MHz, CDCl3) δ ppm 7.30 – 7.10 (5H, m, 5 × ArCH), 7.09 – 7.04 (0.36H, m, 
ArCH, m), 7.02 – 6.99 (0.76H, m, 2 × ArCH, p), 6.85 – 6.82 (0.76H, m, 2 × ArCH, p), 6.78 – 
6.70 (1.5H, m,5H includes o and m ArCH), 6.67 (0.36H, dd, J = 8.8, 3.0, ArCH, m), 6.61 
(0.26H, d, J = 7.4, ArCH, o), 3.77 – 3.62 (2H, m, NCH2), 3.52 – 3.46 (2H, m, NCH2), 2.78 – 
2.49 (5H, m, include 2 × CH2CH and CH), 2.26 (0.78H, s, CH3, o), 2.25 (1.08H, s, CH3, m), 
2.20 (1.14H, s, CH3, p); 13C NMR (101 MHz, CDCl3) δ ppm 151.7 (Cq), 150.3 (Cq), 149.6 
(Cq), 144.9 (Cq), 136.3 (Cq), 136.1 (ArCH), 136.0 (Cq), 133.0 (ArCH), 129.7 (ArCH), 129.4 
(Cq), 129.0 (ArCH), 128.6 (2 × ArCH) 126.8 (2 × ArCH), 126.5 (ArCH), 120.6 (ArCH), 119.2 
(ArCH), 117.6 (ArCH), 117.1 (ArCH), 115.5 (ArCH), 113.8 (ArCH), 51 (2 × NCH2), 43.6 
(CH), 28.7 (ArCH3, o), 28.6 (ArCH3, m), 28.5 (ArCH3, p), 22.0 (2 × CH2CH) ; IR υmax (neat) / 
cm-1 3060, 3028, 2948, 2923, 2810, 2748, 1595, 1425; HRMS data could not be obtained 
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Synthesis of methyl (S)-2-(8-(4-benzoylpiperidin-1-yl)-5-chloro-6-methoxynaphthalen-2-
yl)propanoate 433a 
 
To a stirred solution of the chloroamine 401 (183 mg, 0.82 mmol) in DCM (0.45 mL) at 0 oC 
was added (2S)-2-(6-methoxynaphthalen-2-yl)propanoate (100 mg, 0.41 mmol) MeSO3H (535 
µL, 8.20 mmol) and FeSO4.7H2O (23 mg, 0.082 mmol). The RM was stirred at 0 oC for 1 h. 
The RM was basified using 2 M NaOH (pH 9). The two phases were separated and the aqueous 
phase was extracted with DCM (3 × 15 mL). The organic phases were combined, dried over 
MgSO4 and concentrated in vacuo. Purification by column chromatography, eluting with DCM 
in hexane afforded the title compound (40 mg, 0.09 mmol, 22%) as a colourless oil. 
1H NMR (400 MHz, CDCl3) δ ppm 8.17 (1H, d, J = 8.8, ArCH), 8.04 – 7.97 (3H, m, 3 × 
ArCH), 7.63 – 7.56 (1H, m, ArCH), 7.50 (3H, m, 3 × ArCH), 6.93 (1H, s, ArCH), 4.01 (3H, s, 
COOCH3), 3.95 – 3.86 (1H, m, CH3CH), 3.67 (3H, s, OCH3), 3.55-3.45 (3H, m, includes CH 
and NCH2), 2.95 (2 H, dd, J = 15.9, 6.9, NCH2), 2.27 – 2.05 (4H, m, 2 × NCH2CH2), 1.59 (3H, 
d, J = 7.2, CH3CH); 13C NMR (125 MHz, CDCl3) δ ppm 204.8 (CO), 177.9 (CO), 157.1 (Cq), 
144.1 (Cq), 140.6 (Cq), 136.5 (Cq), 131.2 (Cq), 128.8 (2 × ArCH), 127.4 (Cq), 127.3 (2 × ArCH), 
126.4 (ArCH), 125.1 (ArCH), 124.3 (ArCH), 124.1 (ArCH), 110.0 (Cq) 105.5 (ArCH), 54.6 
(OCH3), 45.6 (2 × NCH2CH2), 45.3 (COOCH3), 42.7 (CHCO), 41.0 (CH), 28.6 (2 × 
CH2CH2N), 17.4 (CHCH3); IR υmax (neat) / cm-1  3055, 2947, 2850, 2808, 1731, 1678, 1593, 
1461; HRMS (ESI+): C27H28ClNNaO4 [M + Na]+: calculated 488.1599, found 488.1597, ∆ = 
+0.5 ppm. 
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Synthesis of methyl (S)-2-(5-chloro-6-methoxy-8-(4-phenylpiperidin-1-yl)naphthalen-2-
yl)propanoate 433b 
 
To a stirred solution of the chloroamine 410 (160 mg, 0.82 mmol) in DCM (0.45 mL) at 0 oC 
was added (2S)-2-(6-methoxynaphthalen-2-yl)propanoate (100 mg, 0.41 mmol) MeSO3H (535 
µL, 8.20 mmol) and FeSO4.7H2O  (23 mg, 0.082). The RM was stirred at 0 oC for 1 h. The RM 
was basified using 2 M NaOH (pH 9). The two phases were separated and the aqueous phase 
was e×tracted with DCM (3 × 15 mL). The organic phases were combined, dried over MgSO4 
and concentrated in vacuo. Purification by column chromatography, eluting with DCM in 
hexane afforded the title compound (36 mg, 0.09, 22%) 
1H NMR (400 MHz, CDCl3) δ ppm 7.99 (1H, d, J = 1.7, ArCH), 7.94 (1H, d, J = 8.7, ArCH), 
7.44 (1H, dd, J = 8.7, 1.7, ArCH), 7.33 – 7.25 (4H, m, ArCH), 7.21 – 7.15 (1H, m, ArCH), 
6.83 (1H, s, ArCH), 3.95 (3H, s, COOCH3), 3.91 – 3.78 (1H, m, CH3CH), 3.60 (3H, s, OCH3), 
3.50 – 3.37 (2H, m, CH2), 2.85 – 2.59 (3H, m, includes CH, CH2), 2.13 – 1.90 (4H, m, 2 × 
CHCH2), 1.54 (3H, d, J = 7.2, CH3CH); 13C NMR (126 MHz, CDCl3) δ ppm 175.0 (CO), 149.4 
(Cq), 145.9 (Cq), 137.4 (Cq), 135.8 (Cq), 131.0 (Cq), 128.8 (2 × ArCH), 127.4 (Cq), 127.0 (2 × 
ArCH), 126.4 (ArCH), 125.1 (ArCH), 123.7 (ArCH), 123.0 (ArCH), 112.4 (Cq) 106.5 (ArCH), 
54.5 (OCH3), 52.1 (2 × NCH2),  45.5 (2 × NCH2CH2), 45.3 (COOCH3), 42.5 (CHCO), 41.9 
(CH) 33.6 (2 x CH2CH2N), 17.8 (CH3CH);  IR υma× (neat) / cm-1 3060, 3027, 2977, 2934, 2847, 
1733, 1599, 1574; HRMS (ESI+): C26H2935ClO3 [M + H]+: calculated 438.1689, found 
438.1690, ∆ = +0.5 ppm. 
 
Synthesis of 4-methoxy-N-methylaniline 439 
 
General procedure H was followed, using anisole (1.14 mL, 10.5 mmol), MeNHOH.HCl (2.54 
g, 30.5 mmol), FeCl2 (67 mg, 0.53 mmol) and FeCl3 (1.70 g, 10.5 mmol). Purification by 
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column chromatography, eluting with 20% EtOAc in hexane afforded the title compound (580 
mg, 4.23 mmol, 40%) as a colourless oil. The NMR data is in accordace with the literature.138 
1H NMR (300 MHz, CDCl3) δ ppm 6.82 (2H, d, J = 8.9, 2 × ArCH), 6.62 (2H, d, J = 8.9, 2 × 
ArCH), 3.77 (3H, s, CH3), 2.83 (3H, s, CH3); 13C NMR (75 MHz, CDCl3) δ ppm 152.6 (Cq), 
142.8 (Cq), 115.0 (2 × ArCH), 114.3 (2 × ArCH), 55.9 (OCH3), 32.1 (NHCH3); IR υmax (neat) 
/ cm-1 3042, 2989, 2934, 2899, 2831, 2809, 1509, 1464; HRMS (ESI+): C8H12NO [M + H]+: 
calculated 138.0913, found 138.0911, ∆ = +2.0 ppm. 
 
Synthesis of N-methyl-5,6,7,8-tetrahydronaphthalen-2-amine 442 
 
General procedure x was followed, using tetralin (100 mg, 0.76 mmol), MeNHOH.HCl (381 
mg, 4.56 mmol), FeCl2 (5 mg, 0.058 mmol) and FeCl3 (123 mg, 0.76 mmol). Purification by 
column chromatography, eluting with 20% EtOAc in hexane afforded the title compound (30 
mg, 0.19 mmol, 25%) as a colourless oil. 
1H NMR (300 MHz, CDCl3) δ ppm 6.82 (1H, d, J = 8.2, ArCH), 6.36 (1H, dd, J = 8.2, 2.6, 
ArCH), 6.27 (1H, d, J = 2.6, ArCH), 2.74 (3H, s, NHCH3), 2.66 – 2.55 (4H, m, 2 × CbH2), 1.72 
– 1.65 (4H, m, 2 × CaH2); 13C NMR (101 MHz, CDCl3) δ ppm 150.0 (ArCH), 136.4 (Cq), 126.1 
(ArCH), 120.8 (Cq), 118.9 (Cq), 106.5 (ArCH), 30.6 (CH3), 27.4 (ArCH2), 24.2 (ArCH2), 22.5 
(CH2), 22.3 (CH2); IR υmax (neat) / cm-1  3430, 2927, 2858, 2825, 1590, 1512, 1448, 1435; 
HRMS (ESI+): C11H16N [M+H]+: calculated 162.1278, found 162.1271, ∆ = 3.6ppm. 
 
Synthesis of 4,4'-di-N-methylbiphenyl 443 
 
General procedure x was followed, using biphenyl (100 mg, 0.65 mmol), MeNHOH.HCl (326 
mg, 3.90 mmol), FeCl2 (7 mg, 0.033 mmol) and FeCl3 (105 mg, 0.65 mmol). Purification by 
column chromatography, eluting with 20% EtOAc in hexane afforded the title compound (15 
mg, 0.071 mmol, 11%) as a colourless oil. The NMR data is in accordance with the literature.139 
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1H NMR (300 MHz, CDCl3) δ ppm 7.60 – 7.54 (2H, m, 2 × ArCH), 7.49 (2H, d, J = 8.6, 2 × 
ArCH), 7.46 – 7.38 (2H, m, 2 × ArCH), 7.32 – 7.23 (1H, m, ArCH), 6.72 (2H, d, J = 8.6, 2 × 
ArCH), 2.91 (3H, s, CH3); 13C NMR (101 MHz, CDCl3) δ ppm 148.8 (Cq), 141.3 (Cq), 130.2 
(Cq), 128.7 (2 × ArCH), 127.9 (2 × ArCH), 126.3 (2 × ArCH), 126.1 (ArCH), 112.7 (2 × ArCH), 
30.8 (CH3); IR υmaX (neat) / cm-1  3414, 3054, 3022, 2926, 2812, 1609, 1524, 1489; HRMS 
(ESI+): C13H14N [M+H]+: calculated 184.1121, found 184.1119, ∆ = 1.2ppm. 
 
Synthesis of 2-methoxy-N-methylnaphthalen-1-amine 444 
 
General procedure x was followed, using 2-methoxynapthlene (100 mg, 0.63 mmol), 
MeNHOH.HCl (316 mg, 3.78 mmol), FeCl2 (6 mg, 0.032 mmol) and FeCl3 (102 mg, 0.63 
mmol). Purification by column chromatography, eluting with 20% EtOAc in hexane afforded 
the title compound (10 mg, 0.053 mmol, 8%) as a colourless oil. 
1H NMR (300 MHz, CDCl3) δ  ppm 8.11 (1H, d, J = 8.5, ArCH), 7.79 (1H, d, J = 8.5, ArCH), 
7.52 (1H, d, J = 8.9, ArCH), 7.47 (1H, ddd, J = 8.5, 6.8, 1.3, ArCH), 7.35 (1H, ddd, J = 8.5, 
6.8, 1.3, ArCH), 7.28 (1H, d, J = 8.9, ArCH), 3.98 (3H, s, OCH3), 3.00 (3H, s, NHCH3); 13C 
NMR (75 MHz, CDCl3) δ ppm 148.4 (Cq), 129.7 (Cq), 128.4 (2 × ArCH), 127.8 (Cq), 126.4 
(ArCH), 125.2 (Cq), 124.0 (ArCH), 122.3 (ArCH), 113.4 (ArCH), 57.0 (OCH3), 37.1 (NHCH3); 
IR υmax (neat) / cm-1 3364, 3053, 2937, 2837, 1639, 1594, 1574, 1512; HRMS (ESI+): 
C12H14NO [M+H]+: calculated 188.1070, found 184.1067, ∆ = 1.6ppm. 
 
Synthesis of methyl 2-(6-methoxy-5-(methylamino)naphthalen-2-yl)propanoate 445 
 
General procedure x was followed, using naproxen methyl ester (100 mg, 0.41 mmol), 
MeNHOH.HCl (205 mg, 2.46 mmol), FeCl2 (3 mg, 0.021 mmol) and FeCl3 (67 mg, 0.41 
mmol). Purification by column chromatography, eluting with 15% EtOAc in hexane afforded 
the title compound (14 mg, 0.05 mmol, 13%) as a colourless oil. 
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1H NMR (300 MHz, CDCl3) δ ppm 7.97 (1H, d, J = 8.8, ArCH), 7.58 (1H, d, J = 1.8, ArCH), 
7.39 (1H, d, J = 8.9, ArCH), 7.32 (1H, dd, J = 8.8, 1.8, ArCH), 7.17 (1H, d, J = 8.9, ArCH), 
3.91 – 3.83 (4H, m, includes OCH3 and CH), 3.60 (3H, s, OCH3). 2.90 (3H, s, NHCH3), 1.51 
(3H, d, J = 7.2, CHCH3); 13C NMR (75 MHz, CDCl3) δ ppm 175.1 (CO), 147.6 (Cq), 135.7 
(Cq), 133.5 (Cq), 130.0 (Cq), 127.3 (Cq), 126.5 (ArCH), 125.3 (ArCH), 123.4 (ArCH), 122.6 
(ArCH), 113.9 (ArCH), 56.9 (OCH3), 52.1 (COOCH3), 45.3 (CHCH3), 37.2 (NHCH3), 18.5 
(CH3); IR υmax (neat) / cm-1 3365, 2975, 2946, 2839, 1730, 1653, 1599, 1573; HRMS (ESI+): 
C16H19NNaO3 [M+Na]+: calculated 296.1257, found 296.1252, ∆ = 1.7ppm. 
 
Synthesis of methyl 2-((N,4-dimethylphenyl)sulfonamido)-3-(4-methoxy-3-
(methylamino)phenyl)propanoate 446 
 
General procedure H was followed, using protected tyrosine (100 mg, 0.26 mmol), 
MeNHOH.HCl (108 mg, 1.56 mmol), FeCl2 (2 mg, 0.013 mmol) and FeCl3 (42 mg, 0.26 
mmol). Purification by column chromatography, eluting with 20% EtOAc in hexane afforded 
the title compound (23 mg, 0.057 mmol, 22%) as a colourless oil. 
1H NMR (300 MHz, CDCl3) δ  ppm 7.38 (2H, d, J = 8.3 Hz, 2 × ArCH), 7.08 (2H, d, J = 8.3 
Hz, 2 × ArCH), 6.54 (1H, d, J = 8.0, ArCH), 6.35 (1H, dd, J = 8.0, 2.0, ArCH), 6.25 (1H, d, J 
= 2.0, ArCH), 4.83 (1H, dd, J = 8.6, 7.0, CH), 3.75 (3H, s, OCH3), 3.48 (3H, s, COOCH3), 3.07 
(1H, dd, J = 14.0, 7.0, CH2), 2.81 (3H, s, NCH3), 2.72 (3H, s, NHCH3), 2.71 – 2.62 (1H, m, 
CH2),  2.31 (3H, s, ArCH3); 13C NMR (75 MHz, CDCl3) δ ppm 171.0 (CO), 146.0 (Cq), 143.0 
(Cq), 139.2 (Cq), 136.2 (Cq), 129.2 (2 × ArCH), 129.1 (Cq), 127.3 (2 × ArCH), 116.7 (ArCH), 
110.0 (ArCH), 109.1 (ArCH), 60.5 (CHCO), 55.5 (OCH3), 52.0 (OCH3), 35.5 (CH2), 30.4 
(NCH3), 30.1 (NCH3), 21.5 (ArCH3); IR υmax (neat) / cm-1 3432, 2950, 2923, 2852, 1737, 1599, 
1523, 1449; HRMS (ESI+): C20H26N2NaO5S [M+Na]+: calculated 429.1455, found 492.1451, 
∆ = 0.9ppm. 
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Synthesis of N-benzyl-4-methoxyaniline 448 
 
General procedure H was followed, using anisole (100 mg, 0.92 mmol), N-
benzylhydroxylamine.HCl (881 mg, 5.52 mmol), FeCl2 (6 mg, 0.050 mmol) and FeCl3 (149 
mg, 0.92 mmol). Purification by column chromatography, eluting with 20% EtOAc in hexane 
afforded the title compound (30 mg, 0.14 mmol, 21%) as a colourless oil. The NMR data is in 
accordance with the literature.140 
1H NMR (300 MHz, CDCl3) δ ppm 7.48 – 7.21 (5H, m, 5 × ArCH), 6.81 (2H, d, J = 9.0, 2 × 
ArCH), 6.64 (2H, d, J = 9.0, 2 × ArCH), 4.32 (2H, s, CH2), 3.77 (3H, s, CH3); 13C NMR (101 
MHz, CDCl3) δ ppm 152.2 (Cq), 142.5 (Cq), 139.7 (Cq), 128.6 (2 × ArCH), 128.0 (2 × ArCH), 
127.0 (ArCH), 115.0 (2 × ArCH), 114.2 (2 × ArCH), 55.9 (OCH3), 49.3 (NHCH3); IR υmax 
(neat) / cm-1 3408, 3061, 3028, 2996, 2931, 2904, 2831, 1509; HRMS (ESI+): C14H16NO [M 
+ H]+: calculated 214.1226, found 214.1226, ∆ = 0.1 ppm. 
 
Synthesis of N-cyclohexyl-4-methoxyaniline 450 
 
General procedure H was followed, using anisole (118 µL, 1.09 mmol), N-
cyclohydroxylamine.HCl (992 mg, 6.54 mmol), FeCl2 (7 mg, 0.055 mmol) and FeCl3 (177 mg, 
1.09 mmol). Purification by column chromatography, eluting with 20% EtOAc in hexane 
afforded the title compound (65 mg, 0.32 mmol, 29%) as a colourless oil. The NMR data is in 
accordance with the literature.141 
1H NMR (300 MHz, CDCl3) δ ppm 6.79 (2H, d, J = 8.9, 2 × ArCH), 6.59 (2H, d, J = 8.9, 2 × 
ArCH), 3.76 (3H, s, CH3), 3.18 (1H, m, CH), 2.14 – 2.00 (2H, m, CH2), 1.87 – 1.72 (2H, m, 
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CH2), 1.72 – 1.56 (1H, m, 1H of CH2), 1.51 – 1.02 (5H, m, 2 × CH2 and 1H of CH2); 13C NMR 
(101 MHz, CDCl3) δ ppm 151.9 (Cq), 141.6 (Cq), 114.9 (2 × ArCH), 114.9 (2 × ArCH), 55.9 
(OCH3), 52.9 (NCH), 33.6 (2 × CH2), 26.0 (CH2), 25.1 (2 × CH2); IR υmax (neat) / cm-1 3389, 
2989, 2993, 2926, 2851, 2831, 1509, 1450; HRMS (ESI+): C13H20NO [M + H]+: calculated 
206.1539, found 206.1544, ∆ = -2.2 ppm. 
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